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SUMMARY 
The  sequence  of  loss  of  the  immunological  and  patho- 
physiological  activities  of  Bordetella  pertussis  during 
the  process  of  antigenic  modulation  in  liquid  medium  was 
investigated.  Modified  Hornibrook  medium  and  Stainer  and 
Scholte  medium  were  used.  Modulation  was  induced  by  growth 
of  cells  in  the  presence  of  high  levels  of  magnesium  sulphate 
and  low  levels  of  sodium  chloride;  cells-grown  in  normal 
media  containing  high  levels  of  sodium  chloride  and  low 
levels  of  magnesium  sulphate  served  as  controls.  The 
levels  of  the  various  activities  present  in  the  cultures 
and  distributed  between  cells  and  culture  supernatant  were 
determined  at  intervals. 
The  leukocytosis-promoting  activity  was  found  to  be 
lost  during  modulation  along  with  other  activities  previously 
reported.  An  assay  method  for  the  quantitation  of  LPF 
potency  was  developed. 
Modulation  occurred  within  1Oh  of  inoculation  of  X-mode 
cells  into  C-medium,  and  required  about  to  2  cell  divisions 
during  which  about  80%  to  98%  of  each  of  the  various  activities 
of  the  X-mode  was  lost. 
The  various  activities  appeared  to  be  lost  at  different 
rates.  The  mouse  protective  activity  and  the  haemagglutinating 
activity  were  lost  more  rapidly  than  the  histamine-sensitizing 
and  leukocytosis-promoting  activities;  the  heat-labile 
toxicity  was  lost  at  a  slower  rate.  Loss  of  X-specific 
surface  agglutinogens  was  shown  but  there  appeared  to  be  no III 
change  in  the  lipopolysaccharide  component  of  the  cells. 
Electrophoretic  analysis  of  cell,,  -  proteins  revealed 
that  2$k,  30k  and  100k  cmol,.  LCwt_'.  polypeptide  bands  in  the 
X-mode  cells  were  absent  or  greatly  reduced  in  the  C-mode 
cells  after  24h  of  growth.  There  was  some  evidence  that 
no  further  synthesis  of  these  polypeptides  occurred  after 
transfer  of  X-mode  cells  into  C-medium. 
The  loss  of  activities  in  C-mode  cells  appeared  to 
be  due  not  only  to  the  dilution  of  the  activities  among 
progeny  cells  and  to  liberation  of  cell  components  into 
the  culture  medium  but  also  to  the  denaturation  or 
degradation  of  these  components. 
Cells  grown  in  media  without  added  sodium  chloride 
or  magnesium  sulphate  also  showed  decrease  in  histamine- 
sensitizing  activity  but  nQt  to  the  same  extent  as  cells 
grown  in  C-medium. 
Results  from  this  investigation  support  the  view  that 
at  least  four  distinct  cellular  components  are  lost 
during  modulation,  namely,  (1)  a  protective  antigen/ 
haemagglutinin  component,  (2)  the  histamine-sensitizing  and 
leukocytosis-promoting  component  (3)  the  heat-labile  toxin 
and  (4)  adenylate  cyclase. 
It  is  proposed  that  cyclic  AMP  may  be  involved  in 
the  control  of  the'synthesis  of  components  responsible 
for  the  various  activities  of  B.  pertussis.  The  level 
of  cyclic  AMP  increased  in  parallel  with  cell  numbers  in 
X-mode  cultures  and  was  not  detectable  in  C-mode  cultures. IV 
Modulation  was  shown  to  be  a  freely  reversible  process  and 
when  cyclic  AMP  formation  was  enhanced  in  reverting  cells, 
the  regeneration  of  the  various  activities  also  appeared 
to  be  enhanced. V.  .1 
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SECTION  1:  TAXONOMY  OF  BORDETELLA 
PERTUSSIS 
Bordetella  pertussis  belongs  to  the  family  Brucellaceae 
of  the  order  Eubacteriales  (Pittman,  1957). 
The  genus  Bordetella  is  divided  into  three  species  : 
the  non-motile  B.  pertussis  and  B.  parapertussis  and  the 
motile  B.  bronchiseptica.  These  are  minute  Gram-negative 
coccobacilli;  all  are  haemolytic;  carbohydrates  are  not 
fermented;  litmus  milk  is  not  made  alkaline  and  dermonecrotic 
toxin  is  produced. 
B.  pertussis,  the  whooping-cough  bacillus,  was  originally 
listed  in  the  genus  Haemophilus  in  an  early  generic  arrangement 
of  bacteria  by  the  Committee  of  the  Society  of  American 
Bacteriologists  (Winslow,  Broadhurst,  Buchanan,  Krumwiede, 
Rogers  and  Smith,  1920).  At  that  time  blood  was  considered 
necessary  for  the  cultivation  of  the  organism.  The 
parapertussis  bacillus  was  placed  in  the  same  genus  (Bradford 
and  Slavin,  1937;  and  Eldering  and  Kendrick,  1938).  This 
organism  causes  about  5%  and  sometimes  up  to  20%  to  30%  of 
the  reported  cases  of  whooping-cough  in  the  United  States  and 
Europe  (Eldering  and  Kendrick,  1952;  Lautrop,  1971;  Borska 
and  Simkovicova,  1972  and  Linnemann  and  Perry,  1977). 
Bor,  de"tella  bronchiseptica  which  occurs  frequently  in  the 
respiratory  tract  of  rabbits,  guinea-pigs,  dogs  and  cats 
was  isolated  from  a  case  of  whooping-cough  by  Brown  in  1926 
(Medical  Research  Council,  1951),  having  previously  been 
isolated  from  dogs  (Ferry,  1911).  Since  then  classification 2. 
of  this  organism  has  been  in  the  genera  Alcaligenes,  Brucelia 
and  Haemophilus  (Bergey's  Manual  of  Determinative  Bacteriology 
eighth  edition,  1974). 
Andersen  (1953)  showed  that  the  three  organisms, 
Haemophilus  Pertussis,  Bacillus  parapertussis  and  Brucella 
bronchiseptica  had  a  number  of  features  in  common  and 
believed  that  they  represented  closely  related  members  of 
the  same  bacterial  group.  It  was  Moreno-Lopez  (1952) 
who  first  proposed  the  generic  term  Bordetella  for  this 
group  of  organisms  and  re-named  the  organisms  Bordetella 
pertussis,  Bordetella  parapertussis  and  Bordetella 
bronchiseptica.  This  proposal  was  supported  by  the 
findings  of  later  workers  (Kendrick,  Nadolski,  Eldering 
and  Baker,  1953;  Proom,  1955;  and  Pittman,  1955).  The 
proposal  was  accepted  and  the  new  genus,  Bordetella,  was 
included  in  the  seventh  and  eighth  editions  of  Bergey's 
Manual  of  Determinative  Bacteriology. 
Table  1  summarizes  the  most  important  differential 
characters  of  the  three  Bordetella  species. 
SECTION  2:  NATURAL  HISTORY  OF 
WHOOPING-COUGH 
Whooping-cough,  or  pertussis,  is  an  acute  communicable 
disease,  characterized  by  spasmodic  attacks  of  coughing 
that  are  accompanied  by  an  inspiratory  whoop;  there  is 
lymphocytosis  and  sometimes  a  neurological  complication. 
According  to  Lapin  (1943),  the  disease  was  first  described 3 
Table  1:  Differential  characteristics  of 
the  three  Bordetella  species 
** 
Characters  B.  pertussis  B.  parapertussis  B.  bronchiseptica 
Flagella  -  -  + 
Reduction  of  -  -  + 
nitrates 
Utilization  of  -  +  + 
citrate 
Urease  -  +  + 
(in  4h) 
Oxidase  +  -  + 
Catalase  +  or  -*  +  + 
Growth  on  peptone  agar 
-  growth  -  +  + 
-  tgrowning  of  agar  -  +  - 
Sensitization  of  mice  +  -  -  to  histamine 
Specific  heat-labile 
agglutinogens 
-  factor  1  +  -  - 
-  factor  12  -  -  + 
-  factor  1lß  -  +  - 
G+C  content 
moles  %  61  61  66 
**  Data  selected  from  Lautrop  (1960)  and  Pittman  (1974). 
*  70%  of  freshly  isolated  strains  are  positive. TEXT  CUT 
OFF  IN 
ORIGINAL 4 
in  1578  by  Baillou  and  epidemics  in  England  between  1670 
and  1680  were  described  by  Sydenham. 
The  organism  causing  pertussis  was  first  observed  and 
isolated  in  1906  by  Bordet  and  Gengou  who  named  the  Gram- 
negative  coccobacillus  "le  microbe  de  la  coqueluche". 
The  aetiology  of  the  disease  was  confirmed  in  1933  by  the 
MacDonalds  who  inoculated  their  own  children  with  a  fresh 
isolate  of  the  organism.  (MacDonald  and  MacDonald,  1933). 
Pertussis  is  non-invasive  and  in  a  typical  case,  there 
is  an  incubation  period  of  seven  to  fourteen  days,  followed 
by  three  main  stages  :  the  catarrhal,  the  spasmodic  and 
the  convalescent  (Bradford,  1959).  Usually,  the  catarrhal 
stage  lasts  from  one  to  two  weeks  and  is  accompanied  by  a 
low  grade  fever  and  a  mild  cough  often  starting  at  night  and 
becoming  progressively  more  intense  and  diurnal.  The 
paroxysms  may  vary  in  number  from  a  few  to  20  or  more  per 
day.  A  severe  paroxysm  may  last  for  5-10  minutes, 
vomiting  is  frequent  and  convulsions  and  exhaustion  may 
follow  bouts  of  violent  coughing.  Occasionally,  toxic 
encephalitis  occurs,  but  the  most  frequent  cause  of  death 
is  secondary  infection.  At  about  the  fourth  week,  the 
number  and  severity  of  the  paroxysms  decrease  and  the 
convalescent  period  begins.  Full  recovery  from  the 
infection  can  take  up  to  several  months  (Bradford,  1957; 
Lorber,  1975). 
Pertussis  is  widely  distributed  throughout  the  world, 
especially  in  highly  populated  and  underdeveloped  countries 
(Table  2).  The  infection  can  occur  in  any  age  group 5 
Table  2:  Incidence  of  pertussis  in 
selected  countries 
Country  No.  of  reported  cases 
1973*  1974*  1975+  1976** 
Europe 
United  Kingdom 
Denmark 
France 
Italy 
Americas 
U.  S.  A. 
Argentina 
Venezuela 
Africa 
Senegal 
Algeria 
Zaire 
Asia  : 
Phillippines 
Japan 
Thailand 
Oceania 
2398  15,998 
560  326 
12,084  8198 
-  1758 
29,604  23,733 
16,726  9562 
20,359  31,867 
21,826  28,595 
20,570 
Fiji  - 
New  Hebrides  508 
Selected  sta 
*  World  Health  Statistics 
+  World  Health  Statistics 
**  World  Health  Statistic 
9978 
1457 
367 
10,397 
1583 
11,169 
9622 
1379 
>19,000 
1052 
2846 
4369 
16,385 
353 
19,246 
927 
44,195 
92  04 
2862 
18,975 
2471 
1980 
154 
tistics  from  : 
Reports  (1975 
Report  (1976) 
Report  (1977) 
7  28 
52  30 
28 
29,416-419 
30,360-364 6 
(Bradford,  1959;  Linnemann  and  Nasenbury,  1977)  but  is 
most  common,  most  severe  and  has  highest  mortality  rates 
in  infants  up  to  one  year  old  or  less  (Bradford,  1957; 
Lorber,  1975;  Kendrick,  1975).  The  disease  occurs  at 
all  times  of  the  year  with  a  peak  incidence  during  the 
winter  months.  Pertussis  has  no  natural  animal  reservoir 
and  no  healthy  carriers  (Wilson  and  Miles,  1975).  It  is 
highly  communicable,  being  transmitted  directly  by  droplets 
from  coughing  or  sneezing  and  the  most  infectious  period 
is  during  the  catarrhal  or  early  paroxysmal  stages. 
After  household  exposure  practically  all  unimmunized 
contacts  acquire  the  disease.  Attack  rates  of  70%  of  all 
children  in  unvaccinated  urban  communities  and  80%  to  90% 
of  children  exposed  to  pertussis  at  home  have  been  reported 
(Medical  Research  Council,  1951;  Joint  Committee  on 
Vaccination  and  Immunization,  1977). 
Little  is  known  of  the  pathology  of  pertussis  infection 
other  than  that  the  organisms  localize  and  multiply  among 
the  cilia  of  the  epithelium  of  the  respiratory  tract.  The 
multiplying  bacteria,  without  invasion  of  the  underlying 
tissues  induce  clinical  symptoms  and  pathology  of  the 
disease  which  include  lymphocyte  infiltration  of  the 
peribronchial  tissues  and  alveolar  walls.  (Pittman,  1970). 
B.  pertussis  is  sensitive  in  vitro  to  several  antibiotics 
(Bass,  K1enk,  Kotheimer,  Linnemann  and  Smith,  1969)  but 
antibiotic  treatment  has  been  of  little  or  no  value  in 
altering  either  the  course  or  the  morbidity  of  the  disease 7 
unless  started  before  the  paroxysmal  stage  (M.  R.  C.  1953; 
Pittman,  1970;  Olson  , 
1975).  However,  some  antibiotics 
notably  erythromycin  and  co-trimoxazole  may  be  prophylactically 
beneficial  to  children  in  a  household  where  whooping-cough 
has  been  confirmed  (Bass.  et  äl,,,  ß  196eck  Adcock,  et  ,  al.  , 
1972; 
Alterier  and  Ayoub,  1977;  Arneil  and  McAllister,  1977; 
Cullen  and  Cullen,  1978).  Chloramphenicol,  erythromycin, 
tetracycline  or  ampicillin  can  be  used  to  control  secondary 
infections  during  whooping-cough  (Pittman,  1970;  Lorber, 
1975). 
An  attack  of  whooping-cough  usually  results  in  good 
immunity  to  the  disease,  although  there  have  been  a  few 
reports  of  second  attacks  (Standfast,  1969).  The  basis 
of  immunity  in  pertussis  is  not  well  understood.  There  is 
some  evidence  suggesting  that  immunity  may  not  be  mediated 
by  serum  antibodies  (Martin,  1958;  Butler,  Wilson,  Bensen, 
Dudgeon,  Ungar  and  Beale,  1962;  Brown,  Volk,  Gottshall, 
Kendrick  and  Andersen,  1964).  There  is  also  a  suggestion 
that  secretory  antibodies  may  be  involved  (Geller  and  Pittman, 
1973).  Pertussis  immune  globulin  (human)  hasubeen,  'used  for 
passive  immunization  of  children  exposed  to  pertussis 
infection  but  opinion  varies  as  to  its  efficacy  (Kabat, 
1963;  Balagtas,  Nelson,  Levine  and  Gotoff,  1971). 
Immunity  to  pertussis,  either  from  infection  or  active 
immunization,  lasts  for  only  a  few  years  (Pittman,  1970) 
and  there  is  no  passive  transfer  of  immunity  from  mother 
to  foetus  (Lorber,  1975). SECTION  3:  PERTUSSIS  VACCINE 
AND  VACCINATION 
Since  an  attack  of  whooping-cough  usually  results  in 
a  good  immunity  to  the  disease,  it  was  reasonable  therefore, 
to  expect  that  some  kind  of  bacterial  vaccine  might  be 
effective  in  prophylaxis  of  the  disease.  Indeed  many 
attempts  dating  back  to  1914  have  been  made  to  achieve  active 
immunization  against  pertussis  (Ungar,  1963).  Zachariassen 
quoted  by  Madsen,  (1933)  was  the  first  to  demonstrate  a 
degree  of  protection  from  a  plain  vaccine  given  shortly 
before  an  epidemic  of  whooping-cough  in  the  Faroe  islands 
where  only  67.5%  of  the  vaccinated  children  contracted  the 
disease  compared  with  98.2%  in  the  unvaccinated  group. 
The  first  well  controlled  field  trial  in  America  was  by 
Kendrick  and  Fldering  (1939)  who  reported  approximately  90% 
protection  in  school  exposures  and  60%  in  home  exposure  in 
vaccinated  children  compared  with  unvaccinated  controls. 
Similar  field  trials  were  organised  by  the  Medical  Research 
Council  in  Britain  from  1942-1944  but  these  were  unsuccessful 
(MoFarlan,  Topley  and  Fisher,  1945).  However,  in  a  later 
series  of  well  organized  field  trials  in  Britain,  some 
vaccineswere  found  to  be  highly  effective  and  others  of 
relatively  low  efficacy.  Also  there  was  a  high  degree  of 
correlation  between  the  results  of  mouse-protection  tests 
and  the  protective  power  of  vaccines  in  the  field  (M.  R.  C., 
1951;  1956(a);  1956(b);  1959).  From  1959,  the 
intracerebral  mouse-protection  test  of  Kendrick  et  al., 
(1947)  became  a  standard  procedure  in  the  control  laboratory. 9 
By  1964,  this  test  was  recommended  by  World  Health 
Organization  as  the  standard  assay  of  vaccine  protective 
potency  prior  to  release  (W.  H.  O.,  1964).  As  a  result  of 
the  success  of  the  M.  R.  C.  field  trials,  pertussis  vaccine, 
consisting  of  inactivated  whole  cells  of  B.  pertussis 
combined  with  diphtheria  and  later  tetanus  toxoids,  was 
introduced  on  a  national  scale  in  Britain  in  1957  (Joint 
Committee  on  Vaccination  and  Immunization,  1977).  In 
Canada,  the  vaccine  had  been  in  general  use  since  1943 
(Wilson,  1945). 
After  the  introduction  of  a  nation-wide  immunization 
programme  in  Britain,  there  was  a  rapid  drop  in  the 
incidence  of  pertussis  (Cohen,  1963;  Warin,  1968; 
Miller  et  al.,  1974).  The  figures  for  the  notifications 
and  deaths  due  to  pertussis  in  England  and  Wales  from  1940- 
1975  are  shown  in  Figure  1.  In  the  1960's  however,  the 
rate  of  drop  in  incidence  of  pertussis  slackened  and 
scattered  outbreaks  of  the  disease  appeared  in  vaccinated 
children.  Doubts  about  the  efficacy  of  pertussis  vaccine 
were  raised  when  the  Public  Health  Laboratory  Service, 
(P.  H.  L.  S.  ),  reported  that  56%  of  fully  vaccinated  children 
contracted  pertussis  following  home  exposure  during  the 
1963-1964  epidemics.  This  report  led  Preston  (1963;  1965) 
to  examine  freshly  isolated  strains  of  B.  Pertussis  from 
cases  of  whooping-cough.  He  reported  a  change  in  the 
prevalent  serotypes  from  types  1,2  and  1,2,3  common 
before  1958  to  type  1,3  strains  which  were  dominant  in 
1963-1964.  Preston's  work,  later  confirmed  by  the  P.  H.  L.  S. 10 
Figure  1  Whooping-cough.  Notifications 
and  deaths  in  England  and  Wales 
from  1940  -  1975. 
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(PHLS,  1973),  showed  that  the  vaccines  in  use  then  lacked 
antigen  3  and  thus  the  change  in  the  serotypic  composition 
of  the  prevalent  bacteria  might  have  accounted  for  the 
reduction  in  the  efficacy  of  the  vaccine  from  1963-1968. 
Other  reasons  offered  for  the  increase  in  the  incidence  of 
pertussis  at  that  time  were  that  some  of  the  vaccines 
in  distribution  were  prepared  according  to  the  British 
standard  which  contained  a  mouse  protective  potency  of  2 
International  units  per  human  dose  as  compared  to  the 
International  standard  with  4  International  units  per  human 
dose.  Also  adjuvant  was  omitted  from  the  British  vaccines 
in  the  1960's  because  of  the  danger  of  provoking  polio- 
myelitis.  Based  on  these  observations,  the  following 
changes  were  recommended  for  the  British  vaccines  in  1967:  - 
1)  raising  the  mouse  potency  requirement  from  2  I.  U.  'to  4  I.  U. 
2)  reintroduction  of  adjuvant  and 
3)  inclusion  of  antigen  3. 
Preston  and  Stanbridge  (1972)  analysed  the  efficacy  of  these 
new  vaccines  over  the  period  1969-1971  and  concluded  that  a 
much  better  degree  of  protection  was  attained.  Thus,  despite 
minor  setbacks,  the  incidence  of  the  disease  in  Britain  has 
fallen  by  about  98%  since  the  nationwide  campaign  started, 
and  at  a  rate  that  probably  cannot  be  accounted  for  by 
natural  trends  e.  g.  changes  in  socio-economic  conditions, 
general  hygiene  etc.  (Perkins,  1970;  Miller  et  al.,  1974). 12 
SECTION  4:  CULTURAL  AND  BIO- 
CHEMICAL  CHARACTERISTICS 
OF  BORDETELLA  PERTUSSIS 
Since  B.  pertussis  was  first  described  by  Bordet  in 
1900,  many  attempts  have  been  made  to  develop  a  suitable 
medium  for  the  isolation  and  growth  of  the  organism.  The 
initial  problem  was  that  B.  pertussis  was  originally  thought 
to  have  complex  growth  requirements.  However,  later  workers 
showed  that  the  organism  has  simple  growth  requirements  and 
that  the  initial  problems  were  due  to  inhibitors  in  the 
media.  These  inhibitors  can  now  be  removed  or  inactivated 
in  various  ways.  There  was  also  the  problem  of  some  media 
not  being  able  to  support  growth  from  small  inocula.  Most 
earlier  media  needed  a 
, 
large  inoculum  to  initiate  growth. 
Bordet  and  Gengou  (1906)  isolated  B,  pertussis  on  a 
solid  medium  containing  glycerinated-potato  extract  and 
50%  (v/v)  whole  human  or  rabbit  blood.  Despite  many 
subsequent  attempts  to  eliminate  the  blood  (Krumwiede 
et  al.,  1923;  Povitsky,  1923;  Silverthorne  and  Cameron, 
1942),  it  appeared  to  be  essential  for  the  growth  of 
Phase  I  organisms,  and  seemed  to  indicate  a  complex  set  of 
growth  requirements  for  B.  pertussis. 
Hornibrook  (1939)  was  the  first  to  grow  the  organism 
successfully  in  a  liquid  medium  without  blood.  His  medium 
consisted  originally  of  hydrolysed  casein,  soluble  starch, 
salts,  cysteine  and  yeast  extract.  Later,  in  1940  he 
modified  the  medium  to  a  defined  mixture  of  amino-acids  in place  of  casein,  inorganic  salts,  cysteine,  starch  and. 
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nicotinic  acid,  the  latter  being  essential  for  growth  from 
small  inocula.  He  noted  that  nicotinamide  was  also  an 
effective  growth  factor  for  B.  pertussis.  Early  trials 
showed  that  modifications  were  necessary  in  Hornibrook's 
medium  because  certain  strains  of  B.  pertussis  grew  poorly 
or  not  at  all  in  the  medium.  Subsequent  attempts  at 
improvements,  which  mainly  involved  the  alteration  of  growth 
factor  source  to  liver  extract,  were  not  much  better  (Wilson, 
1945;  Farrell  and  Taylor,  1945). 
Cohen  and  Wheeler  (1946)  described  a  modification  of 
Hornibrook's  medium  with  casamino  acids,  cysteine, 
inorganic  salts,  yeast  dialysate  and  starch.  They  were 
the  first  and  virtually  the  only  workers  to  determine  the 
optimum  inorganic  salt  composition.  However,  their 
medium  required  a  large  inoculum  of  about  106  organisms 
ml-1  of  medium.  The  medium  gave  a  high  level  of  protective 
antigen  in  the  cells  and  was  recommended  by  W.  H.  O.  as  the 
standard  medium  for  vaccine  production  (W.  H.  O.  )  1953). 
With  a  few  modifications,  it  is  also  the  principle  medium 
used  in  nutritional  and  metabolic  studies  on  B.  pertussis. 
Taking  into  consideration  all  the  problems  encountered 
by  earlier  workers,  Wilson,  (1963)  formulated  a  chemically 
defined  liquid  medium  which  was  essentially  a  modification 
of  Cohen  and  Wheeler's  medium.  It  consisted  of  amino 
acids,  glutamine,  gluthathione,  inorganic  salts,  niacin, 
ascorbic  acid,  ATP,  co-enzyme  A,  NAD,  NADP  and  nucleic  acid 
derivatives  and  tris  (hydroxy-methyl)  amino  methane  for 14 
buffering.  actions.  He  also  noted  that  the  salts  NaCl, 
KC1,  MgC12  and  CaCl 
2  were  required  to  keep  the  cells  in 
suspension.  However,  the  medium  contained  a  large  number 
of  constituents  (e.  g.  20  amino  acids  and  24  other  factors) 
and  belies  the  simple  nutritional  requirements  of  B.  pertussis. 
Stainer  and  Scholte  (1971)  described  the  simplest 
chemically  defined  medium  in  which  excellent  cell  yields 
were  obtained.  However,  the  medium  was  designed  for 
vaccine  production  and  requires  large  inocula;  thus  its 
suitability  for  metabolic  studies  is  questionable. 
Attempts  to  make  solidified  versions  of  early  liquid 
media  were  unsuccessful  unless  blood  or  charcoal  were 
added  (Verwey  et  al.,  1949;  Ungar,  James,  Muggleton, 
Pegler  and  Tomich,  1950;  Powell  et  al.,  1951;  Mazloum 
and  Rowley,  1955;  Jebb  and  Tomlinson,  1955  and  Kuwajima  et  al., 
1956;  1957).  Sutherland  and  Wilkinson  (1961)  claimed  to 
have  developed  a  solid  medium  supporting  the  growth  of  low 
inocula.  Their  medium  was  semi-defined  and  contained  an 
anion-exchange  resin  (Dowex-1,0.1%  (w/v))  to  remove  growth 
inhibitors.  Parker  (1976)  described  a  solid  medium  which 
was  a  modification  of  Stainer  and  Sholte's  medium  but 
solidified  with  agarose.  The  medium  supported  the  growth 
of  small  inocula  and  appeared  to  be  very  promising  for 
future  metabolic  and  genetic  studies  on  B.  pertussis. 
While  attempts  were  being  made  to  formulate  a  suitable 
medium  for  the  growth  of  B.  pertussis,  a  number  of  growth 
inhibitors  were  identified  by  some  workers.  These  included 15 
unsaturated  fatty  acids  (Pollock,  1947),  colloidal 
sulphur  (Proom,  1955;  Rowatt,  1957(a);  1957(b))  organic 
peroxides  (Rowatt,  1957(a))  and  manganous  ions  (Parker, 
1976).  The  fatty  acids  were  neutralized  by  adding  starch, 
charcoal  or  anionic  resins  to  the  medium  (Rowatt,  1957(b); 
Kuwajima  et  al.,  1957;  Sutherland  and  Wilkinson,  1961). 
Rowatt  (1957(a))-and  Parker  (1976),  showed  that  the 
colloidal  sulphur  could  be  neutralized  by  albumin,  activated 
charcoal  or  filter-sterilized  cysteine,  The  effect  of  the 
organic  peroxides  was  prevented  by  filtered  (but  not  auto- 
claved)  ferrous  sulphate  and  haemin  (Rowatt,  1957(a)),  and 
the  manganous  ions  were  neutralized  by  the  addition  of  red 
blood  cells  or  haemin  (Parker,  1976). 
Hornibrook  (1939;  1940)  showed  that  nicotinic  acid 
or  nicotinamide  was  necessary  for  growth.  Later  workers 
(Farrell  and  Taylor,  1945;  Ungar  et  al.,  1950;  Watanabe,. 
Nishimura  and  Tonita,  1952;  Imamura,  1952)  confirmed  the 
requirement  for  nicotinic  acid.  Farrell  and  Taylor  (1945) 
and  Watanabbe  et  al.,  (1952)  found  thiamine  to  be  essential 
to  some  strains  and  further  reported  stimulation  of  growth 
by  riboflavin,  p-aminobenzoic  acid  and  pyridoxine. 
Imamura  (1952)  showed  that  pertussis  organisms  would 
grow  in  a  medium  containing  cystine  and  glutamic  acid  or 
proline  as  the  only  amino-acids.  However,  Proom  (1955) 
stated  that  eight  amino  acids  were  needed  for  the  growth 
of  B.  pertussis.  A  medium  containing  starch,  glutamate, 
cystine,  nicotinamide  and  salts  was  formulated  by  Jebb  and 
Tomlinson  (1957)  but  growth  was  slow  and  the  yield  of 16 
bacteria  was  poor.  Goldner,  Jakus,  Rhodes  and  Wilson 
(1966)  and  Vajdic,  Goldner,  and  Wilson  (1966)  defined  ten 
required  amino-acids  for  growth  of  B.  pertussis  but 
showed  that  growth  was  limited  by  depletion  of  only  three 
of  these,  namely  glutamic  acid,  proline  and  glutamine. 
Some  later  workers  grew  B.  pertussis  with  excellent  yield 
and  with  good  protective  properties  in  a  medium  consisting 
only  of  glutamate,  proline  and  cystine,  with  salts  and 
growth  factors  (Stainer  and  Scholte,  1971)).  No  starch  or 
any  other  absorbent  was  necessary.  It  was  earlier  shown 
that  B.  pertussis  uses  glutamate  for  growth  in  preference 
to  other  amino-acids  (Rowatt,  1955). 
B.  pertussis  does  not  ferment  or  oxidise  any  of  the 
common  sugars  (Jebb  and  Tomlinson,  1951).  These  workers 
showed  the  major  metabolic  activity  of  the  organism  to  be 
oxidative  deamination  of  amino  acids  with  the  formation  of 
NH3  and  CO2.  They  further  stated  that  the  first  step  in 
the  oxidation  of  glutamate  was  deamination  with  the  production 
of  a-ketoglutarate.  Rowatt  (1957  (a))  suggested  that 
glutamate  was  the  principal  source  of  nitrogen  for  the  cell, 
with  only  small  amounts  coming  from  other  amino  acids. 
Furthermore,  only  aspartic  acid,  proline  and  glutamine  are 
thought  to  be  able  to  replace  glutamic  acid  as  an  energy 
and  nitrogen  source  (Jebb  and  Tomlinson,  1955;  Rowatt, 
1957(a);  Goldner  et  al.,  1966)  while  other  utilizable 
amino  acids  (serine,  glycine  and  alanine)  served  only  as 
sources  of  energy  or  possibly  carbon.  It  was  suggested 
that  the  oxidation  of  glutamic  acid  must  be  an  efficient 17 
process  as  2mg  of  glutamic  acid  yielded  lmg  of  cells 
(Rowatt,  1957(a)).  Goldner  et  al.,  (1966)  and  Rowatt 
(1957(a))  have  proposed  that  a  control  mechanism  must 
exist  whereby,  in  a  mixture  of  amino  acids,  glutamic  acid 
is  apparently  utilized  first.  However,  Lane  (1970)  was 
unable  to  confirm  this., 
The  alteration  of  certain  amino-acids  levels  in  the 
culture  medium  may  lead  to  changes  in  the  antigenic 
characters  of  the  pertussis  cell.  (Goldner  et  al.,  1966; 
Stainer  and  Scholte,  1969  and  Lane,  1970).  This  will  be 
discussed  later. 
The  pH  requirement,  of  the  organism  was  also  investigated 
by  many  workers.  Hornibrook  (1939)  recommended  pH  7.4  and 
Cohen  and  P'heeler  (1946),  pH  7.2-7.3. 
The  pH  of  the  media  were  adjusted  to  these  values 
before  autoclaving.  Ungar  et  al.,  (1950)  found  an  optimal 
pH  range  of  7.6-7.85  but  growth  was  very  slow.  Rowatt 
(1957(b))  found  that  the  initial  growth  rate  was  the  same 
from  pH  6.9  to  7.7,  although  at  pH  7.6-7.7  the  growth  rate 
became  slower  than  at  lower  pH  values.  Consequently, 
Rowatt  (1957)  used  the  lowest  possible  value  namely, 
pH  6.9-7.0  which  gave  a  medium  capable  of  taking  up  a 
larger  quantity  of  alkali  than  when  the  initial  pH  was 
higher.  Some  ammonia  in  the  casamino-acids  was  lost 
during  autoclaving,  so  that  to  obtain  a  medium,  containing 
1%  casamino-acids,  at  pH  6.9-7.0  it  was  necessary  to  adjust 
the  pH  to  7.2  before  autoclaving. 18 
'SECTION  5  PATHOPHYSIOLOGICAL  AND 
IMMUNOLOGICAL  ACTIVITIES 
OF  BORDETELLA  PERTUSSIS 
Freshly  isolated  strains  of  B.  pertussis  elicit  a 
variety  of  unique  immunlogical  and  pathophysiological 
responses  in  man  and  certain  experimental  animals. 
These  responses  include  :- 
a)  increased  resistance  of  mice  to  experimental 
infection  with  B.  pertussis, 
b)  increased  susceptibility  to  various  forms  of 
shock, 
c)  increase  in  the  number  of  circulating  leukocytes, 
especially  lymphocytes, 
d)  increased  susceptibility  to  autoimmune  diseases, 
e)  increased  antibody  production  especially  of  the 
IgE  class, 
f)  many  other  responses  usually  associated  with 
adjuvant  action  and  with  the  enhanced  susceptibility  to 
shock, 
A  brief  description  of  the  various  activities  and  the 
cell  components  thought  to  be  responsible  is  given  below. 
i.  Protective  activity 
From  the  point  of  view  of  preventive  medicine  the  most 
important  component  of  B.  pertussis  is  the  one  responsible 
for  immunizing  children  against  pertussis  infection  (M.  R.  C., 
1951;  1956).  This  component,  called  the  protective 
antigen  (PA),  is  probably  the  same  as  that  responsible  for 19 
the  protection  of  mice  against  intra-cerebral  challenge 
with  virulent  pertussis  organisms  (Kendrick  et  al.,  1947). 
Standfast  (1951(b)),  Dolby  and  Standfast  (1958)  demonstrated 
the  presence  of  another  antigen  on  the  pertussis  cell  which 
protected  mice  against  intranasal  challenge  with  virulent 
pertussis  organisms.  Standfast  (1958)  showed  that  the 
intracerebral  and  intranasal  protective  antigens  were  not 
identical  in  that  the  former  was  heat-labile  (100°C  for  ih) 
while  the  latter  was  heat  stable  (100°C  for  lh).  Unless 
otherwise  stated,  it  is  the  intracerebral  PA  that  will  be 
discussed  here.  The  PA  is  believed  to  be  a  cell  wall 
component  (Munoz,  Ribi  and  Larson,  1959;  Billaudelle  et  al., 
1960;  Munoz,  1963;  VTardlaw  and  Jakus,  1966;  Munoz,  1971; 
and  Zakharova  1978)  but  its-  precise  nature  remains  unknown. 
Munoz  (1963),  Guerault  (1962)  and  Dl  n?  (197,5);  showed 
that  the  protective  activity  of  B.  pertussis  was  destroyed 
by  heat  (80°C  for  30  minutes),  by  proteolytic  enzymes 
(trypsin,  pronase)  and  by  45%  (w/v)  phenol  indicating 
that  the  PA  is  protein  in  nature.  This  was  later  confirmed 
by  the  work  of  Jakdaýwl4cC'11-d  erandnVJaxidbaw  . 
(1968)  who  also 
showed  that  the  protective  activity  was  lost  at  high  pH. 
Munoz  (1963)  demonstrated  the  ability  of  the  PA  to  withstand 
acetone  indicating  that  lipid  moieties  were  not  essential 
for  activity.  Further  evidence  for  the  absence  of 
carbohydrate  in  PA  was  shown  by  Wardlaw  and  Jakus  (1966) 
who  found  that  PA  was  insusceptible  to  attack  by  sodium 
metaperiodate,  a  reagent  widely  used  to  degrade 
carbohydrates. 20 
In  the  early  1950's,  three  laboratory  procedures  were 
under  active  consideration  as  assay  methods  for  pertussis 
PA.  They  were  (a)  the  intracerebral  mouse-protection  test 
(Kendrick  et  al.,  1947),  (b)  the  intranasal  mouse-protection 
test  (Standfast,  1951b)  and  (c)  the  agglutinin  production 
test  (Evans  and  Perkins,  1953).  However,  the  intracerebral 
test  came  to  the  fore  as  a  result  of  the  M.  R.  C.  trials  (1951; 
1959)  and  is  the  only  method,  recommended  and  presently  accepted 
by  the  W.  H.  O. 
Sutherland  (1963)  investigated  the  antigenic  relation- 
ship  of  the  protective  antigen  of  Bordetella  species  and 
reported  no  cross  reaction  between  the  protective  antigens 
of  B.  pertussis,  B.  parapertussis  and  B.  bronchiseptica. 
Ross  et  al.,  (1969)  reported  that  B.  bronchiseptica  and 
B.  parapertussis  did  not  protect  against  B.  pertussis. 
Conversely,  both  B.  pertussis  and  B.  parapertussis  protected 
against  B.  bronchiseptica.  There  is  also  evidence  that 
infection  with  B.  pertussis  or  B.  parapertussis  in  man 
does  not  elicit  heterologous  immunity  (Neimark  et  al.,  1961) 
ii.  Histamine-sensitizing  activity 
Parfentjev  and  Goodline  (1947;  1948)  were  the  first 
to  observe  that  the  intraperitoneal  injection  of  pertussis 
vaccine  or  cell  extracts  into  mice  made  the  animals  up  to 
100-fold  more  sensitive  to  a  later  challenge  injection  of 
histamine  or  serotinin.  The  substance  in  pertussis  vaccine 
responsible  for  this  effect  was  named  the  histamine- 
sensitizing  factor  (HSF)  by  Maitland,  Kohn  and  MacDonald  (1955). 21 
Of  the  three  Bordetella  species  only  B.  pertussis  possesses 
HSF  (Ross  et  al.,  1969). 
HSF  is  very  potent  pharmacologically  and  once 
sensitization  has  been  induced  it  may  persist  for  months 
(Munoz  and  Bergman,  1966).  Even  small  numbers  of  killed 
organisms  when  inoculated  intranasally  into  mice  were 
sufficient  to  induce  histamine-sensitization  (Geller  and 
Pittman,  1973).  HSF  has  been  identified  as  a  cell  wall 
component  (Yoshida  et  al.,  1955;  Munoz  et  al.,  1959; 
Billaudelle  et  al.,  1960;  Sutherland,  1963;  Preston  and 
Garrity,  1967),  which  is  protein  in  nature.  (Kind,  1956; 
Pieroni  et  al.,  1965;  , `Jakusw  et  al.,  1968),  and 
carbohydrate  is  not  required  for  activity  (wardlaw  and 
Jakus,  1966).  HSF  isolated  from  intact  cells  contained 
a  considerable  amount  of  lipid  (Lehrer  et  al.,  1974) 
whereass  HSF  from  culture  supernatant  fluids  was  lipid  free 
(Morse  and  Morse,  1976).  These  latter  workers  suggested 
that  this  difference  may  be  because  HSF  is  closely 
associated  with  lipid  when  in  the  cell  envelope  and  that 
this  bond  is  broken  on  release  of  the  HSF  from  the  cells. 
For  some  time  the  action  of  HSF  was  thought  to  be  via 
the  autonomic  nervous  system  either  by  inducing  a  hyper- 
reactive  state  of  the  a-type  receptors  or  by  blockade  of 
the  0-type  receptors  (Fishel,  Szentivanyi  and  Talmage,  1964; 
Bergman  and  Munoz,  1966;  Pieroni  and  Levine,  1967;  OtBryan  and 
Fishel,  1971).  Recently  there  has  been  a  counter  report 
that  B.  pertussis  does  not  induce  ß-adrenegic  blockade 22 
(Hewlett,  Speigel,  Wolff,  Aurbach  and  Manclark,  1978; 
Parker  and  Morse,  1973).  The  latter  workers  have  proposed 
that  the  primary  effect  of  HSF  is  to  alter  cyclic  AMP 
metabolism  in  the  host  either  by  an  effect  on  intracellular 
ATP  concentrations  or  by  interfering  in  some  way  with 
adenylate  cyclase  or  phosphodi;  esterase  activity. 
Thus  the  mechanism  of  action  of  HSF  is  still  obscure. 
In  addition,  its  role  in  the  pathogenesis  of  whooping- 
cough  is  uncertain  though  Pittman  (1970)  has  suggested 
that  the  apparently  neurogenic  nature  of  the  paroxysmal 
cough  of  pertussis  may  be  a  manifestation  of  HSF. 
iii.  Lymphocytosis-promoting  activity 
Frghlich  (1897)  cited  by  Morse  (1965)  first  noted  that 
leukocytosis  occurs  in  cases  of  whooping-cough.  In 
clinical  infection  or  when  experimental-animals  are 
inoculated  with  B.  Pertussis  there  is  an  increase  in  the 
overall  number  of  circulating  leukocytes,  due  mainly  to  an 
increase  in  the  lymphocytes  (Tuta,  1937;  Morse,  1965). 
The  component  of  the  bacterium  responsible  for  this  increase 
is  called  the  leukocytosis-promoting  factor  or  lymphocytosis- 
promoting  factor  (LPF).  Lymphocytosis  has  been  reported  to 
be  less  frequent  in  patients  under  six  months  of  age 
(Lagergren,  1963)  and  to  be  absent  in  adults  infected  with 
B.  Pertussis  (Mannerstedt,  1934;  Lagergren,  1963; 
Linnemann  and  Nasenbury,  1977).  In  mice  inoculated 
intravenously  with  whole  cells  or  culture  supernatant 
maximum  leukocytosis  was  observed  3-5  days  after  injection 23 
and  then  declined  to  base-line  levels  in  2-3  weeks  (Morse, 
1965;  Morse  and  Bray,  1969). 
Other  workers  have  described  a  toxic  component  of 
B.  pertussis  which  on  inoculation  into  mice  shows  late- 
appearing  toxicities  (LAT)  such  as  late  body  weight  loss 
and  late  death  of  mice  (Kurokawa,  Iwasa  and  Ishida,  1965; 
Pittman  and  Cox,  1965;  Iwasa  et  al.,  1968;  Ishida,  1968; 
Kurokawa,  Ishida,  Asakawa  and  Iwasa,  1978).  The  late 
toxicities  occur  after  body  weight  loss  due  to  endotoxin 
and  deaths  due  to  heat-labile  toxin.  This  LAT  component 
was  also  shown  to  have  lymphocytosis-promoting  activity. 
Much  work  has  been  done  to  elucidate  the  mechanism 
of  the  lymphocytosis  (Morse,  1965;  Morse  and  Riester,  1967a; 
1967b;  Iwasa  et  al.,  1970jand  Morse  and  Adler,  1973). 
Although  the  dynamics  of  the  response  are  still  obscure, 
the  main  effect  appears  to  be  the  redistribution  of  the 
mobilizable  lymphocyte  pool  from  tissue  to  blood  rather 
than  t,  h  rapid  production  of  new  cells. 
Chemically,  LPF  was  shown  to  be  mainly  protein  (Morse 
and  Bray,  1969)  and  to  contain  some  carbohydrate  (Sato  and 
Arai,  1972;  Morse  and  Morse,  1976).  Using  partially 
purified  preparations  of  LPF,  Sato  and  Arai  (1972)  and 
Lehrer  et  al.,  (1974)  concluded  that  LPF  contained  up  to 
50%  lipid.  However,  this  was  not  confirmed  by  Morse  and 
Morse  (1976)  who  found  no  lipid  in  LPF.  Sato  and  Arai 
(1972),  Sato  et  al.,  (1973)  suggested  that  LPF  was  idential 
with  the  filaments,  which  measured  about  2X40nm,  appearing  on  the 24 
surface  of  B.  pertussis,  but  again  Morse  and  Morse  (1976) 
could  not  confirm  this  observation.  The  molecular  weight 
of  LPF  obtained  by  different  purification  methods  has  been 
estimated  at  10$,  000  (Sato  and  Arai,  1972)  and  at  87,000 
(Morse  and  Morse,  1976).  Recent  work  (Sato,  1978)  has 
shown  LPF  to  be  a  spherical  molecule  about  6nm  in  diameter 
and  with  a  molecular  weight  of  110,000. 
In  the  laboratory,  the  results  of  LPF  assays  have 
been  shown  to  be  influenced  by  a  number  of  factors  which 
include  :-  the  nature  of  the  vaccine  or  preparation  (Morse 
and  Bray,  1969),  the  route  of  inoculation  and  the  route  of 
bleeding  (Morse,  1965). 
LPF  has  been  reported  to  be  absent  from  B.  parapertussis 
(Morse  and  Morse,  1970)  but  there  are  other  reports  that 
children  infected  with  this  species  may  demonstrate  a 
striking  lymphocytosis  (Zueler  and  Wheeler,  1946;  Shih  Man, 
1950). 
iv.  Haemagglutinating  activity 
Keogh  and  North  (1947;  1948)  demonstrated  that  a  component 
of  B.  pertussis  was  capable  of  agglutinating  red  blood  cells 
of  chickens  and  other  animals  and  attempts  have  been  made 
by  several  workers  to  isolate  and  characterize  this  component. 
Masry  (1952)  showed  that  in  the  early  stages  of  growth  of 
B.  pertussis  in  liquid  medium,  the  haemagglutinin  (HA)  was 
cell-associated,  but  in  the  later  stages  of  growth  most  of 
the  HA  was  extracellular,  He  further  showed  that  HA  was 
produced  by  most  freshly  isolated  strains.  The  exact 25 
nature  of  HA  is  still  not  clear.  though  recent  studies 
by  Morse  and  Morse  (1976)  showed  it  to  be  markedly  sensitive 
to  heat  and  to  proteolytic  enzymes  and  therefore  must  be 
protein.  Electron  microscopic  examinations  of  Phase  I 
B.  pertussis  cells  revealed  surface  appendages  commensurate 
with  pili  or  fimbriae  (Morse  and  Morse,  1970),  and  Sato 
et  al.,  (1974)  showed  these  pili  to  be  similar  in  appearance 
to  HA.  This  was  confirmed  by  Morse  and  Morse  (1976)  who 
reported  that  the  HA  properties  of  B.  Pertussis  resided  in 
the  filamentous  particles. 
lý_ra.  APa1  and  5atd  (1976)  reported  the  separation  and 
characterization  of  two  distinct  types  of  HA.  One  of  these 
(LPF-HA)  had  very  low  HA  activity  and  high  LPF  activity 
and  the  other  (F-HA),  which  was  associated  with  the  fimbriae, 
had  very  high  HA  activity  and  no  LPF  activity.  These 
workers'  further  reported  that  the  haemagglutinins  had 
different  susceptibilities  to  papain  and  that  morphologically 
the  F-HA  consisted  of  filamentous  molecules  of  approximately 
2x  40  nm,  while  the  LPF-HA  had  a  spherical  structure 
approximately-  6nm  in  diameter. 
Irons  and  Maclennan  (1978)  stated  that  LPF-HA  was 
produced  under  variable  conditions  of  culture  while  the 
production  of  F-HA  appeared  to  be  favoured  in  static,  poorly 
aerated  cultures.  They  further  reported  that  pure  serum 
sialoproteins  such  as  haptoglobin  and  ceruloplasmin,  but 
not  transferrin,  are  powerful  inhibitors  of'LPF-HA  activity. 
Salivary  and  bronchial  mucins  are  also  inhibitory  to  the  HA. 26 
Purified  LPF-HA  binds  specifically  to  haptoglobin  and  this 
property  has  been  used  as  the  basis  of  an  affinity 
chromatography  method  for  purification.  On  the  other 
hand,  F-HA  is  unaffected  by  sialoproteins  (Irons  and 
Maclennan,  197$),  but  it  is  specifically  inhibited  by 
cholesterol  (Fisher,  1949;  Sato,  1978).  Using  sodium 
dodecylsulphate  polyacrylamide  gel  electrophoresis  and 
sucrose  density  gradient  centrifugation  methods,  Arai  and 
Satb  (1976)  estimated  the  molecular  weights  of  F-HA  at 
126,000  and  133,000  respectively.  The  molecular  weights  of 
LPF-HA  by  the  same  methods  were  given  as  107,000  and  103,000 
respectively. 
Antisera  against  the  two  haemagglutinins  did  not  cross 
react  in  neutralization  reactions,  and  the'dominant  serological 
specificity  of  LPF-HA  was  expressed  only  by  Phase  I 
. 
B.  pertussis 
organisms  whereas  that  of  F-HA  can  be  detected  in  preparations 
from  Phase  IV  organisms  and  in  other  species  of  Bordetella. 
(Irons  and  Maclennan,  1978). 
The  F-HA  and  LPF-HA  are  readily  distinguished  by  the 
character  of  the  erythrocyte  agglutination  they  produce  in 
test  tubes.  F-HA  produces  a  diffuse  pattern  of  settling 
of  the  red  cells  which  can  be  dispersed  by  the  gentlest 
resuspension;  but  the  LPF-HA,  on  the  other  hand,  is  a  true 
agglutinin  which  binds  red  cells  into  a  coherent  sheet  that 
can  be  dispersed  only  by  vigorous  shaking.  However,  there 
has  been  no  evidence  of  in  vivo  red  blood  cell  agglutination 
in  either  natural  or  experimental  infection  (Morse,  1976). 27 
v.  Heat-labile  toxicity 
While  B.  pertussis  produces  a  superficial  infection 
of  the  respiratory  tract,  pathologically,  there  is  a 
profound  necrotising  ünfla.  mmatiori  of  the  respiratory  tract 
mucosä,  extending  through  it  to  some  depth.  This  suggests 
that  toxins  are  produced  by  B.  pertussis  and  indeed  a  number 
have  been  described.  They  have  been  designated  variously 
as  dermonecrotic  toxin,  heat-labile  toxin,  lethal  factor 
and  lieno-toxin;  but  recent  evidence  suggests  that  these 
various  toxins  may  be  identical  (Banerjea  and  Munoz,  1962; 
Kurokawa,  Ishida  and  Asakawa,  1969;  'Iida  and  Okonogi,  1971) 
When  given  intraperitoneally,  intravenously  or  intra- 
cranially,  the  toxin  is  lethal  to  various  animals  (mice, 
guinea-pigs  and  rabbits)  and  when  given  subcutaneously  or 
intracutaneously  it  is  dermonecrotic.  This  toxin  has  been 
designated  heat-labile  toxin'(HLT)  because  heating  at  56°C 
for  30  min.  destroys  its  activity.  This  further 
distinguishes  it  from  endotoxin  which  is  heat-stable.  The 
mode  of  action  of  the  HLT  is  not  known. 
Its  protein  nature  was  demonstrated  by  Banerjea  and 
Munoz  (1962)  and  Munoz  (1971).  One  of  the  striking 
characteristics  of  HLT  in  contrast  to  many  other  bacterial 
protein  toxins  is  that  it  is  not  a  true  exotoxin.  It  is 
located  in  the  bacterial  cytoplasm  and  the  bulk  of  the 
activity  is  intracellular.  (Munoz  et  al.,  1959;  Billaudelle 
et  al.,  1960;  Banerjea  and  Munoz,  1962;  Munoz,  1963;  1971). 
The  HLT  is  found  in  smooth,  intermediate  and  rough  cells  of 28 
B.  pertussis  (Flosdorf  et  al.,  1941;  Roberts  and  Ospeck, 
1942;  Kuwajima  et  al.,  1958).  Some  strains  contain  more 
toxin  than  others  (Lawson,  1933;  Robert  and  Ospeck,  1942; 
Kasuga  et  al.,  1954;  Kuwajima  et  al.,  1958)  but  usually, 
recently  isolated  cultures  contain  most  toxin  (Lawson,  1933). 
The  amount  of  HLT  produced  by  a  particular'strain  of 
B.  pertussis  depends  on  the  medium  in  which  the  cells  are 
grown  (Munoz,  1971).  Lane  (1968)  found  that  the  toxin 
appeared  in  the  culture  supernatants  during  the  early 
logarithmic  phase  of  growth.  The  HLT  is  found  in  all 
three  species  of  Bordetella  (Strizova  and  Trilfajova,  1964). 
Although  no  relationship  between  virulence  of  B.  pertussis 
and  toxin  production  has  been  found  (Standfast,  1951), 
several  early  workers  believed  that  HLT  was  responsible  for 
much  of  the  observed  symptomatology  and  pathology  of  whooping- 
cough  (Gallavan  and  Goodpasture,  1937;  Sprunt  and  Martin, 
1943;  Asada  1953a;  b;  c;  Uchida  et  al.,  1957;  Kuwajima  et  al., 
1958). 
However,  the  immunology  of  HLT  has  been  investigated  and 
the  opinion  of  some  workers  is  that  the  toxin  does  not  appear 
to  be  involved  in  establishing  active  immunity  to  pertussis 
infection  since  little  or  no  antitoxin  is  demonstrable  in 
convalescent  sera.  (Evans,  1942;  1944;  Ospeck  and  Roberts, 
1944;  Proom,  1947;  Verwey  and  Thiele,  1949;  Cravitz  and 
Williams,  1946  cited  by  Munoz,  1971). 29 
vi.  Heat-labile  agglutinogens 
Certain  surface  components  of  B.  pertussis  are  capable 
of  inducing  agglutinating  antibodies  with  which  the  organism 
will  react  in  vitro.  These  components  of  the  cell  are  the 
agglutinating  antigens  or  agglutinogens.  Andersen  (1953) 
reported  that  the  agglutinating,  agglutinin-absorbing  and 
0-agglutination-inhibitory  powers  of  these  antigens  were 
destroyed  by  heating  for  one  hour  at  120°C  though  their 
immunogenic  properties  were  not  completely  destroyed. 
Serological  studies  of  the  agglutinogens  showed  the 
existence  of  serotypes  of  B.  pertussis  which  possessed 
various  combinations  of  agglutinogens  (Andersen,  1953). 
Eldering,  Hornbeck  and  Baker  (1957)  postulated  14  different 
antigenic  factors  (agglutinogens)  which  they  designated 
agglutinogens  1-14.  The  various  agglutinogen  combinations 
in  the  three  species  of  Bordetella  dresthowni.  in''Table;  3. 
Agglutinogens  1-6  are  found  in  cultures  of  B.  pertussis 
only,  and  agglutinogen  7  in  all  Bordetella  species. 
Agglutinogen  14  is  specific  for  B.  parapertussis,  and  agglutinogei 
12  for  B.  bronchiseptica.  Agglutinogens  8,9  and  10  account 
for  the  relationship  between  B.  parapertussis  and  B.  bronchi- 
septica.  Later  workers  reported  five  serotypes  of 
B.  pertussis,  each  containing  the  principal  heat-labile 
type  1  antigen  and  one  or  more  of  the  heat-labile  type  2,3, 
4  and  5  antigens  (Preston  and  Te  Punga,  1959;  Preston  and 
Evans.  1963;  Preston,  1963;  1965).  The  most  important 
antigen  combinations  appear  to  be  1,2;  1,3;  and  1,2,3 
(Cameron  1967).  Chalvardjian  (1965)  and  Preston  (1965) 30 
Table  3:  Agglutinogen  content  of  the 
three  species  of  Bordetella* 
Strains  Agglutinogens  (Factors) 
B.  pertussis 
strain  5373 
strain  5374 
strain  5375 
B.  parapertussis 
strain  17-90  3 
B.  bronchiseptica 
strain  5376 
strain  214 
strain  899 
7,1,3,6,13 
7,1,2,5,6,13 
7,1,2,4,13 
7,8,9,10,14 
7,  8,  9,  12,13 
7,  9,  12,  13 
7,  8,  10,  11,12 
*  From  Eldering,  Hornbeck  and  Baker  (1957). 31 
showed  that  type  1,3  was  the  most  commonly  isolated  at 
that  time. 
Agglutinogen  1  is  known  to  be  highly  antigenic  and 
easily  extractable  from  the  cells  (Munoz,  1963).  - 
This  agglutinogen  has  been  purified  and  shown  to  be  a  simple 
protein  of  molecular  weight  10,000  (Onoue,  Kitazawa  and 
Yamamur.  a,  1961).  The  agglutinogen  is  not  associated  with 
the  antigen  inducing  protection  in  mice  (Schuchardt  et  al., 
1963)  and  its  relation  to  protection  in  children  is  not 
clear.  However,  Preston  (1963;  1965;  1966)  linked  the 
type  specific  agglutinogens  2  and  3  as  well  as  the  species 
specific  agglutinogen  1  with  immunity  to  pertussis  infection 
in  man.  He  suggested  that  the  pertussis  epidemic  in 
Britain  between  1963-1964  was  due  to  the  lack  of  agglutinogen 
3  in  the  vaccine  then  used. 
vii.  Heat-stable  toxin  (endotoxin  or  lipopolysaccharide) 
Substances  which  have  similar  properties  to  the 
lipopolysaccharide-protein  complexes  isolated  from  the 
enteric  group  of  bacteria  have  also  been  isolated  from 
B.  pertussis  and  other  species  of  Bordetella  (Cruickshank 
and  Freeman,  1937;  Eldering,  1942;  Maclennan,  1960;  Farthing, 
1961)  .  1962) 
. 
There  is  very  limited  information  on  the  chemical 
composition  and  structure  of  the  lipopolysaccharide  (LPS) 
of  B.  Pertussis.  Although  hexosamine,  aldoheptose,  hexose, 
2-keto-3-deoxyoctonate  (KDO),  D-glucosamine,  D-glucose  and 
lipid  have  been  found  in  B.  pertussis  LPS  (Maclennan,  1960; 32 
Nakase  et  al.,  1970;  Aprile  and  Wardlaw,  1973a;  Konstantinov, 
Kalinova  and  Mihailova,  1978),  the  precise  nature  and 
organisation  of  the  monosaccharide  units  making  up  the 
polysaccharide  moiety  of  the  molecule  is  not  known  (Morse, 
1976).  Recent  workers  have  reported  two  non-identical 
polysaccharide  chains  within  the  B.  pertussis  LPS  (LeDur, 
Caroff,  Chaby  and  Szabo,  -1978).  Each  of  these  polysacch- 
arides  was  shown  to  be  linked  to  a  complex  Lipid  A  moiety 
of  the  LPS. 
Thus  the  LPS  of  B.  pertussis  appears  to  be  different 
from  those  elaborated  by  enterobacteria.  The  exact 
monosaccharide  structure  and  arrangement  of  B.  pertussis  LPS 
is  important  because  of  the  number  of  serologically  specific 
reactions  which  can  be  obtained  with  the  isolated  LPS 
(Aprile  and  Wardlaw,  1973b).  Milner  et  al.,  (1963)  claimed 
that  the  electron  microscopic  appearance  of  B.  pertussis  LPS 
was  that  of  fibres  with  diameters  of  50-100nm. 
Although  the  exact  role  of  endotoxin  in  human  pertussis 
is'not  known,  the  endotoxin  content  of  the  organism  has  been 
shown  to  contribute  to  certain  biological  effects  observed 
after  inoculation  into  experimental  animals.  Among  these 
biological  effects  are  the  leukopenia  in  sheep,  goats  and 
calves  (Rai  et  al.,  19711,  the  induction  of  certain  kinds 
of  heterologous  immunity  (Iida  and  Tajima,  1971)  adjuvant 
effects'(Farthing,  1961;  Farthing  and  Holt,  1962), 
sensitization  to  histamine  (Malkiel  and  Hargis,  1964; 
Kuratsuka  and  Homma,  1975),  an  effect  on  certain  transplanted 
t- 33 
tumors  (Malkiel  and  Hargis,  1961)  and  the  induction  of 
interferon  release  in  cell  cultures  (Kojima,  Yoshida  and 
Nakase,  1973) 
viii.  Islets-activating  protein 
Recent  in  vivo  and  in  vitro  studies  have  shown  that 
much  more  insulin  is  secreted  in  response  to  various  stimuli 
from  the-pancreas  of  rats  injected  with  B.  pertussis  cells 
than  from  the  pancreas  -of  normal  rats  (Sumi  and  Ui,  1975; 
Katada  and  Ui,  1976;  1977;  1978).  This  unique  action  of 
the  bacterium  has  recently  been  attributed,  to  the  so-called 
Islets-activating  protein-(IAP)  purified  from  the  culture 
medium  of  B.  pertussis  strain  Tohama  (Phase  I)  (Yajima, 
Hosoda,  Kanbayashi,  Nakamura,  Nogimori,  Mizushima,  Nakase  and 
Ui,  1978a). 
Purified  IAP,  when  injected  intravenously  at  a  dose 
as  low  as  0.02µg-0.1µg,  doubled  the  insulin  secretory 
response  of  rats  to  glucose'  loading  three  days'later.  The 
maximal,  about  12-fold,  response  was  obtained  with  lµg  of  IAP. 
The  action  persisted  for  longer  than  one  month,  with  the  peak 
value  from  3  to  10  days  after.  injection  (Yajima,  Takahashi, 
Kurokawa)  Nakase  and  Ui  1978b;  Yajima  et  al.,  1978a; 
Toyota,  Kakizaki,  Kimura,  Yajima,  Okamoto  and  Ui,  1978; 
Ui 
' 
Katada  and  Ya  jima,  1978). 
Purified  IAP  injected  into  mice  at  higher  doses  of  more 
than  O.  5µg  exhibited  HSF  and  LPF  activities.  Lower  doses 
were  effective  in  potentiating  the  insulin-secretory  response 
of  mice  and  dogs  without  inducing  leukocytosis.  Thus,  IAP 34 
appears  to  potentiate  the  insulin  secretory  response  of 
animals  rather  selectively  (Yajima  et  al.,  1978b). 
Injection  of  IAP  at  a  dose  of  10µg/Kg  into  *spontaneously 
diabetic  animals  successfully  improved  the  diabetic  state 
for  a  month.  (Goto,  Kakizaki  and  Masaki,  1975;  Toyota  et  al., 
1978). 
Further  studies  showed  purified  IAP  to  be  mainly 
protein  with  a  carbohydrate  content  of  1.0-1.5%  and  no 
lipid.  The  molecular  weight  by  polyacrylamide  gel 
electrophoresis  was  estimated  to  be  77,000  (Yajima  et  al., 
1978a;  Ui  et  al.,  1978).  Upon  incubation  with  8M  urea,  the 
IAP  molecule  was  dissociated  into  three  subunits,  F-1,  F-2, 
F-3,  none  of  which  was  biologically  active  by  itself. 
However,  the  same  biological  activity  as  the  native  IAP 
was  recovered  when  F-3  was  incubated  with  either  one  of  the 
other  subunits.  No  biological  activity  was  detected  when 
F-l  was  combined  with  F-2.  Thus,  the  subunit  F-3  was 
essential  for  the  biological  activities  of  IAP  while  F-1 
and  F-2  were  only  permissive  (Ui,  et  al.,  1978). 
Since  the  enhancement  induced  by  IAP  is  comparable  to 
the  potentiation  of  insulin  secretion  observed  upon  pertussis 
vaccination  of  rats,  it  is  very  likely  that  IAP  is  one  of  the 
factors  responsible  for  the  diverse  pathophysiological 
actions  of  B.  pertussis. 
ix,  Adjuvanticity 
Immunological  adjuvants  potentiate  the  immune  response 
to  a  given  antigen.  Numerous  micro-organisms  and  some  of 35 
their  structural  components,  such  as  the  endotoxins  from 
Gram-negative  bacteria,  possess  significant  adjuvant 
activity  (Johnson  et  al.,  1956;  Neter,  1969).  B.  pertussis 
appears  to  be  of  special  interest  because  pertussis 
organisms  function  as  an  adjuvant  to  other  bacterial  components 
which  may  be  present  in  vaccines. 
There  is  increasing  evidence  that  B.  pertussis  is  an 
effective  adjuvant,  for  example,  in  the  induction  of 
experimental  encephalomyelitis  (Levine  et  al.,  1966),  a 
disease  which  is  largely  due  to  direct  activity  of  sensitized 
lymphocytes  rather  than  serum  antibody  and  is  therefore  a 
product  of  the  cell-mediated  immune  response. 
The  organism  has  also  been  found  to  augment  markedly 
the  sensitization  of  mice  to  inhaled  antigens  (Chang  and 
Gottshall,  1972).  This  finding  correlated  with  the 
observation  that  the  administration  of  pertussis  organisms 
enhanced  the  production  of  reaginic  antibody  (Binaghi  and 
Benacerraf,  1964;  Reed  et  al.,  1972;  Tada  et  al.,  1972)  an 
IgE-like  homocytotropic  antibody  whose  production  is  regulated 
by  thymus-dependent  lymphocytes.  The  most  recent  evidence 
suggests  that  it  is  the  effect  on  T-lymphocyte  helper 
functions  which  result  in  an  augmented  humoral  immune 
response  in  general  (Taub  et  al.,  1972).  The  organism 
seems  to  contain  no  components  affecting  the  secretory 
immune  response  (Tada  et  al.,  1972). 
B.  pertussis  has  been  reported  to  decrease  the  growth 
of  tumours  implanted  into  experimental  animals  (Likhite,  1974) 
and  this  effect  may  also  be  due  to  enhanced  cell-mediated 36 
immunity,  although  critical  evidence  on  this  point  has  not 
been  obtained.  Conversely  there  are  instances  where 
pertussis  apparently  enhances  the  growth  rate  of  tumours 
(Floersheim,  1967;  Likhite,  1974). 
The  factor  or  factors  of  B.  pertussis  involved  in 
these  immunological  reactions  has  not  been  defined.  One 
candidate  for  the  role  of  adjuvant  in  B.  pertussis  is 
endotoxin,  since  endotoxins  from  other  Gram-negative 
organisms  are  known  adjuvants.  However,  at  heat-labile 
component  is  also  believed  to  be  important  in  pertussis- 
induced  adjuvanticity,  and  it  has  been  suggested  that  this 
component  plays  a  role  in  the  cell-mediated  reactions 
(Levine  et  al.,  1966;  Levine  and  Pieroni,  1966). 
The  mode  of  action  of  B.  pertussis  and  other  adjuvants 
is  still  unknown.  In  principle  B.  pertussis  may  affect 
the  multiplication  of  antibody-producing  cells,  increase 
the  antibody-sensitizing  activity  of  cells  or  act  by  a 
combination  of  these  two  mechanisms  (Finger,  1975). 
x,  Mitogenicity  for  lymphocytes 
Recent  work  (Kong  and  Morse,  1975;  1976)  has  revealed 
that  pertussis  culture  supernatant  fluids  contain  a  potent 
mitogen  for  murine  lymphocytes.  The  active  material  appears 
to  be  identical  to  LPF.  Spleen  and  lymph  node  cells  respond 
fully  but  pertussis  mitogen  does  not  stimulate  normal 
thymocytes. 37 
A  variety  of  experimental  procedures  have  been  employed 
to  delineate  the  proliferating  cell  and  there  is  evidence 
that  it  is  the  T-cell  that  responds,  although  a  second  cell 
type,  probably  the  macrophages,  is  required  to  initiate  the 
stimulatory  events,  perhaps  by  processing  the  mitogen  (Morse, 
1976). 
Recent  studies  by  Kong  and  Morse  (1975;  1976;  1977a;  1977b) 
showed  that  human  lymphocytes  also  proliferate  in  response  to 
the  pertussis  mitogen.  This  response  was  not  due  to 
sensitized  lymphocytes  since  cord  blood  cells  were  also 
stimulated.  The  type  of  human  lymphocytes  involved,  B  or  T, 
has  not  as  yet  been  established. 
xi.  Adenylate  cyclase 
Wolff  and  Cook  (1973)  first  detected  the  presence  of 
adenylate  cyclase  activity  in  the  supernatant  of  a 
merthiolate  preserved  whole  cell  pertussis  vaccine.  This 
observation  stimulated  further  studies  on  the  adenylate 
cyclase  of  B.  pertussis.  Hewlett  and  Wolff  (1976) 
demonstrated  the  presence  of  adenylate  cyclase  in  the' 
supernatant  fluid  of  exponentially  growing  organisms. 
This  indicated  that  the  adenylate  cyclase  might  be  an 
exoenzyme  and  would  therefore  differ  from  previously  studied 
bacterial  adenylate  cyclases,  which  are  intracellular  and 
either  membrane  associated  or  soluble  in  the  cytoplasm 
(Ide,  1969).  Hewlett  and  Wolff  (1976)  purified  the 
enzyme  by  ion-exchange  chromatography  and  gel  filtration 
and  showed  that  from  its  presence  in  the  culture  supernatant, 38 
its  low  molecular  weight  (70,000),  its  insensitivity  to 
a-keto-acids  and  nucleotides,  and  its  inhibition  by  fluoride, 
the  enzyme  from  B.  ýpertussis  differed  from  other  bacterial 
adenylate  cyclases  previously  described. 
Hewlett,  Urban,  Manclark  and  Wolff  (1976),  proposed  the 
following  four  compartments  of  adenylate  cyclase  in  B.  Pertussis; 
(1)  Soluble  enzyme  in  the  culture  supernatant  (up  to  20%  of 
the  total  activity);  (2)  enzyme  associated  with  intact  cells 
and  measurable  without  cell  disruption  (20%  -  45%); 
(3)  extracytoplasmic  enzyme  sensitive  to  trypsin,  but  not 
measurable  in  intact  cells  at  standard  substrate  concentration 
(40%  -  60%);  (4)  intracellular  enzyme  (7%  -  9%).  These 
workers  further  added  that.  in  comparison  with  previously 
studied  bacterial  adenylate  cyclases,  the  extracytoplasmic 
location  appears  to  be-unique  to  the  B.  pertussis  enzyme. 
Some  workers  measured  the  adenylate  cyclase  activity 
in  a  number  of  commercial  pertussis  vaccines  and  observed 
that  although  these  vaccines  met  the  required  limits  for 
potency,  toxicity,  adjuvant  content  and  organism  concen- 
tration,  they  differed  significantly  in  their  adenylate 
cyclase  activity  (Hewlett,  Manclark  and  Wolff,  1977). 
Although  no  explanation  was  offered  for  these  differences, 
they  speculated  that  several  factors  might  be  influencing 
the  persistence  of  the  enzyme  activity  during  the  handling 
of  the  organisms  in  the  preparation  of  vaccines. 
The  activity  of  adenylate  cyclase  was  shown  to  vary 
with  growth  medium.  On  Bordet-Gengou  agar  with  rabbit 39 
blood,  the  organism  had  very  high  adenylate  cyclase  activity 
(approximately  10-1000nmol  cAMP/min/mg  protein),  but  when 
grown  on  a  synthetic  Stainer  and  Scholte  medium,  the 
adenylate  cyclase  activity  decreased  as  much  as  by  1000- 
fold  (Hewlett,  Underhill,  Vargo,  Wolff  and  Manclark,  1978). 
These  workers  isolated  from  rabbit  erythrocytes  a  protease- 
sensitive  activator  which  increased  the  adenylate  cyclase 
activity  of  B.  pertussis  organisms  grown  in  Stainer  and 
Scholte  medium  by  100-1000  fold. 
Parton  and  Durham  (1978)  recently  reported  the  loss 
of  adenylate  cyclase  activity  in  degraded  strains  of 
B.  Pertussis.  This  observation  is  currently  directing  the 
interest  of  workers  towards  attempting  to  determine  whether 
adenylate  cyclase  is  associated  with  any  of  the  well  known 
toxic  effects  of  B.  pertussis  and  what  its  role  may  be  in 
regulating  the  metabolism  of  the  organism.  Cyclic  AMP 
in  other  organisms  appears  to  play  an  important  regulatory 
role.  In  E.  cola,  for  example,  cyclic  AMP  appears  to 
control  many  cellular  functions  of  the  type  that  are  not 
required  under  all  conditions  of  growth  (Rickenberg,  1974). 
SECTION  6:  INTERRELATIONSHIP  BETWEEN 
THE  VARIOUS  IMMUNOLOGICAL 
AND  PATHOPHYSIOLOGICAL 
ACTIVITIES 
Numerous  attempts  have  been  made  to  isolate,  purify 
and  characterize  the  cell  components  responsible  for  the 
pathophysiological  activities  of  B.  pertussis.  The  protective 
antigen  (PA)  has  been  particularly  intensively  investigated. 40 
An  aspect  of  recent  fractionation  studies  which  has 
generated  much  interest  is  the  relationship  between  the  PA 
and  the  HSF.  Early  reports  indicated  that  both  the  PA  and 
HSF  activities  could  be  attributed  to  the  same  fraction  of 
the  cell  envelope  (Maitland  and  Guerault,  1958;  Munoz, 
Ribi  and  Larson,  1959;  Niwa,  Hiramatsu,  Kawasaki  and 
Kuwajima,  1965;  Nakase,  ýFujita,  Takatsu,  Yoshioka  and 
Kasuga,  1965;  Munoz  and  Hestekin,  1966). 
Levine  and  Pieroni  (1966)  postulated  a"Unitarian 
Hypothesis"in  which  they  stated  that  PA,  HSF  activities  and 
other  pathophysiological  activities  of  B.  pertussis  were 
attributable  to  a  heat-labile  protein  substance  which  was 
presumably  the  whooping-cough  immunogen.  This  "Unitarian 
Hypothesis"  was  supported  by  results  of  certain  other 
workers  who  showed  that  purified  preparations  of  HSF  still 
had  PA  activity  (Munoz  and  Bergman,  1968).  Further  work 
by  Manclark,  Hansen,  Treadwell  and  Pittman  (1975)  suggested 
some  relationship  between  the  PA  and  HSF  when  they  reported 
that  mice  of  a  particular  line  were  more  sensitive  to  HSF 
and  more  immunisable  with  pertussis  vaccine,  and  vice  versa. 
The  most  recent  support  for  the  Unitarian  Hypothesis  was 
demonstrated  by  the  "Pertussigen  Theory"  of  Munoz  (1976). 
He  isolated  a  substance  Itpertussigen1I  from  B.  pertussis 
which  contained  PA,  HSF,  LPF,  IgE  and  EAE  adjuvant  activities. 
However,  the  purity  of  this  substance  is  questionable. 
Contrary  to  the  Unitarian  Hypothesis,  other  workers 
indicated  that  the  PA  and  HSF  were  attributable  to  different 
components  of  the  cell  (Dolby,  1958;  Pusztai,  Jod  and 41 
Juhasz,  1961;  Griffith  and  Mason,  1964;  Wilson  and  Jakus, 
1970).  Using  different  colonial  forms,  Cameron  (1976) 
reported  some  discrepancies  between  the  levels  of  HSF  and 
PA  in  the  resulting  cultures.  Zakharova  (1978)  reported 
that  the  PA  was  located  in  the  cytoplasmic  membrane  while 
the  LPF,  HSF  and  endotoxin  were  located  on  the  outer  structures 
of  the  cell  wall.  From  fractionation  studies  on  B.  pertussis, 
Nagel  and  Graaf  (1978)  obtained  a  sediment  which  contained 
endotoxin  and  PA  but  was  devoid  of  HSF  and  LPF  activities. 
Nakase  et  al.,  (1972)  found  that  purified  preparations  of 
HSF  had  no  significant  PA  activity  in  the  mouse.  Partially 
purified  PA  had  no  detectable  HSF  activity  (Nakase,  1978). 
Apart  from  the  HSF,  the  relationship  between  the  PA 
and  the  other  pathophysiological  properties  has  been  studied. 
Keogh  and  North  (1945)  suggested  that  the  HA  was  a  PA. 
Sato's  fimbriae-haemagglutinin  fraction  had  PA  activity 
(Sato  et  al.,  1974;  Arai  and  Sato,  1976;  Sato,  1978). 
The  relation  between  HA  and  PA  was  also  suggested  by  Morse 
and  Morse  (1976).  However,  Nakase  et  al.,  (1975)  showed 
that  their  purified  preparation  of  HA  had  no  significant  PA 
activity  in  mice  but  it  was  not  clear  which  of  the  two 
haemagglutins  they  isolated. 
The  relationship  between  the  PA  and  agglutinogens 
has  also  been  examined.  Agglutinogens  had  no  PA  activity 
(Andersen  and  Bentzon,  1958;  Schuchardt,  Munoz,  Verwey  and 
Sagin,  1963;  Eldering,  Holwerda  and  Baker,  1966;  Nakase 
et  al.,  1969;  Nakase  et  al.,  1970;  1971;  Ross  and  Munoz, 42 
1971,,  Zakharova,  1978).  But  other  workers  reported  the 
converse  :  that  agglutinogens  had  PA  activity  (Preston, 
1963;  Preston  and  Evans,  1963;  Preston,  1966;  Sato,  1978). 
Nagel  and  Graaf  (1978)  in  their  fractionation  studies 
obtained  a  sediment  which  contained  endotoxin  and  some  PA 
activity.  A  relationship  between  the  LPF  and  PA  activities 
has  also  been  reported  (Nakase,  1978). 
Lehrer,  Vaughan  and  Tan  (1975;  1976)  partially  purified 
the  HSF  component  and  found  it  also  had  LPF  activity  and 
enhanced  the  production  of  homocytotropic  but  not  of 
conventional  antibody.  It  has  also'been  shown  that  highly 
purified  LPF  served  as  an  adjuvant  for  reaginic  antibody 
production  (Tada  et  al.,  1972).  Morse  and  Morse  (1974; 
1976)  purified  LPF,  which  also  induced  histamine-sensitization, 
;:  hypoglycemia  unresponsiveness  to  the  hyperglycemic  effect 
of  epinephrine  and  in  vitro  proliferation  of  lymphocytes. 
Two  distinct  types  of  HA  were  separated  and  characterized 
by:  Arai  and  Sato  (1976)  and  one  of  these  was  shown  to  have 
LPF"activity.  Sato  (1978)  purified  LPF  which  possessed 
high  HSF  activity  and  also  showed  strong  T-cell  mitogenicity, 
T-cell  adjuvant  and  insulin  secretive  activities. 
The  IAP  was  shown  to  stimulate  insulin  secretion, 
suppress  epinephrine  hyperglycaemia  and  induced  lymphocytosis 
and  histamine-sensitization.  The  IAP  appears  to  be  very 
similar  to  the  LPF  preparation  of  Morse  and  Morse  (1976). 
Other  reports  on  the  interrelationship  of  the  patho- 
physiological  properties  have  shown  that  the  heat-stable 43 
toxin  (endotoxin)  has  (a)  some  HSF  activity  (Malkiel  and 
Hargis,  1964;  Kuratsuka  and  Homma,  1975),  (b)  an  adjuvant 
effect  (Farthing  and  Holt,  1962)  and  (c)  LPF  activity 
(Kurokawa,  Ishida,  Asakawa  and  Iwasa,  1978). 
Thus,  there  is  still  no  conclusive  evidence  either  for 
or  against  the  relationship  between  PA  and  HSF  or  other 
pathophysiological  activities  because  of  the  heterogeneity 
of  the  preparations  so  far  obtained.  From  evidence 
available  it  appears  that  there  are  at  least  five  components 
which  may  contribute  to  the  immunological  and  pathophysiological 
properties  of  B.  pertussis  ;  1)  component  with  PA  and  HA 
2)  component  with  LPF,  HA,  HSF,  IAP,  heat-labile  adjuvant 
and  mitogen,  3)  endotoxin,  4)  HLT  and  5)  adenylate  cyclase. 
SECTION  7:  ANTIGENIC  VARIATION  IN 
B.  PERTUSSIS 
One  of  the  most  striking  features  of  B.  pertussis  is 
its  great  propensity  for  variation  both  culturally  and 
serologically.  Two  main  types  of  variations  have  been 
described;..  'hase  variation,  which  is  a  genotypic  change 
during  which  the  organism  undergoes  a  series  of  mutational 
changes;  and  antigenic  modulation,  which  is  a  freely- 
reversible  phenotypic  process  induced  by  changes  in  the 
environment. 44 
i.  Phase  variations 
Bordet  and  Sleeswyk  (1910)  cited  by  Aprile  (1971), 
first  observed  that-anti-sera  raised  against  old  cultures 
of  B.  pertussis  maintained  on  nutrient  agar  did  not 
agglutinate  fresh  isolates  grown  on  Bordet-Gengou  medium 
and  vice-versa.  Krumwiede,  Mfsh  ikow  and  Oldenbusch  (1923) 
also  observed  that  strains  grown  on  chocolate  agar  fell  into 
two  different  serologic  groups.  Leslie  and  Gardner  (1931) 
studied  these  phenomena  in  greater  detail.  They  analysed 
32  strains  of  B.  pertussis  by  agglutination  and  agglutinin 
absorption  and  distinguished  four  serologically  and 
culturally  different  groups  which  they  called  phases  I,  II,  III 
and  IV.  They  suggested  that  Phases  I  and  II  corresponded  to 
the  smooth  or  pathogenic  forms  of  other  bacteria  and  Phases 
III  and  IV  to  the  rough,  relatively  avirulent  forms.  They 
also  showed  that  a  culture  derived  from  a  single  colony  could 
be  converted  by  subculture  on  various  media,  through  Phases  II 
and  III  to  the  stable  Phase  IV.  This  work  was  essentially 
confirmed  by  Lawson  (1932)  who  was  however  unable  to  obtain 
Phase  II.  Flosdorf,  Dubois  and  Kimball  (1941)  also 
confirmed  the  existence  of  Phases  I,  III  and  IV  but  failed 
to  find  Phase  II.  These  workers  suggested  that  variation 
in  B.  pertussis  was  considerably  more  complex  in  minor 
relationships  than  stated  by  Leslie  and  Gardner  (1931). 
Shibley  and  Hoelscher  (1934)  suggested  that  the  terms 
smooth  and  rough  be  used  for  the  stable  Phases  I  and  IV 
respectively  without  differentiation  of  the  intermediate 
forms. 45 
Phase  IV  strains  have  lost  many  of  the  biologically 
active  components  associated  with  Phase  I  or  fresh  isolates. 
These  include  PA  (Kasuaga  et  al.,  1954;  Aprile,  1972), 
HSF  (Kind,  1953;  Aprile,  1972;  Parton  and  Wardlaw,  1975), 
agglutinogen  1  (Eldering,  Eveland  and  Kendrick,  1962), 
HA  (Keogh  and  North,  1948;  Standfast,  1951),  2$k  and  30k 
envelope  polypeptides  found  in  Phase  I  strains  (Parton  and 
Wardlaw,  1975)  and  adenylate  cyclase  activity  (Parton  and 
Durham,  1978). 
Parker  (1976)  proposed  a  "genetic  hypothesis"  for 
degraded  Phase  IV  strains  whereby  Phase  I  to  Phase  IV 
transition  was  affected  by  a  series  of  spontaneous 
mutations  and  selected  for  by  the  presence  of  inhibitors 
in  the  medium.  This  hypothesis  suggests  that  intermediate 
strains  will  show  a  variety  of  types,  depending  on  the 
sequence  of  mutations,  but  leading  ultimately  to  the 
fully  degraded  Phase  IV  strains. 
Earlier  workers  thought  that  Phase  I  strains  were  of  a 
single  homogenaous  serotype  (Leslie  and  Gardner,  1931; 
Standfast,  1951).  However,  Andersen  (1952)  clearly 
showed  the  existence  of  several  Phase  I  serotypes.  The 
works  of  Andersen  (1953);  Eldering,  '  Hornbeck  and  Baker 
(1957),  Preston  and  Te  Punga  (1959);  Preston  (1963;  1965) 
and  Preston  and  Evans  (1963)  showed  fiver  serotypes  in 
,  B.  Pertussis,  each  containing  the  principle  heat-labile 
. 
type  2,3  antigens.  The  most  important  antigen 
combinations  appear  to  be  1,2;  1,3;  and  1,2,3. 46 
Cameron  (1967)  suggested  that  B.  pertussis  ündergoes'a 
stepwise  loss  of  heat-labile  antigens  converting  a  parent 
type  1,2,3  to  a  degraded  strain  of  type  1.  This 
suggestion  was  supported  by  similar  findings  in  the  child 
(Preston  and  Stanbridge,  1972)  and  in  the  marmoset  (Stanbridge 
and  Preston,  19744)in  which  these  workers  showed  that  the 
parent  (1,2,3)  and  the  intermediates  (1,2;  1,3)  could 
each  establish  infection  and  could  change  to  a  different 
serotype  during  the  course  of  the  infection.  Type  1 
organisms  were  found  only  at  a  late  stage  of.  the  infection 
and  even  then,  did  not  constitute  a  predominant  serotype. 
Further  study  by  Stanbridge  and  Preston  (1974b  showed 
that  the  four.  main  serotypes  of  B.  pertussis  (1,2,3; 
1,2;  1,3;  1)  undergo  spontaneous  variation  involving  loss 
or  gain  of  antigen  2  or  antigen  3.  By  serial  subculture 
from  single  colonies  on  charcoal-blood-agar  medium  they 
detected  loss  mutations  from  type  1,2,3  to  1,2  or  1,3 
and  from  type  1,2  to  type  1.  Similarly,  they  found  gain 
mutations  from  type  1  to  1,2  or  1,3  and  from  1,2  to 
1,2,3.  They  reported  that  these  mutations  occurred 
with  a  high  frequency  in  some  strains,  while  other  strains 
had  a  low  mutation  rate  and  were  more  stable  antigenically. 
Dolby  and  Bronne-Shanburry  (1975)  induced  L-forms  with 
glycine  and  by  a  combination  of  antibody  and  complement. 
The  L-forms  were  called  eel""  variants  because  they  contained 
agglutinogen  1  but  lacked  agglutinogens  2-6.  There  was 
little  difference  in  HSF,  HA  ahd0mouse  weight-gain  toxicity 
between  the  parent'types  and  their  nlrr  variants  and  it 47 
seemed  that  properties  other  than  the  agglutinogens  were 
unchanged.  Vaccines  made  from  I'1',  variants  protected  mice 
challenged  intracerebrally  with  virulent  strains  of 
B.  pertussis. 
These  various  findings  appeared  to  explain  the  changes 
in  serotype  that  occurred  during  the  course  of  a  pertussis 
infection  in  the  child  and  in  the  marmoset.  They  also 
indicated  the  possible  antigenic  instability  of  laboratory 
strains,  especially  relevant  in  the  production,  absorption 
and  testing  of  diagnostic  antisera  and  in  the  preparation 
of  pertussis  vaccine. 
ii.  Antigenic  modulation 
A  number  of  environmentally  induced  phenotypic  changes 
have  been  reported  for  B'.  pertussis.  The  two,  most  fully 
described  are  "Antigenic  Modulation's  (Lacey,  1960)  and 
changes  due  to  growth  in  high  levels  of  nicotinic  acid 
(Pusztai  and  Joo,  1967). 
Lacey  (1951;  1960),  while  developing  a  selective  medium 
for  B.  pertussis,  observed  that  a  crude  rabbit  serum  against 
B.  parapertussis  which  agglutinated  B.  pertussis  to  a  titre 
of'800  failed  even  at  a  titre  of  2,  to  agglutinate  the 
same  strain  of  B.  pertussis  grown  on  BG  medium  containing 
MgSO4  instead  of  NaCl.  Further  experiments  showed  that  the 
change  was  not  the  result  of  mutation  and  selection,  for  it 
occurred  simultaneously  in  the  whole  population,  was 
regularly  reproducible,  completely  reversible  within  one 
subculture  and  shown  by  all  freshly  isolated  strains. 48 
Lacey  showed  that  this  change  was  quite  different  from  the 
relatively  stable,  unpredictable  and  mutational  phase 
variation  described  by  Leslie  and  Gardner  (1931).  He 
called  this  variation  "antigenic  modulation"  and  described 
three  antigenic  modes  :  X,  I  and  C  which  were  equilibrium 
states  in  a  continuous  change  from  X-  to  C-  mode.  X  stands 
for  ttxanthictt  which  describes  the  yellowish-ochre  hue  of 
confluent  growth  of  freshly  isolated  strains  on  Bordet- 
Gengou  medium  containing  NaCl;  Cfor  ""cyanic",  describes 
the  greyish-blue  appearance  of  growth  on  BG  medium 
containing  a  high  level  of  MgSO4.  The  I-mode  is  the 
intermediate  state  between  these  two  extremes. 
Lacey  (1960)  reported  that  the  follöwing  factors  can 
cause  modulation  -  (a)  the  ionic  composition  of  the  growth 
medium,  e.  g.  MgSO4  in  place  of  NaCl  (b)  growth  at  low 
temperatures,  e.  g.  2$°C  and  (c)  miscellaneous  factors, 
e.  g.  fatty  acids,  tellurite  or  old  blood.  More  detailed 
study  on  the  effect  of  salts  showed-that  merely  suspending 
the  X-  and  C-  mode  cells  in  salt  solutions  did  not  cause 
modulation  and  this  indicated  that  cell  division  was 
necessary  for  modulation  to  occur.  Conclusions  about 
modulation  were  based  on  differences  in  agglutinability 
of  the  modes  with  X  and  C  antisera  and  with  B.  parapertussis 
antiserum  from  a  variety  of  animals.  By  replacing  the 
NaCl  in  the  medium  with  a  chemically-equivalent  amount  of 
another  salt,  he  investigated  the  influence  of  over  100 
salts  on  modulation.  He  concluded  that  cations  and  anions 
had  independent  potencies  for  modulation,  and  that  it  was 49' 
the  ratio  of  the  ionic  species  which  determined  the  final 
mode  of  the  cells.  Furthermore,  he  studied  the  combined- 
effect  of  salts  and  temperature  and  showed  that  they  were 
independent  but  that  the  sum  of  their  individual  potencies 
for  modulation  determined  the  final  mode  of  the  cells. 
He  showed  that  at  250C,  cells  grew  in  the  C-mode  irrespective 
of  the  salt  added  to  the  medium.  During  growth  at  any 
temperature  above  27°C,  the  mode  changed  from  X  through 
I  to  C  as  the  proportion  of  the  MgSO4  was  increased. 
Similarly  at  any  NaC1:  MgSO4  ratio  greater  than  2:  1  a 
similar  change  of  mode  occurred  as  the  temperature  was 
lowered. 
From  calculations  involving  the  equivalent  concentrations 
and  conductance  ratio  of  salts,  Lacey  (1960)  concluded  that 
butyrate  and  glutarate  had  about  the  same  pro-C-mode  power 
as  sulphate  but  in  both  the  mono-  and  dicarboxylic  acid 
series,  pro-C  mode  power  rose  steeply  with  increase  in 
chain  length.  Sodium  pelargonate  was  seventy  times  more 
powerful  (equivalent  for  equivalent)  than  magnesium  sulphate 
and  was  the  most  active  pro-C  substance  so  far  discovered. 
Lacey  (1960)  postulated  an  agglutinogen,  'tX-antigent' 
which  induced  agglutinins  to  B.  parapertussis  and  X-mode 
B.  Pertussis.  This  agglutinogen  was  present  on  the  surface 
of  the  X-mode  cells  but  Itserologically  submerged"  in  the 
C-mode.  He  further  identified  a  C-mode  agglutinogen  but 
found  it  to  be  a  very  poor  immunogen  compared  with  the 
X-antigen.  Whereas,  the  X-antigen  induced  a  high  slide 50 
agglutination  titre  of  2560  or  more  by  every  route  and  in 
almost  every  individual  animal  injected,  the  C-mode  antigen 
was  unproductive  in  raising  antibody  to  intraperitoneal, 
intracardiac  and  intravenous  inoculations  of  various 
animals  except  turkey  and  fowls.  In  rabbits,  intravenous 
inoculation  with  C-antigen  yielded  titres  of  up  to  640  but 
only  when  the  animal  was  first  given  a  subdermal  injection  of 
C-cells  two  weeks  before  the  intravenous  course.  Thus 
apart  from  rabbit  and  fowl,  no  other  animal  was  found  to 
produce  useful  amounts  of  antibody  to  C-mode  B.  pertussis. 
In  both  rabbits  and  fowls  the  C-mode  antibodies  appeared 
to  be  maximal  about  seven  days  after  a  course  of  five  to 
six  inoculations.  Thereafter,  they  diminished  even  if 
further  inoculations  were  given.  This  contrasted  with  the 
X-mode  titre  which  increased  with  extra  inoculations. 
Lacey  also  reported  a  number  of  other  characters  which  were 
altered  during  modulation  of  X  to  C  mode  (Table  4). 
His  results  showed  that  in  the  change  from  X-  to  C- 
mode,  equilibrium  was  reached  between  the  21st  and  36th  hour 
which  was  after  7  to  12  subdivisions.  On  the  time  sequence 
of  loss  of  characters,  Lacey  (1960)  observed  that  under 
pro-C  mode  conditions,  the  HA  activity  of  the  X-mode  dis- 
appeared  long  before  the  X-antigen  was  lost.  The  HA 
activity  returned  rapidly  under  pro-X  mode  conditions  and 
this  suggested  that  HA,  though  highly  associated  with  the 
X-antigen,  may  not  be  entirely  dependent  on  the  presence 
of  the  X-antigen. 51 
Table  4:  Distinguishing  characteristics.  of 
the  X-  and  C-  mode  cultures 
Character  X-mode  C-mode 
Zone  of  haemolysis  0.5mm  nil 
Colour  of  confluent  growth  ochre  pale  greenish  bluý 
'y 
Haemagglutinin  titre  64 
Agglutination  titres  in  sera  ; 
J.  to  B.  parapertussis  grown  on  12$0 
BG  at  35"C 
ii.  to  B.  bronchiseptica  grown  on  2560 
BG  at  35°C 
<2 
<  2.5 
<  2.5 
iii.  of  normal  rabbits  6  of  120  >5  All  of  120  <  2.5 
LD50  Mice  inoculated 
J.  intraperitoneally 
ii,  intranasally 
C.  2x  108  C.  2x  109 
C.  107  C.  1010 
*  from  Lacey  (1960) 52 
Summing  up  his  results,  Lacey  (1960)  speculated  that 
modulation  in  B.  pertussis  was  not  a  saltative  change  but 
a  process  of  continuous  change  leading  at  equilibrium  to 
one  of  a  large  number  of  antigenic  states.  He  postulated  two 
possible  hypotheses  to  explain  modulation.  The  first  was 
that  modulation  could  be  attributed  to  changes  in  the 
position  of  constant  amounts  of  antigens  and  the  second 
that  modulation  could  be  attributed  to  changes  in  position 
accompanying  or  resulting  from  changes  in  amount  of  antigens. 
In  the  first  case,  environment  would  primarily  determine 
which  antigen,  solely  because  of  its  position,  would  determine 
the  antigenicity.  In  the  second  case,  the  environment  would 
primarily  determine  the  rates2o£c6ypthesis  of  the  various 
antigens;  the  most  rapidly  synthesized  would  be  present 
in  greatest  amount  and  for  this  reason  would  both  dominate 
the  antigenicity  and  monopolize  the  surface.  He  further 
stated  that  the  first  hypothesis  could  not  explain  how  low' 
temperature  or  the  ionic  balance  had  an  effect  on 
modulation.  In  contrast,  since  the  influence  of  the  physico- 
chemical  environment  on  synthesis  of  antigens  in  other 
organisms  and  on  enzyme  activity  is  well  known,  the  second 
hypothesis  seemed  much  more  probable. 
Lacey  (1960)  investigated  primarily  the  haemagglutinating 
and  agglutinating  properties  of  the  X-  and  C-  mode  cells. 
With  the  exception  of  virulence,  he  did  not  investigate  the 
other  pathophysiological  properties  associated  with  freshly 
isolated  strains  (X-mode).  However,  later  workers  have 
shown  that  many  of  the  properties  associated  with  the  X-mode 
cells  are  lost  during  modulation.  These  properties  include 53 
PA  activity,  HSF  activity,  2$k  and  30k  cell  envelope 
polypeptides  (Parton  and  Wardlaw,  1975;  Wardlaw,  Parton  and 
Hooker,  1976),  HLT  (Livey,  Parton  änd  Wardlaw,  1978), 
adenylate  cyclase  (Parton  and  Durham,  1978)  and  heat-labile 
adjuvant  for  reaginic  antibody  production  and  hyperacute 
EAE  (Wardlaw,  Parton,  Bergman  and  Munoz,  1979).  These 
workers  noted  the  loss  of  these  activities  in  modulated 
C-mode  cells  but  gave  no  attention  to  the  time  of  loss  or 
the  sequence  of  loss  of  the  various  pathophysiological 
activities  during  the  actual  process  of  modulation. 
Apart  from  antigenic  modulations  other  phenotypic  variations 
have  been  reported. 
'Pusztai  and  Joo  (1967)  described  a  phenotypic  change 
which  occurred  when  B.  pertussis  Phase  I  strains  were  grown 
in  high  levels  of  nicotinic  acid.  Such  cells  had  lost  the 
PA,  HSF  and  agglutinogens  but  the  HLT  was  unaffected.  -  The 
process  was  completely  reversible  by  subculture  onto  normal 
medium  containing  low  levels  of  nicotinic  acid  and  this  was 
thought  to  be  the  result  of  impaired  cell  wall  synthesis  as 
only  cell  wall  antigens  (PA.  HSF  and  agglutinogens)  were 
affected  and  not  the  cytoplasmic  antigens  e.  g.  HLT. 
Wardlaw  et  a1.,  (1976)  showed  that  growth  in  high  nicotinic 
acid,  but  not  in  high  nicotinamide,  resulted  in  a  loss  of 
PA  and  HSF.  They  also  showed,  on  electrophoretic  analysis, 
that  the  cell  envelopes  of  the  high  nicotinic  acid  cells 
had  a  protein  profile  almost  identical  to  those  of  Phase  IV 
and  C-mode  cells  i.  e.  two  envelope  polypeptides  (28k  and  30k) 
associated  with  the  normal  Phase  I  cells  were  lost. 54 
Andersen  (1952)  observed  differences  in  the  colony 
sizes  of  B.  pertussis  after  a  series  of  intracerebral 
passages  in  mice.  She  showed  that  the  small  colonies  were 
more  virulent,  more  toxic  and  more  easily  agglutinable  than 
the  large  colonies. 
Rowatt  (1957)  reported  that  a  freshly  isolated  strain 
of  B.  pertussis  grown  on  horse  blood-agar  became  avirulent 
and  filamentous  but  the  same  strain  grown  on  sheep  or  human 
blood-agar  remained  virulent  and  was  coccobacillary. 
There  are  also  reports  of  changes  in  the  pathophysiological 
activities  resulting  from  alterations  in  the  carbon  source  of 
the  growth  medium.  Goldner  et  al.,  (1966)  reported  that 
an  increase  in  the  glutamic  acid  content  of  the  growth 
medium  increased  the  antigenic  potency  of  the  cells. 
Replacing  casein  hydrolysate  in  the  growth  medium  with 
glutamate  also  led  to  loss  of  toxicity,  HSF  potency  and 
intracerebral  protective  potency.  Stainer  and  Scholte 
(1971)  reported  a  reduction  of  the  mouse-protective  activity 
and  agglutinability  of  Phase  I  strains  after  29  serial  transfers 
in  one  of  their  chemically  defined  media  z.  They  showed 
that  only  5%-10%  of  the  original  mouse-protective  activity 
was  present  after  21  transfers. 
The  reports  discussed  in  this  section  tend  to  confirm 
the  unique  ability  of  B.  pertussis  to  undergo  a  wide  range 
of  genotypic  and  phenotypic  variations.  Recently  Bemis; 
Greisen  and  Appel  (1977)  examined  the  biochemical,  cultural 
and  morphological  characteristics  of  B.  bronchiseptica 55 
isolates  from  dogs  and  other  species  and  reported  a  type 
of  phase  variation  which  involved  changes  in  colonial 
morphology,  haemagglutination,  haemolysis,  flagellation  and 
fimbriation.  In  addition,  Kumazava  and  Yoshikawa  (1978) 
reported  the  conversion  of  B.  pertussis  to  B.  parapertussis 
by  treatment  with  Nt-methyl  LN'-nitro-N  nitrosoguanidine. 
They  postulated  that  B.  parapertussis  was  a  mutant  of 
B.  pertussis  which  appeared  in  these  experiments  probably 
by  the  selective  pressure  of  antibiotics.  It  is  interesting 
to  note  that  the  apparent  mutation  of  B.  pertussis  to 
B.  parapertussis  resulted  in  a  gain  of  the  ability  to  split 
urea  and  utilize  citrate.  It  also  resulted  in  a  loss  of 
the  histamine-sensitizing  ability. 
SECTION  8:  PRESENT  DAY  CONTROVERSY 
OVER  PERTUSSIS  VACCINES  AND 
ATTEMPTS  TO  PRODUCE  A  SAFER  AND 
MORE  EFFECTIVE  VACCINE 
Despite  the  reported  control  of  pertussis  infection 
by  immunization,  a  number  of  problems  are  still  associated 
with,  the  present  day  vaccines. 
'Almost  all  pertussis  vaccines  in  current  use  are  whole 
cell  preparations.  Because  the  present  vaccines  are 
manufactured  by  various  companies,  they  vary  in  quality, 
safety  and  efficacy  according  to  the  production  strains  of 
B.  Pertussis,  the  method  of  manufacture  and  quality  control 
procedures  (Griffith,  1978).  Even  vaccines  produced  by 
the  same  company  have  been  found  to  vary  from  batch  to 56 
batch.  These  problems  are  related  to  the  fact  that  the 
antigenic  profile  of  B.  pertussis  strains  varies  continuously 
with  environmental  conditions  of  growth  (Lacey,  1960;  Goldner 
et  al.,  1966;  Lane,  1970;  Stainer  and  Scholte,  1971). 
The  other  problem  of  present  vaccines  has  been  the 
possible  side  effects  of  the  vaccine  on  children.  Such 
side  effects  include  shock,  abnormal  screaming  fits,  vomiting, 
convulsions  and  brain  damage.  The  most  controversial  at 
the  moment  is  the  reported  occasional  brain  damage  associated 
with  vaccination.  Byres  and  Moll  (1948)  first  reported 
that  brain  damage  appeared  to  follow  the  use  of  the  vaccine. 
This  complication  was  so  uncommon  that  its  incidence  was 
difficult  to  estimate.  Strom  (1967)  reported  the  incidence 
of  brain  damage  in  Sweden  as  1  in  every  170,000  children 
vaccinated,  whereas,  Dick  (1974)  put  the  incidence  in  the 
United  Kingdom  at  1-2  in  10,000.  This  statement  has  been 
challenged  though  not  substantiated  by  Griffith  (1974). 
Kulenkampff  et  al.,  (1974)  reported  50  cases  of  brain 
damage,  in  children,  recorded  from  January  1961  to 
December  1972  in  a  London  hospital.  Dick  (1974)  and 
Kulenkampff  et  al.,  (1974)  raised  serious  questions 
regarding  the  safety  of  the  vaccine  and  this  stimulated 
considerable  interest  in  the  neurological  complications 
following  pertussis  vaccination.  This  interest  was 
fostered  by  the-formation  in  Britain  of  an  Association  of 
Parents  of  Vaccine-Damaged  Children  which  sought  some 
compensation  from  the  government. 57 
Stephenson  (1977)  and  Ounstead  (1977)  pointed  out  the 
chance  association  of  side  effects  and  immunization  from  the 
fact  that  pertussis  vaccines  are  routinely  administered  to 
the  infants  at  an  age  when  serious  clinical  disorders  of 
unknown  causes  are  particularly  likely  to  occur  or  become 
evident.  Stewart  (1977)  suggested  that  the  incidence  of 
brain  damage  following  pertussis  vaccination  might  be  1  per 
168,000  injections,  but  Wilson  (1977)  reported  that  there 
was  no  case  of  reported  brain  damage  in  the  180,000  children 
that  received  immunization  in  the  Greater  Glasgow  area  from 
1961-1975.  The  report  of  Wilson  was  supported  by  Grist 
(1977)  whose  survey  found  no  cases  of  brain  damage  in  the 
whole  of  Scotland  from  1968-1969.  Bassili  and  Stewart 
(1976)  and  Stewart  (1977)  claimed  that  the  changing  socio- 
economic  conditions  have  been  more  important  than  vaccination 
in  the  reduction  of  the  incidence  of  pertussis  and  that  the 
risk  of  serious  neurological  complications.  following  pertussis 
vaccination  was  too  great  to  justify  national  use  of  the 
vaccine.  They  therefore  advocated  the  withdrawal  of  the 
vaccine.  This  led  the  Joint  Committee  on  Vaccination  and 
Immunization  in  Britain  to  review  the  vaccination  problems 
of  whooping-cough  in  1977.  The  Committee  concluded  that 
the  risks  of  vaccination  were  far  outweighed  by  the  risks 
of  infection  and  recommended  that  vaccination  should 
continue  (Joint  Committee  on  Vaccination  and  Immunization 
Report,  1977). 
As  a  result  of  this  controversy,  there  has  been  a 
decline  in  the  acceptance  rate  of  the  pertussis  vaccine. 58 
The  acceptance  rate  in'1977  was  40%  or  less  as  compared 
to  70%-$0%  before  1974  (Stuart-Harris,  1978).  This 
present  low  acceptance  rate  may  in  part  be  responsible  for 
the  sharp  outbreak  of  pertussis  which  began  in  October  1977 
and  in  fact  the  intensity  of  the  infection  as  judged  by 
notifications  in  the  first  quarter  of  1978  was  higher  than 
at  anytime  since  the  1950's. 
These  present  problems  have  prompted  the  need  for  a 
safer  and  more  effective  vaccine.  However,  a  major  difficulty 
at  present  in  preparing  an  entirely  satisfactory  pertussis 
vaccine  is  the  inability  to  identify  precisely,  by  reliable 
laboratory-tests,  the  antigen  or  antigens  necessary  for  the 
protection  of  children.  The  mouse-protection  test  used 
in  control  of  pertussis  vaccines  gives  some  guide  to  the 
efficacy  in  children  but  the  test  cannot  be  regarded  as 
precise  and  the  immunological  mechanisms  involved  are  not 
understood.  Furthermore,  there  are  no  in  vitro  tests  by 
which  the  protective  antigens  of  pertussis  vaccine  can  be 
identified  or  assayed.  Because  of  these  gaps  in  knowledge, 
pertussis  vaccines  are  at  present  prepared  as  whole  bacterial 
suspensions.  As  stated  earlier,  B.  pertussis  cells  have  an 
array  of  antigens,  some  of  which  are  protective  and  others 
quite  toxic  and  appear  to  be  responsible  for  some  of  the 
reported  side  effects.  To  produce  a  safer  and  more  effective 
vaccine,  it  is  necessary  to  retain  the  protective  antigen  and 
remove  or  inactivate  the  toxic  components  of  the  cells. 
One  of  the  possible  approaches  to  this  is  the  isolation 
and  purification  of  the  biologically  active  components  of 59 
B.  pertussis.  This  will  help  identify  and  purify  the 
actual  component  responsible  for  protection  and  eventually 
lead  to  replacing  the  present  whole-cell  vaccine  with 
preparations  containing  the  purified  protective  immunogen. 
extracted  from  the  cells.  This  approach  is  at  the  moment 
attracting  the  interest  of  many  workers  (e.  g.  Nagel  and 
Graaf,  1978;  Nakase,  1978;  Helting  and  Blackkolb,  1978). 
Another  approach  to  a  safer  and  more  effective  vaccine 
might  be  to  utilize  the  ability  of  B.  Pertussis  to  undergo 
antigenic  variations.  Since  it  has  been  reported  that  the 
manipulation  of  cultural  conditions  affects  the  amount  of 
various  antigens  present  on  the  bacterial  surface,  it  might 
be  possible  to  determine  cultural  conditions  which  would 
yield  cells  with  high  levels  of  protective  antigens  and  very 
low  levels  of  toxic  components. OBJECT  OF  RESEARCH 60 
OBJECT  OF  RESEARCH 
Lacey  (1960)  originally  showed  that  during  antigenic 
modulation  of  B.  pertussis,  surface  agglutinogens,  haema- 
gglutinin  and  mouse  virulence  were  lost  in  C-mode  cells. 
Later  workers  reported  that  the  protective  antigen,  the 
histamine-sensitizing  factor,  the  heat-labile  toxin  and 
adenylate  cyclase  activity  were  also  lost  in  C-mode  cells. 
(Wardlaw  et  al.,  1976;  Livey  et  al.,  1978;  Parton  and 
Durham,  1978).  However,  in  all  these  studies,  there  was 
no  indication  of  the  time-sequence  of  loss  of  these  various 
properties  during  modulation. 
Furthermore,  because  of  a  number  of  undesirable  toxic 
side  effects  associated  with  the  present  vaccine,  efforts 
are  being  made  by  many  workers  to  develop  a  vaccine  free 
from  toxicity.  Attempts  to  isolate  and  purify  a  single 
potent,  protective  antigen  from  the  numerous  other  biologically- 
active  components  of  B.  pertussis,  or  to  produce  cells  with 
altered  levels  of  activities  by  manipulation  of  cultural  con- 
ditions,  have  so  far  not  been  successful. 
The  aims  of  this  investigation  were 
(a)  To  determine  if  the  immunological  and 
pathophysiological  properties  associated  with 
X-mode  cells  were  lost  at  the  same  rate  or  at 
different  rates  during  modulation. 
(b)  To  determine  whether  one  component  or  several 
distinct  components  of  the  cell  were  responsible 
for  the  various  pathophysiological  activities. 61 
(c)  To  explore  the  possibility  of  utilizing 
the  process  of  modulation  for  the  production 
of  a  safer  vaccine  by  attempting  to  produce 
cells  with  high  protective  activity  and  low 
toxicity. 
(d)  To  attempt  to  determine  the  mechanism  of 
antigenic  modulation. MATERIALS  AND  METHODS 62 
SECTION  1:  BACTERIOLOGICAL  MATERIALS 
AND  METHODS 
i.  Strains 
Four  Phase  I  strains  of  B.  pertussis-were  studied  :- 
Strain  18334,  a  vaccine  strain  from  the  Connaught 
Laboratories  Limited,  Toronto; 
Strain  134,  a  strain  originally  used  by  Pillemer  (1950) 
in  the  preparation  of  his  protective  antigen; 
Strain  18323,  the  original  mouse-virulent  Kendrick 
strain  used  in  the  mouse-protection  test  (Kendrick, 
Eldering,  Dixon  and  Misner,  1947); 
Strain  D30042,  originally  supplied  by  Dr.  Jean  Dolby 
of  the  Lister  Institute  of  Preventive  Medicine,  Elstree, 
Hertfordshire,  England., 
, 
All  strains  were  maintained  in  theefreezeý--dried  state 
ii.  Media 
The  following  were  used  for  the  cultivation  of 
B.  pertussis  :  - 
Charcoal  agar  (Difco  Laboratories,  Detroit,  Michigan,  U.  S.  A.  ). 
Bordet-Gengou  medium  (Gibco)  containing  20%  (v/v)  citrated 
horse  blood  (Gibco  Bio-Cult  Diagnostics,  Glasgow,  Scotland). 
A  modified  Hornibrook  medium  (Parton  and  Wardlaw,  1975) 
based  on  the  original  recipe  of  Hornibrook  (Hornibrook, 
1939).  For  C-mode  growth,  the  0.5%  (w/v)  NaCl  in  modified 
Hornibrook  medium  was  replaced  by  0.5%  (w/v)  MgSO4.7H2O, 
other  ingredients  being  the  same.  The  medium  with  added 63 
NaCl  is  designated  X-medium  and  the  medium  with  MgSO4.7H20, 
C-medium  (Parton  and  Wardlaw,  1975). 
Stainer  and  Scholte  defined  liquid  medium  (Stainer  and 
Scholte,  1971).  C-mode  growth  in  Stainer  and  Scholte  medium 
was  obtained  by  replacing  the  0.25%  (w/v)  NaC1  in  the  medium 
with  0.5%  (w/v)  MgSO4.7H20. 
The  composition  and  preparation  methods  for  all  media 
are  given  in  Appendix  1. 
iii.  Mice 
Mice  used  were  from  a  randomly-bred  closed  colony 
originally  derived  from  the  Ham/ICR  strain  (Charles  River, 
U.  K.  Ltd.,  Manston  Road,  Margate,  Kent). 
Mice  from  a  similar  colony  of  strain  NIH  originally 
obtained  from  Anglia  Laboratories  (Alconbury,  Huntingdon, 
Cambridgeshire,  England)  by  the  Wellcome  Institute  of 
parasitology,  Veterinary  College,  University  of  Glasgow, 
Scotland,  were  also  used  in  some  experiments. 
iv.  Growth  of  cultures 
Freeze-dried  cultured  were  reconstituted  with  1%  (w/v) 
casamino  acids  solution  and  grown  on  charcoal  agar  slopes  or 
on  Bordet-Gengou  agar  plates. 
Slopes  and  plates  were  incubated  at  35°C  for  2-3  days. 
Plates  were  placed  in  a  closed  plastic  box  containing  a 
beaker  of  water  to  saturate  the  atmosphere. 
Seed  cultures  were  grown  by  inoculating  2-litre  dimpled 
conical  flasks,  containing  500m1  of  Hornibrook  X-  or  C-medium 64 
with  a  loopful  of  cells  from  growth  on  Bordet-Gengou  plates 
incubated  for  72h.  Flasks  were  incubated  in  an  orbital 
incubator  (Gallenkamp,  London)  at  80  r.  p.  m.  and  350C  for 
48h. 
For  larger  scale  growth,  2-litre  dimpled  flasks 
containing  1-litre  amounts  of  X-  or  C-medium,  were 
inoculated  with  50m1  or  100mi  of  seed  culture  with  sterile 
50m1  pipettes  Flasks  were  then  incubated  in  an  orbital 
incubator  at  80  r.  p.  m.  and  35°C.  Cultures  were  harvested 
at  various  intervals  during  growth.  Purity  of  each  culture  was 
checked  by  Gram  staining  and  by  inoculation  onto  nutrient 
agar  (Oxoid)  plates. 
Challenge  cultures  for  the  mouse  protection  test  had 
been  passaged  several  times  through  mouse  brain  to  enhance 
virulence.  These  cultures  were  suspended  in  casamino  acids 
solution  containing  20%  (w/v)  glycerol,  sealed  in  sterile 
plastic  ampoules  (Sterilin  Ltd.,  Teddington,  Middlesex, 
England)  and  stored  frozen  in  liquid  nitrogen.  For  use, 
ampoules  were  allowed  to  thaw  at  room  temperature  and  the 
suspension  was  plated  onto  two  or  three  Bordet-Gengou  plates 
which  were  then  incubated  at  35°C  for  48h.  Fresh  Bordet- 
Gengou  plates  were  heavily  inoculated  with  cells  from  the 
48h  plates  and  incubated  for  24h  at  35°C.  Challenge 
suspensions  were  prepared  from  these  24h  cultures. 65 
v.  Harvesting  of  cultures 
Cultures  were  harvested  by  centrifugation  at  8000  r.  p.  m. 
(10,000  x  g)  in  250m1  bottles  at  40C  for  30  min.  on  an 
MSE  18  centrifuge.  Supernatant  fluid  was  carefully  decanted 
and  the  cell  pellets  were  evenly  resuspended  in  0.85%  (w/v) 
sterile  saline.  The  concentration  of  the  cell  suspension 
was  adjusted  to  100  opacity  units  (see  section  l(vi))  and 
heated  in  a  water  bath  at  56°C  for  30  min  to  kill  the  cells. 
Heated  cell  suspensions  were  then  preserved  by  the  addition 
of  thiomersal  (BDH  Chemicals  Ltd.,  Poole,  England)  to  a 
final  concentration  of  0.  lmg/ml. 
vi.  Standardization  of  bacterial  concentration  by  opacity 
The  concentration  of  bacterial  suspensions  was 
estimated  by  comparison  with  the  International  Opacity 
Reference  Preparation  designated  as  having  10  international 
opacity  units. 
The  dilution  factor  used  to  obtain  matching  of  cell 
suspension  with  the  reference  preparation  was  calculated 
and  multiplied  by  10  to  give  the  concentration  in  opacity 
units  of  the  undiluted  bacterial  suspension.  A  concentration 
of  1  o.  u.  was  considered  to  be  equivalent  to  approximately 
109  organism  per  ml.  The  opacity  reference  was  supplied 
by  the  World  Health  Organisation  International  Laboratory 
for  Biological  Standards  (National  Institute  for  Biological 
Standards  and  Controls,  Holly  Hill,  Hampstead,  London). 66 
vii.  Estimation  of  optical  density 
The  optical  density  of  bacterial  suspensions  and  other 
optical  density  measurements  were  made  at  a  wavelength  of 
540nm  in  a  Pye-Unicam,  model  SP500  spectrophotometer  using 
polystyrene  cuvettes  with  a  lcm  light  path. 
viii.  Estimation  of  viable  cell  numbers 
Serial  ten-fold  dilutions  of  cultures  were  made  in 
sterile  saline.  Duplicate  0.2m1  amounts  of  each  dilution 
were  spread  onto  BG  plates.  After  incubation  at  35°C  for 
72h,  plates  with  countable  number  of  colonies  were  selected. 
The  average  number  of  colonies  per  dilution--,  was-multiplied  by 
the  dilution  factor  to  obtain  an  estimate  of  the  number  of 
viable  cells  per  millilitre  of  the  original  culture. 
SECTION  2:  BIO-ASSAY  METHODS 
i.  Expression  of  bacterial  dose 
Having  standardized  a  bacterial  suspension  in  terms  of 
opacity  units  (which  is  a  measure  of  concentration),  the 
doses  injected  into  mice  for  PA,  HSF  and  LPF  tests  were 
expressed  in  "opacity  unit  millilitres"  (ou.  ml)  as 
suggested  by  Wardlaw  (personal  communication).  Ou.  ml. 
were  calculated  as  opacity  units  X  volume  in  millilitres. 
ii.  Estimation  of  protective  activity 
Protective  activity  of  samples  was  determined  by  a 
slight  modification  of  the  original  method  of  Kendrick  et  al., 
(1947). 67 
Three-week  old  Ham/ICR  mice  of  either  sex  were 
injected  intraperitoneally,  in  randomized  groups  of 
ten,  with  0.5m1  of  graded  doses  of  heated  (56°C  for 
30  min)  B.  pertussis  cell  suspensions.  Fourteen  days 
later  the  mice  were  anaesthetized  with  ether  and  challenged 
intracerebrally  with  0.03m1  of  casamino  acids  solution 
containing  approximately  105  organisms  of  B.  pertussis 
strain  18323  of  enhanced  virulence  (Section  1  (iv)). 
The  virulence  of  the-challenge  culture  was  checked  by 
injecting  groups  of  unimmunized  mice  with  105.104.2  x  103 
and  2x  102  organisms  per  mouse,  respectively.  Surviving 
mice  were  counted  daily  for  14  days.  Mice  dying  within 
three  days  of  challenge  were  excluded  from  the  results. 
Mice  moribund  on  day  14  were  counted  as  dead. 
ii.  Histamine-sensitizing  activity 
Seven  to  nine-week  old  Hant/ICR  mice  of  either  sex 
were  injected  intraperitoneally,  in  groups  of  five,  with 
0.5m1  of  graded  doses  of  heated  (56°C  for  30  min)  B..  pertussis 
cell  suspensions  or  0.5ml  of  heated  whole  culture  or  heated 
culture  supernatant. 
Five  days  later  the  mice  were  injected  intraperitoneally 
with  3mg  of  histamine  dihydrochloride  (Sigma  Chemical  Co., 
St.  Louis,  Mo.,  U.  S.  A.  )  contained  in  0.5m1  of  saline. 
Survivors  were  counted  4h  after  challenge  with  histamine. 68 
iii.  Leukocytosis-promoting  activity 
Unless  otherwise  stated,  five-week  old  female  Ka_m/ICR 
mice  were  used.  Groups  of  five  mice  were  inoculated 
intravenously  with  0.2m1  or  intraperitoneally  with  0.5m1 
amounts  of  B.  pertussis  samples.  Control  mice  were 
inoculated  with  saline  only.  Four  days  after  inoculation 
mice  were  anaesthetized  and  bled  from  the  orbital  plexus 
with  heparinized  capillary  tubes  (Harshaw  Chemicals  Ltd., 
Daventry,  Northants,  England).  The  blood  sample  (40111) 
was  immediately  transferred  with  a  Coulter  pipette  to  plastic 
vials  containing  20m1  Isoton  II  diluent  (Coulter  Electronics 
Ltd.,  Harpenden,  Herts,  England)  to  give  a  final  blood 
concentration  of  1:  501. 
Immediately  before  counting,  six  drops  of  Zap-Oglobin 
(Coulter'Electronics  Ltd.,  Harpenden,  Herts,  England)  were 
added  to  each  vial  to  lyse  the  red  blood  cells.  Enumeration 
of  leukocytes  was  done  using  a  Coulter  Counter  model  FN 
(Coulter  Electronics  Ltd.,  Harpenden,  Herts,  England). 
Duplicate  or  triplicate  counts  of  each  diluted  blood  sample 
were  made  and  the  mean  of  these  counts  was  calculated  for 
each  sample.  To  correct  for  coincidence  losses  during 
counting,  mean  counts  above  10,000  were  adjusted  with  a 
coincidence  correction  chart.  Mean  background  counts, 
from  diluent  alone,  were  subtracted  from  each  corrected 
count  to  obtain  the  final  corrected  mean  count  for  each 
animal  or  group  of  mice. 69 
iv.  Heat-labile  toxicity 
Three  to  four-week  old  Ham/ICR  male  mice  were  injected 
intraperitoneally,  in  groups  of  five,  with  0.5ml  of  graded 
doses  of  unheated  samples  of  B.  pertussis.  Deaths  were 
recorded  over  the  next  three  days. 
When  samples  were  heated  (56°C  for  30  min)  lethality 
was  completely  abolished. 
v.  Toxicity  as  measured  by  the  mouse  weight-gain  test 
Three  to  four-week  old  Ham.  /ICR  male  mice  were  injected 
intraperitoneally,  in  groups  of  five  (of  approximately  same 
weight)  with  0.5ml  of  graded  doses  of  heated  (56°C  for  30  min) 
cell  suspensions.  Mice  were  weighed  just  before  inoculation 
and  then  daily  for  seven  days. 
vi.  Estimation  of  the  distribution  of  biological 
activities  between  cells  and  culture  supernatant 
Aliquots  of  50ml  of  culture  were  harvested  at  various 
stages  of  growth  by  centrifugation  at  8000  r.  p.  m.  (10,000  x  g) 
in  50m1  bottles  at  4°C  for  30  min  in  an  MSE  25  centrifuge. 
Supernatant  fluid  was  carefully  removed  and  cell  pellets 
were  thoroughly  resuspended  to  the  original  volume  with 
saline.  The  cell  suspension  and  supernatant  samples  were 
heated  in  a  water  bath  at  56°C  for  30  min,  then  cooled  and 
stored  at  -20°C  until  they  could  be  used.  Samples  were 
assayed  for  HSF  and  LPF  activities.  Samples  for  assay  of 
HLT  activity  were  not  heated. 70 
vii.  Disruption  of  cells 
Packed  cells  were  adjusted  to  100  o.  u.  and  after  freezing 
in  dry  ice,  were  broken  by  three  passages  through  an  X-press 
(LKB,  Instruments  Ltd.,  South  Croydon,  Surrey). 
SECTION  3:  BIOCHEMICAL  MATERIALS  AND 
METHODS 
i.  Protein  estimation 
Compositions  of  reagents  used  are  shown  in  Appendix  2.  ' 
Estimates  were  done  by  the  method  of  Herbert,  Phipps  and 
Strange  (1971)  with  bovine  serum  albumin  (Sigma  Chemical  Co., 
St.  Louis,  U.  S.  A.  )  as  a  standard). 
a)  0.5m1  of  distilled  water  (or  buffer)  were 
dispensed  into  duplicate  tubes  as  blanks. 
b)  0.5ml  of  samples  were  dispensed  into  duplicate 
test  tubes. 
c)  Dilutions  of  the  standard  protein  (BSA)  (500)  400, 
300,200,100  and  501g/m1)  were  prepared.  0.5m1  of  each 
dilution  was  dispensed  into  duplicate  test  tubes. 
d)  0.5m1  of  1N  NaOH  was  added  to  each  of  the  tubes  (a,  b 
and  c  above).  All  the  tubes  were  placed  in  a  boiling  water 
bath  for  5min,  then  removed  and  allowed  to  cool. 
e)  2.5ml  of  reagent  C  was  added  to  each  of  the  tubes, 
after  which  the  tubes  were  allowed  to  stand  for  10  min. 
f)  0.5m1  of  reagent  D  was  added  to  all  the  tubes.  Tubes 
were  allowed  to  stand  for  30  min  for  full  colour  development. 
g)  The  optical  density  of  the  solution  in  each  tube 
was  measured  at  750nm  against  the  blanks  (a). 71 
h)  A  curve  of  the  optical  density  values  against 
concentrations  of  the  standard  protein  was  drawn  and  from 
this  curve  the  protein  concentrations  in  samples  were 
estimated. 
ii.  Slab-gel  electrophoresis 
The  method  used  was  based  on  that  of  Laemmli  (1970) 
as  modified  by  Ames  (1974).  Electrophoresis  was  done  in  the 
presence  of  sodium  dodecyl  sulphate  (SDS)  in  a  discontinuous 
gel  and  buffer  system.  Seperating  and  stacking  gels 
contained  respectively  10%  (w/v)  and  5%  (w/v)  acrylamide 
(British  Drug  Houses  Ltd.,  Poole,  England).  Both  the  gels 
and  buffers  contained  0.1%  (w/v)  SDS. 
The  dimensions  of  the  slabs  were  approximately  8.0  x  7.0 
x  0.3cm,  the  seperating  gels  being  6.0  x  7.0  x  0.3cm. 
Details  of  reagents,  preparation  of  gels,  staining  and 
destaining  are  given  in  Appendix  3.  Samples  were  adjusted 
to  contain  2mg  protein/ml  and  0.5m1  of  sample  was  added  to 
0.5m1  of  0.125M  Tris-HCL  buffer  pH  6.8  containing  4%  (w/v) 
SDS,  10%  (v/v)  P-mercaptoethanol,  20%  (v/v)  glycerol  and 
0.002%  (w/v)  bromophenol  blue.  The  mixture  was  heated  at 
100°C  for  5  min  prior  to  application  of  between  20  and  100µ1 
to  the  gel. 
Electrophoresis  was  done  in  a  Uniscil  slab  gel  electro- 
phoresis  unit  (Universal  Scientific  Ltd.,  London)  at  a 
constant  current  of  15  mA/gel  for  approximately  3h. 
Staining  and  destaining  was  by  the  method  of  Weber  and 
Osborn  (1969).  Destaining  was  accomplished  with  several 72 
changes  of  the  destaining  solution. 
For  molecular  weight  estimations,  the  following 
mixture  of  protein  standards  was  run  under  identical 
conditions  :  bovine  serum  albumin  (Mol.  wt.  67,000. 
Sigma  Chemical  Co.,  St.  Louis,  U.  S.  A.  ),  ovalbumin  (43,000. 
Sigma  Chemical  Co.,  St.  Louis,  U.  S.  A.  ),  bovine  chymotrypsinogen 
(25,700.  Miles  Seravac,  Maidenhead,  Berkshire),  trypsin 
(23,000.  Armour  Pharmaceutical  Co.,  Eastbourne,  Sussex)  and 
horse-heart  cytochrome  c  (11,700.  Koch  Light,  Colnbrook, 
Buckinghamshire). 
iii,  Tube-gel  electrophoresis 
The  same  method  and  reagents  were  used  as  for  slab-gel 
electrophoresis  except  that  gels  were  prepared  in'clean  glass 
tubes  and  run  ine  Shandon  analytical  polyacrylamide  gel 
electrophoresis  outfit  (Shandon  Southern  Instruments  Ltd., 
Surrey,  England)  at  a  constant  current  of  imA  per  tube  for 
approximately  22h. 
iv.  Uptake  of  labelled  glutamate 
Twenty  ml  volumes  of  48h  cultures  of  B.  pertussis 
strain  134  in  Stainer  and  Scholte  X-medium  were  spun  down 
in  sterile  universals  at  4000  r.  p.  m.  (3000  x  g)  for  30  min 
in  a  bench  centrifuge  (MSE  super  minor).  The  cell  pellets 
were  evenly  resuspended  in  40m1  of  Stainer  and  Scholte  X-  or 
C-mediumin  50m1  conical  flasks.  These  media  contained  one 
tenth  of  the  normal  amount  of  glutamate  (1.072g) 
and  ten  times  the  normal  amount  of  proline  (2.4g). 73 
200µl  of 
14C 
glutamate  (>250mCi/m  mol)  (Radiochemical 
Centre,  Amersham)  was  added  to  each  flask.  Flasks  were 
incubated  in  a  shaking  water  bath  at  35°C  for  $h.  Cultures 
were  harvested  by  centrifugation  and  the  cell  pellets  obtained 
were  washed  twice  and  resuspended  in  distilled  water.  To 
determine  the  distribution  of 
14C 
glutamate  in  the  cellular 
proteins,  cell  suspensions  were  adjusted  to  a  concentration 
of  80  o.  u.  and  prepared  for  tube-gel  electrophoresis  as 
described  in  Section  3  (iii). 
v.  Densitometry  and  gel  slicing 
Densitometer  traces  of  stained  gels  were  obtained  by 
means  of  a  Joyce-Loebi  Ultraviolet  Scanner  with  an  effective 
scanning  aperture  of  0.05mm  and  fitted  with  a  280nm 
interference  filter  (Joyce-Loebl  and  Co.  Ltd.,  Gateshead, 
England). 
For  gel  slicing,  destained  gels  were  carefully  wrapped 
in  aluminium  foil  and  frozen  in  crushed  dry  ice.  Frozen 
gels  were  sliced  into  1.00mm  sections  starting  from  the 
bottom  end,  with  a  Mickle  gel  slicer  (Mickle  Laboratory 
Engineering  Co.  Surrey,  England). 
vi.  Determination  of 
14C 
in  gel  slices 
Gel  slices  were  transferred  to  numbered  test  tubes 
and  allowed  to  dry  under  an  infra  red  lamp  for  2h.  To 
each  tube  was  added  0.25m1  of  a  mixture  of  one  volume  of 
concentrated  NH4OH  added  to  99  volumes  of  30%  H202  which 
had  been  cooled  to  00C  in  ice.  This  mixture  was  used 74 
immediately  after  preparation.  Tubes  were  incubated  at 
37°C  for  3-4h.  The  gel  slices  were  completely  dissolved  by 
this  treatment. 
The  content  of  each  tube  was  transferred  to  a 
scintillation  vial,  the  tubes  rinsed  with  distilled  water  and 
the  washing  also  transferred  to  the  vial.  The  volume  in 
each  vial  was  made  up  to  1.5ml  with  distilled  water  and  10mi 
of  Triton-toluene  scintillant  was  added.  The  vial  was 
capped,  mixed  and  counted  for  one  minute  in  an  Automatic 
Spectrometer,  Model  NE8312  (Nuclear  Enterprises  Ltd., 
Edinburgh).  Composition  of  the  Triton-toluene  scintillant 
is  given  in  Appendix  2. 
vii.  Estimation  of  proteolytic  activity  of  samples 
Two  colourimetric  methods  were  used  for  the  estimation 
of  the  proteolytic  activity  of  samples.  The  methods 
involved  the  use  of  Azocoll  and  Azocasein  respectively  as 
substrates. 
a.  Use  of  Azocoll 
Azocoll  (Calbiochem.,  San  Diego,  California)  is  an 
insoluble.  powdered  cowhide  to  which  is  bound  a  red  dye. 
, 
It  contains  an  assortment  of  peptide  linkages  characteristic 
of  all  proteins  and  is  used  for  a  non-specific  assay  for 
proteolytic  activity. 
In  the  presence  of  a  proteolytic  enzyme,  some  of  these 
linkages  are  split,  leading  to  the  release  of  the  dye  into 
solution.  The  colour  intensity  of  the  solution  after 75 
centrifugation  indicates  the  degree  of  splitting  of  the 
peptide  bonds  and  thus  the  level  of  proteolytic  activity. 
For  the  preliminary  estimation  of  proteolytic  activities 
of  X  and  C  cultures,  the  enzyme  pronase  (Sigma  Chemical  Co., 
St.  Louis,  U.  S.  A.  )  was  used  as  a  standard.  Serial  dilutions 
of  a  stock  solution  of  the  enzyme  (5mg/ml)  was  made  in  0.1M 
phosphate  buffer  at  pH  7.0.  To  5ml  of  each  enzyme  dilution, 
and  5ml  of  culture  samples  in  61,  x  5/8"  test  tubes,  25mg  of 
. 
Azocoll  was  added.  Tubes  were  incubated  in  a  water  bath 
at  37°C  for  30  min  with  constant  mixing.  After  incubation 
the  insoluble  azocoll  was  deposited  by  centrifugation  at 
4000  r.  p.  m.  (3000  x  g)  for  30  min  and  the  optical  density  of 
the  supernatant  solutions  measured  at  520nm. 
b.  Use  of  Azocasein 
Azocasein  (Sigma  Chemicals  Co.,  St.  Louis,  U.  S.  A.  ) 
is  essentially  fat-free  casein  to  which  a  red-orange  dye  has 
been  coupled.  The  principle  of  the  assay  method  is  the 
same  as  for  azocoll. 
The  substrate  solution  used  in  the  assay  contained 
25mg  of  azocasein  and  5mg  NaHCO3  per  ml.  This  was 
prepared  by  dissolving  2.5g  of  azocasein  in  50m1  of  1%  (w/v) 
NaHCO3  at  60°C  with  stirring..  The  pH  was  adjusted  to  8.3 
and  the  solution  diluted  to  100ml  with  distilled  water. 
The  enzyme  subtilisin  (Sigma  Chemicals  Co.,  St.  Louis, 
U.  S.  A.  ),  a  protease  prepared  from  Bacillus  am  loli  uefaciens, 
was  used  as  the  standard  enzyme.  Serial  dilutions  of  the 
enzyme  were  made  in  bicarbonate  buffer,  pH  8.3. 76 
For  the  estimation  of  proteolytic  activity,  0.3m1  of  each 
of  the  X-  and  C-  mode  samples  in  duplicates  and  the  various 
enzyme  dilutions  were  pipetted  into  6"  x  5/81,  test  tubes. 
To  each  tube  0.3m1  of  the  substrate  solution  was  added 
Control  tubes  with  madýamohiy  were  set  up.  All  the  tubes 
were  incubated  in  a  water  bath  at  37°C.  After  30  min 
the  digestion  was  stopped  and  undigested  azocasein 
precipitated  from  the  solution  by  the  addition  of  2.4m1 
of  5%  (w/v)  trichloroacetic  acid  to  each  tube.  The 
contents  of  each  tube  was  centrifuged.  To  2ml  aliquots 
of  supernatant  from  each  tube  was  added  2ml  of  0.5N  NaOH 
and  the  optical  density  was  measured  at  440nm. 
SECTION  4:  IMMUNOLOGICAL  MATERIALS 
AND  METHODS 
1.  Preparation  of  rabbit  anti-serum  to  B.  pertussis 
Rabbit  anti-B.  pertussis  serum  was  raised  by  immunizing 
female  adult  rabbits.  with  X-  and  C-mode  cell  suspensions 
adjusted  to  a  concentration  of  10  o.  u.  Each  rabbit  was 
given  four  subcutaneous  injections  of  1.5m1  amounts  and 
one  intravenous  injection  of  4ml  of  the  cell  suspensions. 
The  subcutaneous  injections  were  repeated  at  weekly  intervals 
for  six  weeks.  After  a  rest  period  of  two  weeks,  the 
rabbits  were  given  similar  subcutaneous  injections  for 
two  further  weeks.  The  animals  were  bled  through  the 
ear  vein  seven  days  after  the  last  injection.  The  blood 
was  allowed  to  clot,  then  refrigerated  for  four  hours  and 
the  serum  collected  by  centrifugation  and  stored  at  -20°C. 77 
ii.  Preparation  of  specific  X  and  specific  C 
anti-sera 
Aliquots  of  25m1  of  48h  X-  and  C-  cultures  in  modified 
Hornibrook  medium  were  spun  down  in  universal  containers 
at  3000  r.  p.  m.  for  30  min.  X-mode  cell  pellets  obtained 
were  resuspended  in  5ml  of  undiluted  anti-C  serum. 
Similarly,  C-mode  cell  pellets  were  resuspended  in  5m1  of 
undiluted  anti-X  serum.  Both  cell  suspensions  were 
incubated  at  37°C  for  1h,  then  shaken  for  20  min  at  room 
temperature  with  a  wrist-action  shaker  (Griffin  and  Tatlock 
Ltd.,  London).  Bacterial  cells  were  removed  by  centrifugation 
and  the  absorption  repeated  three  times  with  fresh  batches  of 
cells. 
iii.  Agglutination  tests 
Fresh,  unheated  cell  suspensions  were  used  for  agglutination 
tests.  X-  and  C-  mode  cultures  were  harvested  at  various 
intervals  during  growth.  Cell  pellets  obtained  were 
evenly  resuspended  in  0.85%  (w/v)  saline  and  adjusted  to 
a  concentration  of  10  o.  u. 
Doubling  dilutions  of  anti-sera  in  normal  saline  were 
made  in  22ºº  x  3/$1º  test  tubes.  Each  dilution  was  dispensed 
in  0.05m1  amounts  into  wells  in  plastic  disposable  Cooke 
micro-titre  trays  (Sterilin  Ltd.,  Sussex,  England). 
0.05m1  amounts  of  cell  suspensions  were  added  to  each 
well.  Controls  with  no  antiserum  (cell  suspension  and 
saline)  were  also  included.  Trays  were  shaken 
periodically  for  30  min  at  room  temperature  and  incubated 78 
at  37°C  for  lh.  After  incubation,  trays  were  refrigerated 
for  another  lh  and  results  were  read  with  a  plate  microscope. 
The  end  point  was  taken_as_the  reciprocal  of  the  highest 
dilution  still  showing  definite  agglutination. 
iv.  Haemagglutination  tests 
Tests  were  performed  in  Cooke  plastic  micro-titre 
trays  (Sterilin  Ltd.,  Sussex,  England)  with  microdroppers 
and  microdiluters  (Cooke  Engineering  Co.,  Alexandria, 
Virginia). 
Serial  two-fold  dilutions  of  samples  were  made  in 
Dulbecco  A  phosphate  buffered  saline  pH  7.3  (Oxoid  Ltd). 
Two  drops  (0.05m1)  of  2%  (v/v)  horse  erythrocytes  in  PBS 
were  added  to  each  well.  Controls  with  no  B.  pertussis 
samples  (only  PBS  and  red  cells)  were  included.  Each 
test  was  done  in  duplicate.  Mixtures  were  shaken  and 
incubated  at  37°C.  After  24h,  results  were  read,  then 
trays  were  left  at  4°C  overnight  and  read  again.  The 
haemagglutination  titre  was  taken  as  the  reciprocal  of  the 
highest  dilution  showing  complete  agglutination  of  the 
erythrocytes. 
SECTION  5  :"  STATISTICAL  METHODS 
i,  Probit  analysis 
Results  from  the  HSF,  mouse-protection  and  heat-labile 
toxicity  assays  were  analysed  by  the  probit  method  (Finney, 
192)  using  a  computer  programme  developed  in  the  Department 
of  Epidemiology  and  Biometrics,  School  of  Hygiene,  University 
of  Toronto,  Canada.  One  sample  was  used  as  a  standard  and 79 
the  potencies,  with  the  95%  confidence  limits,  of  other 
samples  relative  to  the  standard  were  estimated.  In  some 
experiments,  a  local  B.  pertussis  18334,  vaccine  produced 
in  this  laboratory  was  used  as  standard.  The  ED50  values 
of  the  samples  were  also  calculated. 
ii.  Rankit  analysis  of  leukocyte  counts 
Rankit  plots  of  leukocyte  counts  were  done  to  see  if 
the  data  could  reasonably  be  regarded  as  random  samples 
from  a  normal  distribution.  This  was  to  facilitate 
subsequent  statistical  processing. 
The  leukocyte  count  for  each  group  of  mice  was  arranged 
in  rank  order,  from  the  highest  to  the  lowest  counts.  The 
log10  of  the  arithmetic  counts  were  also  arranged  in  rank 
order.  From  a  rankit  table  (Bliss,  1967),  rankit  values 
were  assigned  to  the  counts.  Results  were  analysed  by 
plotting  the  graphs  of  the  rankit  values  against  arithmetic 
counts.  Similar  rankit  plots  were  done  with  the  log10 
values  of  the  leukocyte  counts. 
iii.  The  4-point  and  6-point  assays 
LPF  activities  of  unknown  samples  and  standards  were 
compared  by  the  4-point  or  6-point  assay  methods  (A.  C. 
V'ardlaw,  personal  communication). 
The  4-point  assay  design  involves  testing  low  and  high 
doses  of  standard  and  unknown  preparations.  The  6-point 
assay  tests  three  evenly  spaced  doses  of  the  unknown  against 
the  same  three  similarly  spaced  doses  of  the  standard. 80 
The  C-mode  preparations  were  compared  with  the  X-mode 
preparations  as  standards.  X-mode  samples  from  various 
stages  of  growth  were  also  compared  with  a  standard  X-mode 
preparation. 
Results  of  the  4-point  or  6-point  assays  were  analysed 
by  an  Olivetti  computer  programme  (A.  C.  Wardlaw,  personal 
communications)  using  a  Programma  101  Electronic  desk-top 
computer  (British  Olivetti  Ltd.,  Berkeley  Square,  London). 
The  relative  potency  values  and  the  95%  confidence  limits 
of  the  unknown  preparations  to  the  standards  were  obtained. 
iv.  Bartlett's  test  and  the  analysis  of  variance 
Variances  were  tested  for  homogeneity  by  the  Bartlett 
test  and  analysis  of  variance  was  done  according  to  schemes 
prepared  by  Wardlaw  (personal  communication). RESULTS 81 
SECTION  I:  DEVELOPMENT  OF  AN  ASSAY 
METHOD  FOR  THE  LEUKOCYTOSIS- 
PROMOTING  FACTOR  (LPF) 
Preliminary  experiments  in  this  study  showed  that  LPF 
was  lost  in  C-mode  cells.  One  of  the  aims  of  this  project 
was  to  determine  the  time  sequence  of  loss  of  the  various 
immunological  and  pathophysiological  activities  during 
modulation.  The  experimental  approach  was  to  quantitate 
the  potency  of  each  of  the  active  factors  in  the  C-mode  cells 
at  various  intervals.  At  the  beginning  of  this  study, 
methods  were  available  for  quantitating  the  potencies  of 
HSF,  PA  and  HLT  in  B.  pertussis  preparations  but  there  was 
no  suitable  method  for  determining  LPF  potency.  Thus 
initial  experiments  were  set  up  to  devise  a  suitable  assay 
system. 
1.  Factors  influencing  the  LPF  response 
in  mice 
In  order  to  obtain  the  optimal  conditions  for  an  LPF 
assay,  it  was  first  necessary  to  examine  the  effect  of  a 
number  of  variables  on  the  LPF  response  of  mice.  This 
was  important  because  factors  like  sex,  age  and  strain 
have  been  reported  to  influence  histamine-sensitization  in 
mice  (Bergman  and  Munoz,  1964;  Munoz  and  Bergman,  1968; 
Morse,  1977). 82 
i.  Time  interval  between  inoculation  and  bleeding 
Seven-week  old  female  Ham/ICR  mice  were  inoculated 
intraperitoneally,  in  groups  of  five,  with  0.5m1  of  heated 
(560C/30  mins)  cell  suspensions  obtained  from  a  48h  X-mode 
culture  of  B.  pertussis  strain  1$334.  Another  group  of 
mice  received  saline  only.  Mice  were  bled  for  leukocyte 
counts  on  days  1,3,4  and  8  after  inoculation. 
As  depicted  in  Figure  2A,  striking  leukocytosis 
occurred  in  all  animals  inoculated  with  the  cell  suspensions. 
The  response  reached  maximum  levels  by  about  day  4  and  began 
to  show  a  slight  decline  by  day  8.  Figure  2B  shows  that 
the  leukocyte  count  was  dose-dependent.  In  subsequent 
LPF  experiments  mice  were  routinely  bled  for  leukocyte 
counts  on  day  4  after  inoculation  in  order  to  obtain  the 
maximum  LPF  response. 
ii.  Sex 
To  determine  the  effect  of  the  sex  of  mice  on  the  LPF 
response,  seven-week  old  male  and  female  Ham/ICR  mice  were 
injected  intraperitoneally  with  heated  cell  suspensions 
obtained  from  a  48h  X-mode  culture  of  strain  18334.  Similar 
groups  of  mice  were  inoculated  with  saline  only  and  all 
animals  were  bled  4  days  later  for  leukocyte  counts. 
Figure  3  shows  that  the  dose-response  curve  for  the 
male  mice  was  more  elevated  than  for  the  female  mice. 
Analysis  of  variance  of  the  data  confirmed  that  the  LPF 
responses  in  the  male  mice  were  significantly  higher  than 
in  the  female  mice  at  all  doses  tested  (Appendix  4a). 
There  was  no  significant  difference  in  the  leukocyte  counts Figure  2:  A.  Determination  of  peak  of  LPF 
response  with  time. 
Groups  of  five  7-week  old  female 
Ham/ICR  mice  were  injected 
intraperiotoneally  with  graded 
doses  of  B.  pertussis  strain 
18334  X-mode  cell  suspensions 
and  bled  at  intervals  for 
leukocyte  counts. 
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Figure  3  Effect  of  sex  of  mouse  on  LPF  response. 
Groups  of  five  7-week  old  male  and 
female  Ham/ICR  mice  were  injected 
intraperitoneally  with  graded  doses 
of  heated  X-mode  cell  suspensions 
from  a  48h  culture  of  B.  pertussis 
strain  18334.  Mice  were  bled  four 
days  later  for  leukocyte  counts. 
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of  male  and  female  mice  inoculated  with  saline  alone. 
Although  the  males  were  somewhat  more  responsive  and 
therefore  would  be  more  suitable  for  LPF  assay,  female  mice 
were  used  in  subsequent  LPF  experiments  because  they  were 
more  readily  available  in  the  numbers  required. 
iii.  Route  of  inoculation 
The  intraperitoneal  and  the  intravenous  routes  of 
inoculation  were  compared.  Groups  of  five-week  old 
female  Ham/ICR  mice  were  inoculated  intravenously  or 
intraperitoneally  with  identical  graded  doses  of  a  48h 
heated  X-mode  culture  of  strain  18334  contained  in  0.2m1 
or  0.5m1  volumes  respectively. 
Figure  4  shows  that  the  dose  response  curve  for  the 
intravenous  route  was  much  steeper  than  that  for  the 
intraperitoneal  route.  Further  analysis  of  data  by  the 
Student  t-test  showed  that  mice  were  four  times  more 
responsive  by  the  intravenous  route  than  by  the  intraperitoneal 
route  (Appendix  4b).  Based  on  this  observation  the  intravenous 
route  of  inoculation  was  therefore  used  in  subsequent  LPF 
experiments. 
iv.  AEe 
Groups  of  female  Ham/ICR  mice  of  various  ages  were 
inoculated  intravenously  with  0.2m1  of  heated  cell 
suspensions  obtained  from  a  48h  X-mode  strain  18334  culture. 
Similar  groups  of  mice  of  approximately  equal  weights  were 
inoculated  with  saline  alone.  In  another  experiment  female 86 
Figure  4  Effect  of  route  of  inoculation  on 
LPF  response. 
Five-week  old  Ham/ICR  mice  were 
inoculated  intravenously  or 
intraperitoneally  with  graded 
doses  of  B.  pertussis  strain  18334 
X-mode  whole  culture. 
6A  intravenous  route 
AA  intraperitoneal  route 
Bars  represent  the  standard  deviations 
from  the  mean  leukocyte  counts. 
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NIH  mice  of  various  ages  were  used. 
With  both  strains  of  mice  the  various  ages  tested  were 
equally  responsive  to  LPF  and  there  was  no  apparent  trend 
for  leukocytosis  to  increase  or  decrease  with  age  (Figures 
5A  and  5B).  It  was  concluded  that  the  age  of  the  mice, 
from  3  to  20  weeks,  had  no  significant  effect  on  the  LPF 
response.  However,  for  the  sake  of  uniformity  and  because 
they  were  more  convenient  to  handle,  five-week  old  mice 
were  used  in  all  subsequent  LPF  experiments. 
v.  Strain 
The  possible  effect  of  the  strain  of  mouse  on  LPF 
response  was  examined  further.  Groups  of  five-week  old  and 
eight-week  old  female  NIH  and  Ham/ICR  mice  each  containing 
five  animals,  were  inoculated  intravenously  with  0.2ml  of 
heated  X-mode  cell  suspension.  Similar  groups  of  the  two 
strains  of  mice  were  inoculated  with  saline  only. 
Table  5  shows  both  the  mean  arithmetic  and  the  mean 
log10  leukocyte  counts  obtained.  Log10  leukocyte  counts 
were  further  examined  by  analysis  of  variance  (Appendix  4c). 
It  was  apparent  that  there  was  no  significant  difference  in 
the  LPF  responses  of  the  different  groups  with  regards  to 
either  strain  or  age. 
In  subsequent  experiments,  Ham/ICR  mice  were  routinely 
used  because  they  were  more  readily  available. 88 
Figure  5:  Comparison  of  LPF  responses  in  mice 
of  different  ages. 
Strains  Ham/ICR  and  NIH  mice  of  different 
ages  were  inoculated  intravenously  in  groups 
of  five  with  B.  Pertussis  strain  18334 
X-mode  whole  cultures.  Similar  groups  of 
different  ages  of  mice  were  inoculated  with 
saline  alone.  Mice  were  bled  four  days 
later  for  leukocyte  counts. 
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Table  5:  Comparison  of  LPF  responses  in 
two  mouse  strains 
Ham/ICR  NIH 
Mean  leukocyte  count  (WBC/mm3)  and  standard  deviations 
Age  arithmetic  g0  arithmetic  g  mean  mean  mean  mea0 
8  weeks  47,483  4.6669  46,574  4.66 
+  1052  +  0.11  +7,797  +0.09 
5  weeks  59,031  4.7588  57,327  4,75 
+  1449  +  0.12  +  1033  +0.08 
5  weeks  5,657  3.75  6,391  3.802 
(saline  control)+1028  +0.09  +  784  +0.06 90 
2.  Quantitation  of  LPF  response 
i.  Rankit  analysis  of  leukocyte  counts 
For  t-test  and  analysis  of  variance  to  be  valid,  the 
following  conditions  should  be  satisfied 
a.  data  within  each  group  should  approximate  to  a 
normal  distribution. 
b.  the  standard  deviations  within  the  various  groups 
should  not  be  significantly  different. 
Since  the  application  of  statistical  analysis  of  LPF 
results  in  later  experiments  was  intended,  it  was  important 
to  show  that  the  data  obtained  from  the  particular  assay 
method  used  satisfied  the  above  conditions.  Groups  of 
equal  numbers  of  mice  were  used  and  leukocyte  counts  obtained 
were  checked  for  their  normal  distribution. 
Figures  6A  and  6B  show  that  both  the  arithmetic  and  the 
log10  leukocyte  counts  were  evenly  distributed  about  straight 
lines  by  the  rankit  method.  On  application  of  the  Bartlett 
test  for  homogeneity  of  variances,  it  was  found  that  the 
variances  of  the  arithmetic  counts  were  highly  heterogenous. 
However,  with  the  log10  counts,  variances  within 
groups  had  a  satisfactory  degree  of  homogeneity  (Appendix  4d). 
Thus  although  the  rankit  plots  did  not  discriminate  between 
normal  and  log10  normal  distribution,  the  transformation  to 
log10  values  was  desirable  because  of  the  homogeneity  of 
variance  which  then  followed. 91 
Figure  6:  Rankit  analysis  of  arithmetic  and 
log10  leukocyte  counts 
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Figure  6B  Log10  counts 
Dose  per  mouse 
0  -O  0.5m1  of  'culture 
O-O  0.25m1  of  culture 
=--A  0.125m1  of  culture 
0.5m1  of  saline  (control) 2.0 
U) 
w 
3 
I- 
YZ 
Q 
cc 
4.5  5.0  3.6  4.0  (WBC/mm3) 
LOG10  COUNT 93 
ii.  Estimation  of  LPF  potencies 
Having  worked  out  suitable  conditions  for  an  LPF  assay, 
attempts  were  made  to  estimate  the  LPF  potencies  of  samples 
using  the  4-point  and  6-point  assay  methods.  (A.  C.  Wardlaw, 
personal  communication).  These  are  parallel  line  assays 
in  which  unknown  preparations  are  compared  with  standard 
preparations.  In  the  4-point  assay,  two  doses  of  the 
unknown  preparation  are  compared  with  the  same  two  doses 
of  the  standard;  in  the  6-point  assay  three  doses  of  the 
unknown  preparation  are  compared  with  the  identical  doses 
of  the  standard  preparation.  For  these  assays  to  be  valid, 
the  dose-response  curve  of  the  unknown  preparation  must 
parallel  that  of  the  standard  preparation  over  the 
particular  dose  range  tested. 
Groups  of  five-week  old  female  Ham/ICR  mice  were 
inoculated  intravenously  with  graded  doses  of  heated  cell 
suspensions  harvested  at  various  intervals  after  inoculation 
of  X-mode  cells  into  X-  and  C-media.  Cells  harvested  from 
C-medium  after  lOh  growth,  although  they  still  had  some 
X-mode  characteristics,  were  referred  to  as  C-mode  cells  in 
the  present  study.  With  X-mode  samples  as  standards,  an 
attempt  was  made  to  estimate  the  relative  LPF  potencies  of 
the  C-mode  samples  by  the  4-point  and  6-point  assay 
programmes  using  an  Olivetti  computer  (Programma  101). 
The  dose-responses  of  X  and  C-mode  10h  samples  showed 
some  degree  of  parallelism  in  the  4-point  assay  apparently 
because  these  C-mode  cells  still  retained  some  LPF  activity 
(Figure  7).  However,  the  dose-responses  of  older  C-mode 94 
Figure  7:  LPF  dose-response  curves  for  10h  X- 
and  C-mode  cell  suspensions. 
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samples  which  contained  very  little  LPF  activity  showed  no 
parallelism  with  dose-responses  of  their  X-mode  counterparts 
at  the  doses  tested.  The  assay  method  was  valid  only  when 
the  10h  samples  were  compared  but  the  method  was  invalid 
when  the  older  C-mode  samples  were  compared  against  their 
X-mode  counterparts  (Appendix  4e).  At  10h,  the  LPF 
activity  of  the  C-mode  sample  was  only  20%  of  the  activity 
of  the  X-mode  sample  (Table  6). 
With  the  6-point  assay  method,  there  was  lack  of 
parallelism  between  the  dose-responses  for  the  10h  X- 
and  C-mode  samples  (Figure  8),  suggesting  that  the  assay 
method  would  not  be  valid  for  comparing  the  potency  of  any 
C-mode  sample  against  those  of  the  X-mode.  Confirmation  of 
this  observation  was  obtained  statistically  from  the 
tabulated  F-ratio  results  (Appendix  4f). 
Both  the  4-point  and  6-point  assay  methods  were  valid 
when  comparing  any  of  the  X-mode  samples  against  another 
X-mode  sample  as  standard  (Figure  9).  The  LPF  potencies 
of  the  various  X-mode  samples  obtained  by  these  assay  methods 
are  shown  in  Tables6  and  7  and  are  reported  in  detail  in 
Section  2,  part  2iii. 
In  conclusion,  the  LPF  potencies  of  preparations  with 
low  levels  of  activity  can  be  estimated  only  by  the  4-point 
assay  method  while  the  potencies  of  preparations  with 
relatively  high  levels  of  LPF  activity  can  be  estimated  by 
either  the  4-point  or  6-point  assay  methods. 96 
Table  6:  LPF  p  otencies  of  X-  and  C-mode 
cell  suspensions  by  4-p  oint  assay 
Age  of  Relative  potency  (and  95%  confidence 
culture  limits) 
X-mode  C-mode 
10h  1.00  0.20- 
(0.17-0.44) 
24h  1.5  ** 
(0.65-5.6) 
48h  1.5  ** 
(0.57-8.1) 
72h  0.96  ** 
(0.55-5.7) 
**  assay  not  valid  at  doses  tested 
expected  potency  based  on  observed  number  of  cell 
divisions  is  0.8 97 
Figure  8:  LPF  dose-response  curves  for  10h 
X-  and  C-mode  cell  suspensions. 
6-point  assay. 
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Figure  9:  LPF  dose-response  curves  for  10h  and 
48h  X-mode  cell  suspensions. 
6-point  assay. 
10h  X-mode 
ý-ý  48h  X-mode 
Bars  represent  the  standard  deviations 
from  the  mean  leukocyte  counts. 99 
Table  7:  LPF  potencies  of  X-  and  C-mode 
cell  suspensions  by  6-point  assay 
Age  of  Relative  potency  (and  95%  confidence 
culture  limits) 
X-mode  C-mode 
Inoculum  1.00  ** 
(4$h  X-mode) 
10h  0.93  ** 
(0.70-1.2) 
24h  0.95  ** 
(0.76-1.2) 
48h  0.99  ** 
(0.7$-1.3) 
72h  0.97  ** 
(0.55-1.5) 
**  assay  not  valid  at  doses  tested. 4.5 
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SECTION  2:  CULTURAL  CHANGES  DURING 
MODULATION 
Subsection  A:  X  to  C  modulation 
Modulation  was  induced  by  inoculating  X-mode  B.  pertussis 
into  modified  Hornibrook  medium  containing  high  levels 
(5g/1)  of  MgSO4.7H20  (C-medium).  A  number  of  shake  flasks 
containing  either  X-  or  C-medium  were  inoculated  with 
equal  amounts  of  a  48h  X-mode  liquid  culture.  Flasks  were 
incubated  and  harvested  at  various  intervals  during  growth. 
Samples  obtained  were  later  assayed  for  various  pathophysio- 
logical  and  immunological  activities. 
1.  Growth  characteristics 
J.  Comparability  of  shake-flask  cultures 
In  early  experiments,  one  X-mode  and  one  C-mode  shake- 
flask  culture  were  used  and  sampled  repeatedly  at  various 
intervals  during  growth.  However,  this  led  occasionally 
to  problems  with  contamination  and  did  not  provide  enough 
cells  for  all  tests  undertaken.  To  overcome  these  initial 
problems,  a  number  of  flasks  of  X-  and  C-mode  cultures 
were  set  up  in  parallel  so  that  the  contents  of  one  flask 
could  be  harvested  at  each  sampling  time.  In  order  to 
check  the  validity  of  this  procedure  the  following  experiment 
was  done.  At  various  intervals,  estimation  of  viable  cell 
numbers  was  done  on  three  X-mode  and  three  C-mode  flasks. 
The  aim  was  to  determine  if  parallel  shake  flasks  receiving 
the  same  size  of  inoculum  and  grown  under  the  same  conditions 'f 
101 
showed  any  difference  in  viable  cell  numbers  at  any 
sampling  time  during  growth.  The  experiment  was  repeated 
several  times  and  results  obtained  showed  that  viable  counts 
of  the  parallel  cultures  did  not  differ  significantly  at 
any  time  during  growth.  Thus  in  later  experiments  this 
parallel  shake-flask  culture  method  was  adopted. 
ii.  Viable  count  and  optical  density 
At  each  sampling  time  during  growth,  the  viable  cell 
numbers  and  optical  densities  of  X-  and  C-mode  cultures  were 
measured. 
The  viable  counts  in  a  typical  experiment  showed  that 
the  X-  and  C-mode  cells  grew  at  approximately  the  same  rate, 
though  there  seemed  to  be  an  initial  lag  in  the  C-mode 
cultures  (Figure  10A).  The  mean  generation  time  for  both 
X-  and  C-mode  cells  was  found  to  be  approximately  6-7h. 
Despite  the  close  similarity  of  the  viable  counts  of 
X-  and  C-mode  cultures  at  any  given  time,  the  optical 
densities  of  the  C-mode  cultures  were  consistently  higher 
than  those  of  the  X-mode  cultures  throughout  growth 
(Figure  10B).  There  was  an  indication  that  for  the  same 
viable  cell  number  the  C-mode  cells  had  a  higher  optical 
density  than  the  X-mode  cells. 
The  viable  cell  numbers  and  optical  density  values  of 
X-  and  C-mode  cultures  obtained  in  a  number  of  independent 
experiments,  in  which  5%  (v/v)  or  10%  (v/v)  inocula  were 
used,  are  shown  in  Figures  11A  to  12D.  A  10%  (v/v)  inoculum 
was  used  in  some  experiments  to  provide  sufficient  cells  at 102 
Figure  10  Changes  in  viable  cell  numbers  and' 
optical  density  during  growth. 
(Typical  growth  experiment). 
Data  were  obtained  from  growth  of 
B.  pertussis  strain  18334  in  X-  and 
C-media.  A  5%  (v/v)  inoculum  of 
48h  X-mode  culture  was  used. 
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Figure  11  :  Changes  in  viable  cell  numbers 
and  optical  density  during  growth. 
(5%  (v/v)  inoculum) 
Data  were  obtained  from  four 
similar  experiments  in  which 
B.  pertussis  strain  18334  was 
grown  in  X-  and  C-media.  In 
each  experiment,  inoculum  was 
obtained  from  a  48h  X-mode 
culture. 
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Figure  11C  Viable  cell  numbers  in  C-medium 
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Figure  12  Changes  in  viable  cell  numbers 
and  optical  density  during  growth. 
(10ý  (v/v)  inoculum). 
Data  were  obtained  from  three 
similar  experiments  in  which 
B.  pertussis  strain  18334  was 
grown  in  X-  and  C-media. 
In  each  experiment,  inoculum  was 
obtained  from  a  48h  X-mode 
culture.  . 
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Figure  12C  Viable  cell  numbers  in  C-medium 
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10h  to  allow  bio-assays  to  be  repeated  where  necessary. 
2.  Immunological  and  pathophysiological 
activities 
i.  Protective  activity 
Heated  (56°C/30  min)  X-  and  C-mode  cell  suspensions 
harvested  at  various  intervals  during  growth  were  assayed 
for  their  mouse-protective  activities.  In  each  mouse- 
protection  test  the  48h  X-mode  sample  was  used  as  a 
standard  against  which  the  protective  potencies  of  the  other 
-samples  were  compared. 
Results  (Appendix  5)  were  analysed  by  the  probit  method 
using  a  computer  programme.  In  four  independent  experiments 
`.  t 
the  relative  potency  values  obtained  for  each  sample  were 
very  similar,  ranging  from  0.52-0.81  for  X  10h  samples; 
0.006-0.015  for  C  10h  samples  and  0.001-0.008  for  C  48h 
samples  (Table  8).  The  best-estimated  relative  potency 
values  (obtained  as  shown.  in  Appendix  Jig),  from  the  four 
mouse-,  protection  experiments  showed  that  at  10h,  cells 
grown  in  C-medium  had  only  2%  of  the  PA  activity  of  the 
same  age  of  cells  grown  in  X-medium.  At  48h,  the  level 
of  activity  in  the  C-cells  had  decreased  to  0.5%  of  the 
level  of  activity  in  their  X-mode  counterparts,  although 
'  based  on  the  95%  confidence  limit  values,  the  C  10h  and 
C  48h  samples  were  not  significantly  different  in  their 
. 
protective  potencies.  There  was  also  no  significant 
,,, 
difference  between  the  levels  of  activities  in  the  10h  and 
=4  h  X-mode  samples  because  the  protective  potency  value  of H 
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the  48h  X-mode  sample  was  within  the  95%  confidence  limits 
of  the  potency  value  for  the  l0h  X-mode  sample  (Table  8). 
In  view  of  the  rapid  loss  of  PA  activity  in  C-medium, 
it  was  of  interest  to  determine  the  potencies  of  C-mode 
F 
cells  which  would  be  expected  if  there  was  no  further 
synthesis  of  the  PA  when  X-mode  cells  were  inoculated  into 
C-medium.  If  the  original  PA  activity  in  the  inoculum  was 
diluted  among  the  progeny  cells,  the  expected  potencies  of 
the  C-mode  samples  based  on  the  number  of  cell  divisions  which 
had  occurred  in  C-medium,  would  be  0.77  and  0.15  for  C  10h  and 
C  4ßh  samples  respectively  (Table  8).  The  actual  results 
obtained,  0.012  and  0.005  for  C  10h  and  C  48h  samples 
respectively,  deviated  greatly  from  these  expected  results. 
This  suggested  that  the  loss  of  PA  activity  in  the  C-mode 
cells  was  greater  than  would  be  expected  from  a  simple 
dilution  effect.  It  thus  appeared  that  the  original  PA 
contained  in  the  X-mode  inoculum  was  degraded  or  denatured 
during  modulation., 
iil.  Histamine-sensitizing  activity 
The  HSF  activities  of  heated  X-  and  C-mode  cell 
suspensions  harvested  at  various  intervals  during  growth 
were  also  estimated.  In  some  experiments,  the  HSF  activities 
of  X-  and  C-mode  whole  cultures  were  estimated. 
The  dose  of  each  sample  required  to  sensitize  50%  of  the 
test  animals  to  subsequent  challenge  with  histamine  (HSD50) 
was  obtained  by  probit  analysis  using  a  computer  programme. 110 
Results  obtained  from  eight  independent  experiments, 
in  which  5%  (v/v)  inocula  were  used,  were  very  consistent. 
Similarly  the  individual  results  from  six  independent 
experiments  in  which  10%  (v/v)  inocula  were  used,  did  not 
differ  significantly.  In  three  of  these  experiments  with 
a  10%  inoculum,  whole  culture  samples  were  also  assayed 
and  again  results  were  consistent.  From  the  various 
individual  experiments,  the  best-estimated  HSD50  values 
were  calculated  (Tables  9A,  9B  and  9C)  and  the  reciprocal 
of  these  values  were  plotted  against  sampling  time. 
Figures  13A  and  13B  show  that  with  a  5%  (v/v)  inoculum,  the 
level  of  HSF  activity  in  the  X-mode  cell  suspensions  remained 
relatively  constant  during  growth.  However,  with  the 
C-mode  cell  suspensions,  the  level  of  activity  decreased 
rapidly  with  time.  After  10h,  the  C-cells  had  only  12% 
of  the  activity  of  their  X-mode  counterparts  and  by  the  72h 
the  activity  in  the  C-mode  cells  had  dropped  to  1%  of  that 
of  the  72h  X-mode  cells  (Table  9A). 
Results  from  experiments  with  a  10%  (v/v)  inoculum 
further  showed  that  the  activity  in  X-mode  cells  per  unit 
of-opacity  again  stayed  relatively  constant  during  growth 
but  decreased  rapidly  with  time  in  the  C-mode  cells 
(Figures  14A  and  14B).  By  10h  and  72h,  the  percentage 
activities  of  the  C-mode  cells  relative  to  their  X-mode 
counterparts  were  11%  and  2%  respectively  (Table  9B). 
Thus  these  values  were  very  similar  to  those  obtained  with 
a,.  5%  inoculum. 111 
Table  9A:  Histamine-sensitizing  activity 
°  in  X-  and  C-mode  cell  suspensions 
harvested  at  various  intervals  during 
growth  (5%(v/v)  inoculum) 
Sample  HSD50  in  opacity  unit.  ml  (Best-estimate  values 
from  eight  independent  experiments). 
10h  24h  48h  72h 
X-mode  0.36  0.47  0.29  0.23 
C-mode  3.1  4.9  16.4  20.8 
Percentage 
activity  of  12%  10%  2%  1% 
C-mode  relative 
to  X-mode 
Table  9B:  Histamine-sensitizing  activity 
X-  and  C-mode  cell  suspensions 
harvested  at  various  intervals  during 
growth  (10%(v/v)  inoculum). 
Sample  HSD50  in  opacity  unit.  ml  (Best-estimate  values 
from  six  independent  experiments). 
10h  24h  48h  72h 
X-mode  0.62  0.55  0.61  0.57 
C-mode  5.6  12.9  33.3  33.3 
Percentage 
activity  of  11%  4%  2%  2% 
C-mode  relative 
to  X-mode 112 
Table  9C:  Histamine-sensitizing  activity  in 
X-  and  C-mode  whole  cultures  obtained 
at  various  intervals  during  growth 
(10%(v/v)  inoculum). 
Sample  HSD50  (ml  of  whole-culture  sample).  (Best- 
estimate  values  from  three  independent 
experiments) 
10h  24h  48h  72h 
X-mode  0.13  0.07  0.06  0.08 
C-mode  0.56  0.70  1.3  2.9 
Percentage 
activity  of  23%  10%  5%  3% 
C-mode  relative 
to  X-mode 113 
Figure  13  :  Changes  in  the  levels  of  histamine- 
sensitizing  activity  and  viable  cell 
numbers.  (5%  (v/v)  inoculum). 
Histamine-sensitizing  activity  was 
measured  in  cells  harvested  at  various 
intervals  during  growth  of  X-mode 
B.  pertussis  strain  18334  in  X-  and  C- 
media.  Data  represent  the  reciprocal  of 
the  best-estimated  HSD50  values  and 
mean  viable  cell  numbers  obtained  from 
eight  similar  experiments. 
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Figure  14  :  Changes  in  the  levels  of  histamine- 
sensitizing  activity  and  viable  cell 
numbers  (10%  (v/v)  inoculum) 
Histamine-sensitizing  activity  was 
measured  in  cells  harvested  at  various 
intervals  during  growth  of  X-mode 
B.  pertussis  strain  18334  in  X-  and 
C-media.  Data  represent  the 
reciprocal  of  the  best  estimated 
HSD50  values  and  mean  viable  cell 
numbers  obtained  from  six  similar 
experiments 
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When  the  total  HSF  activity  present  in  the  culture  was 
estimated  by  testing  graded  doses  of  whole  culture  samples, 
it  was  found  that  the  activity  of  the  X-mode  cultures 
increased  simultaneously  with  cell  numbers  whereas  the 
activity  in  the  C-mode  cultures  showed  a  slight  increase 
initially  then  decreased  gradually  with  time  (Figures  15A 
and  15B).  As  depicted  in  Table  9C,  the  total  levels  of 
activity  in  10h  and  72h  C-mode  cultures  were  only  23%  and  3% 
respectively  of  the  levels  of  activity  in  the  10h  and  72h  X-mode 
cultures.  The  results  suggested  that  HSF  may  be  transiently 
synthesized  immediately  after  transfer  of  X-mode  cells  to 
C-medium  but  as  the  culture  aged,  the  level  of  activity 
declined. 
In  order  to  determine  if  loss  of  HSF  activity  in  C-mode 
cells  could  be  accounted  for  solely  by  dilution  among  progeny 
cells,  the  levels  of  HSF  activities  of  X-  and  C-mode  cell 
suspensions  were  correlated  with  the  viable  cell  numbers  up 
to  the  end  of  log  phase.  Results  from  experiments  with 
5%  (v/v)  and  10%  (v/v)  inocula  are  shown  in  Figures  16A  and 
16B.  Line  1  in  both  graphs  represents  the  expected  level 
of  HSF  activity  in  the  X-mode  cells  assuming  that  cells 
from  any  part  of  the  growth  curve  would  contain  similar 
amounts  of  HSF.  The  actual  results  obtained  were  in 
accordance  with  the  expected  results. 
On  the  other  hand,  if  in  C-medium  there  was  no  further 
synthesis  of  HSF  and  the  original  activity  in  the  inoculum 
was  diluted  among  progeny  cells,  the  expected  levels  of 
activity  in  the  C-mode  cells  would  be  represented  by  line  2 116 
Figure  15  Changes  in  the  levels  of  histamine- 
sensitizing  activity  and  viable  cell 
numbers  (10%  (v/v)  inoculum) 
Histamine-sensitizing  activity  and 
viable  cell  numbers  were  estimated 
in  whole  culture  samples  obtained 
at  various  intervals  during  growth 
of  X-mode  B.  pertussis  in  X-  and 
C-media.  Data  represent  the 
reciprocal  of  the  best-estimated 
HSD50.  values  and  mean  viable  cell 
numbers  obtained  from  three 
similar  experiments. 
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Figure  16  Correlation  between  viable  cell 
numbers  and  level  of  histamine- 
sensitizing  activity  during  growth 
(Cells) 
Data  represent  the  reciprocal  of 
the  best-estimated  HSD50  values  and 
mean  viable  cell  numbers  obtained 
from  eight  similar  experiments  with 
5%  (v/v)  inocula  and  six  similar 
experiments  with  10%  (v/v)  inocula. 
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in  the  graphs.  However,  the  actual  results  obtained  for 
the  C-mode  cells  deviated  markedly  from  the  expected  results 
and  indicated  that  the  loss  of  activity  in  the  C-mode  cells 
was  faster  than  could  be  explained  by  a  simple  growth-dilution 
effect. 
Figure  17  shows  the  correlation  between  the  viable  cell 
numbers  and  the  total  HSD50  contained  in  X-  and  C-mode  whole 
cultures.  Line  2  predicts  what  would  be  expected  if  there 
was  neither  synthesis  nor  degradation  of  HSF  on  transfer  of 
X-mode  cells  to  C-medium.  On  the  other  hand,  line  1  predicts 
the  expected  result  if  HSF  was  synthesized  in  direct  pro- 
portion  to  viable  cell  numbers.  The  actual  results 
indicated  that  in  C-mode  cultures  the  HSF  appeared  to  be 
synthesized  initially  but  after  a  time,  this  synthesis 
presumably  ceased  and  the  activity  decreased  even  below 
the  level  originally  present  in  the  inoculum.  With  the 
X-mode  cultures,  the  actual  results  again  deviated  from  the 
expected  (line  1)  and  showed  that  HSF  was  synthesized  at  a 
faster  rate  than  could  be  accounted  for  by  the  increase  in 
viable  cell  numbers. 
iii.  Leukocytosis-promoting  activity 
Changes  in  the  levels  of  the  LPF  activity  during  growth 
of  X-mode  cells  in  X-  and  C-media  were  examined  as  previously 
described. 
Both  cell  suspensions  and  whole  culture  samples  obtained 
from  more  than  a  dozen  similar  growth  experiments  were  assayed. 
In  initial  experiments  mice  were  injected  by  the  intraperitoneal 119 
Figure  17  Correlation  between  viable  cell  numbers 
and  level  of  histamine-sensitizing 
activity  during  growth. 
(Whole  cultures). 
Data  represent  the  reciprocal  of  the 
best-estimated  HSD50  values  and  mean 
viable  cell  numbers  obtained  from7,  three 
similar  experiments. 
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route  but  having  demonstrated  that  the  intravenous  route 
was  more  sensitive  and  results  more  amenable  to  statistical 
analysis,  the  intravenous  route  of  inoculation  was  used  in 
the  later  part  of  the  work.  Leukocyte  counts  were  expressed 
as  log10. 
Figures  1$A  and  18B  show  results  obtained  when  mice 
were  inoculated  intraperitoneally  with  samples  obtained 
from  a  typical  growth  experiment  in  which  a  10%  (v/v) 
inoculum  was  used.  Figures  19A  and  19B  show  the  results 
from  a  similar  growth  experiment  using  the  intravenous  route 
of  inoculation.  With  either  route  of  inoculation  the  levels 
of  activity  in  the  X-mode  cell  suspensions  remained  relatively 
constant  (Figures  18B  and  19B).  With  the  intraperitoneal 
route  counts  of  between  20,224  and  27,669  wbc/mm3  were 
obtained  and  between  28,380  and  32,220  wbc/mm3  with  the 
intravenous  route.  On  the  other  hand,  the  level  of  activity 
in  the  C-mode  cell  suspensions  decreased  considerably  to  just 
above  control  level  with  the  72h  samples. 
A  similar  decrease  in  activity  was  also  observed  in  the 
C-mode  whole  culture  samples  (Figures  18A  and  19A). 
However,  with  the  X-mode  whole  culture  samples,  the  total 
level  of  activity  increased  initially  with  time,  as  expected, 
since  the  cell  numbers  were  increasing.  By  both  routes  of 
inoculation,  the  LPF  activity  appeared  to  be  maximal  in  the 
24h  cultures  and  the  older  culture  samples  showed  a  slight 
decline  in  the  level  of  activities. 
The  loss  of  activity  in  both  the  C-mode  whole  cultures 
and  cell  suspensions  did  not  drop  below  control  levels. 121 
Figure  18  :  Changes  in  the  levels  of  LPF  responses 
in  mice  inoculated  intraperitoneally. 
Groups  of  five  Ham/ICR  mice  were  inoculated 
intraperitoneally  with  whole  culture  samples 
and  cell  suspensions  obtained  at  various 
intervals  during  growth  of  B.  Pertussis 
strain  18334  in  X-  and  C-media.  A  10% 
(v/v)  inoculum  from  a  48h  X-mode  culture 
was  used. 
A.  Responses  to  whole  cultures 
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Figure  19  :  Changes  in  the  levels  of  LPF  responses 
in  mice  inoculated  intravenously. 
Groups  of  five  Ham/ICR  mice  were 
inoculated  intravenously  with  whole 
culture  samples  and  cell  suspensions 
obtained  at  various  intervals  during 
growth  of  B.  Pertussis  strain  18334  in 
X-  and  C-media.  A  10%  (v/v)  inoculum 
from  a  48h  X-mode  culture  was  used. 
A.  Responses  to  whole  cultures. 
O---;  X-mode 
.  -O  C-mode 
B.  Responses  to  cell  suspensions. 
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This  indicated  either  that  not  all  the  LPF  activity  was 
--lost 
during  one  subculture  in  C-medium  or  that  apart  from 
the  LPF,  some  other  component  of  the  cell  was  involved  in 
inducing  leukocytosis. 
The  leukocytosis-promoting  potencies  of  the  various 
samples  of  X-  and  C-mode  cell  suspensions  were  quantitated 
by  the  4-point  and  6-point  assay  methods.  The  4-point 
assay  was  valid  for  estimating  the  potency  of  only  the 
C'-10hýsample  because  the  sample  still  retained  some  LPF 
;  -activity.  The  potency  of  the  C  10h  sample  was  20%  of  the 
',  potency  of  the  X  10h  sample  which  had  an  assigned  value  of 
x1.00  (Table  6).  The  4-point  and  6-point  assays  were  not 
..  valid  for  estimating  the  potencies  of  the  older  C-mode 
, -,  samples  which  contained  very  low  levels  of  activity 
(Appendices  4e  and  4f).  However,  both  assay  methods  were 
.. 
valid  for  estimating  the  potencies  of  the  various  X-mode 
samples  which  contained  relatively  high  levels  of  LPF 
activity.  The  potencies  of  the  X-mode  samples,  by  the  4-point 
assay,  ranged  from  0.96  to  1.5  (Table  6).  Comparing  the 
potency  values  and  the  range  of  the  95%  confidence  limits, 
there  was  no  significant  difference  between  these  values. 
.. 
+ý: 
"F'wý,  x  T-Cýý'  4ý  "ý,  r  ,:.  -"v  ti.  ý"S.  ti  Ef  ý'F  .ýrq  ý+ 
. 
Similarly,  the  potency  values  of  the  X-mode  samples  by  the 
6-point  assay  ranged  from  0.93  to  0.99  (Table  7).  Again 
based  on  the  range  of  the  95%  confidence  limits,  these  values 
..,  were  not  significantly  different.  These  results  further 
,; 
confirmed  that  the  LPF  potency  of  the-X-mode  cell  suspensions 
remained  relatively  constant  during  growth.  However  with 
the  C-mode  cells,  the  expected  potency,  based  on  the  observed 124 
number  of  cell  divisions  after  10h  was  0.8  (Table  6). 
The  actual  value  of  0.2  indicated  that  the  loss  of  the 
LPF  was  not  due  solely  to  dilution  among  progeny  cells. 
Like  the  HSF,  it  also  appeared  to  be  denatured  or  degraded 
when  cells,  initially  in  the  X-mode,  were  grown  in  C-medium. 
iv.  Heat-labile  toxicity 
Freshly  isolated  cells  of  B.  pertussis  (X-mode)  possess 
a  factor  which  is  lethal  to  mice  when  injected  intraperitoneally, 
or  causes  dermonecrosis  when  injected  intradermally.  The 
lethal  and  dermonecrotic  properties  have  been  attributed  to 
the  HLT.  In  this  study  attempts  were  made  to  determine  if 
this  HLTJknown  to  be  lost  in  C-mode  cells  (Livey  et  al.,  1978), 
was  lost  in  parallel  with  the  other  biological  activities. 
Aliquots  of  unheated  X-  and  C-mode  whole  cultures 
obtained  at  various  intervals  during  growth  were  assayed  for 
their  HLT  activities  by  intraperitoneal  injection.  Results 
were  expressed  as  the  dose  required  to  kill  50%  of  the  mice 
inoculated  (LD50).  The  reciprocal  of  the  best-estimated 
LD50  values  from  four  independent  experiments  performed 
under  the  same  conditions  were  plotted  against  time  of 
sampling  (Figure  20).  It  was  observed  that  the  content 
of  the  HLT  in  the  X-mode  whole  culture  increased  with  time. 
The  increase  in  toxicity  reached  a  peak  after  about  4ah  of 
growth  and  then  started  to  decline.  On  the  other  hand,  the 
content  of  the  toxin  in  C-mode  whole  cultures  decreased 
gradually  during  growth. 125 
Figure  20  Changes  in  the  levels  of  heat- 
labile  toxicity  during  growth 
of  B.  pertussis  strain  18334  in 
X-  and  C-media 
(10%  (v/v)  inoculum). 
Data  represent  the  reciprocal 
of  the  best-estimated  LD50 
values  obtained  from  four 
similar  experiments 
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Further  analysis  of  results  showed  that  at  10h,  the 
level  of  toxicity  in  the  C-mode  whole  culture  was  only 
16%  of  the  toxicity  of  the  X-mode  culture.  The  level 
of  toxicity  in  the  C-mode  culture  had  dropped  to  1%  of 
the  X-mode  toxicity  after  72h  of  incubation  (Table  10). 
In  the  four  independent  experiments,  a  total  of 
300  mice  were  used  and  the  individual  results  showed  that 
at  10h,  the  levels  of  toxicity  in  the  C-mode  cultures  were 
between  12.1%  and  17%  of  the  toxicity  of  their  X-mode 
counterparts.  By  72h,  the  levels  of  toxicity  in  the  C-mode 
cultures  had  droppednto  between  1-2%  of  the  activity  of  the 
,. 
72h  ,,  X-mode  cultures.  In  later  experiments,  it  was  shown 
that-the  toxicity  of  the  X-mode  cultures  was  lost  when  the 
,  samples  were  heated  at  56°C  for  30  min  before  assay. 
This  confirmed  the  heat-labile  nature  of  the  factor 
responsible  for  the  mouse-lethal  toxicity. 
v,  Toxicity  as  measured  by  the  mouse  weight-gain  test. 
The  mouse  weight-gain  test  was  recommended  by  the 
W.  H.  O.  (1964)  as  a  test  for  determining  the  toxicity  of 
B.  pertussis  vaccines.  Using  this  method,  the  toxicities 
of  the  X-  and  C-mode  samples  were  compared. 
Mice  were  weighed  just  before  inoculation  and  then 
daily  for,  seven  days.  Weighings  were  done  at  the  same 
time  each  day.  Three  independent  assays  were  performed 
with  samples  from  similar  experiments.  Each  assay  involved 
the  use  of  140  mice  and  the  results  obtained  from  all  three 127 
Table  10:  Heat-labile  toxicity  in  X-  and 
C-mode  whole  cultures  obtained 
at  various  intervals  during 
growth  (10%  (v/v)  inoculum). 
Sample,  LD50  (ml  of  whole-culture).  Best- 
estimate  val  ues  from  four  independent 
experiments. 
10h  24h  48h  72h 
X-mode  0.8  0.66  0.32  0.42 
C-mode  5.06  15.4  23  34 
percentage 
activity  of  16%  4%  l%  1% 
C-mode  relative 
to  X-mode 
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assays  were  consistent.  The  weight  change  per  mouse 
for  a  typical  assay  is  given  in  Appendix  6. 
Results  from  this  assay  are  summarized  in  Figures  21A, 
21B  and  21C.  A  steady  gain  in  weight  was  observed  in  the 
uninoculated  mice  as  well  as  in  the  mice  injected  with 
saline  only  (Figure  2lA).  Mice  inoculated  with  X-mode 
cell  suspensions  (Figure  21B)  and  C-mode  cell  suspensions 
(Figure  21C)  showed  an  initial  weight  loss  at  day  1  and  a 
subsequent  weight-gain.  However,  the  rate  of  weight  gain 
was  faster  in  mice  injected  with  the  C-mode  cells  than  with 
mice  injected  with  X-mode  cells. 
The  similar  pattern  of  initial  weight  loss  in  the  mice 
suggested  the  presence  of  a  common  toxic  factor  in  both  the 
X-  and  C-mode  samples.  However,  the  subsequent  slower 
weight-gain  in  the  mice  inoculated  with  X-mode  samples 
indicated  an  additional  toxicity  in  the  X-mode  cell 
suspensions  which  was  absent  in  the  C-mode  cell  suspensions. 
Although  the  weight  changes  with  all  the  X-mode  samples 
were  quite  similar,  the  X  48h  sample  appeared  most  toxic. 
The  pattern  of  subsequent  weight-gain  in  mice  inoculated 
with  the  10h  C-mode  samples  was  much  slower  compared  to 
other  C-mode  samples  but  faster  than  the  X-mode  samples. 
vi.  Haemagglutination  activity 
The  haemagglutinating  (HA)  activities  of  whole  cultures, 
culture  supernatants  and  cell  suspensions  harvested  at 
various  intervals  during  growth  in  X-  and  C-media  were 
estimated.  At  each  sampling  time,  whole  culture  samples 129 
4 
Figure  21  'Changes  in  the  level  of  toxicity  of 
X-  and  C-mode  cells  as  measured 
by  the  mouse  weight-gain  test 
A.  Weight  change  in  control  mice 
.4  uninoculated 
---0  saline 
Bars  represent  the  standard  deviations 
from  mean  weight  change 
Figure  21  B:  Weight  change  in  mice  inoculated 
with  X-mode  cell  suspensions 
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Figure  21  C:  Weight  change  in  mice  inoculated 
with  C-mode  cell  suspensions 
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were  centrifuged,  the  supernatant  fluids  were  decanted  and 
the  bacterial  cell  pellets  were  resuspended  in  saline  to 
the  original  volume. 
Results  from  six  independent  experiments  were  similar 
and  a  typical  result  is  shown  in  Table  11.  HA  activity 
'was.  found  to  be  associated  with  the  bacterial  cells  during 
the  early  stages  of  growth  in  the  X-medium  and  thereafter 
the  level  remained  relatively  constant.  On  the  other 
hand,  the  culture  supernatant  contained  no  HA  in  the  early 
stages  of  growth  but  showed  increasing  titres  after  24h. 
With  the  growth  in  C-medium,  there  was  no  activity  detected 
at  any  sampling  time.  It  thus  appeared  that  the  original 
activity  in  the  inoculum,  which  was  mainly  in  the  super- 
￿natant 
rather  than  cell-associated,  once  diluted  in 
C-medium  was  no  longer  detectable  and  no  further  HA  was 
synthesized  in  detectable  amounts. 
-vii'.  Agglutinability 
Possible  changes  in  cell  surface  agglutinogens  during 
modulation  were  examined.  This  was  done  by  determining 
the'  titres  of.  specific  and  unabsorbed  X-  and  C-mode 
antisera  against  X-  and  C-mode  cell  suspensions  harvested 
at  various  intervals  during  growth.  Results  are  shown 
in  Figures  22  and  23. 
The  titres  of  unabsorbed  anti-X  serum  against  X-mode 
cells  stayed  constant  at  4096  throughout  growth.  The 
titres  of  unabsorbed  anti-X  serum  against  C-mode  cells 
showed  a  slight  drop  from  4096  to  2048  by  10h,  decreased 
further  to  512  by  24h  and  remained  unchanged  (Figure  22). 131 
Table 
Sample 
11:  Haemagglutinating  activities  of 
X-  and  C-mode  whole  cultures, 
supernatant  and  cell  suspensions 
harvested  at  various  intervals 
during  growth 
Haemagglutination  titres* 
Whole  culture  Supernatant  Cell  suspension. 
Inocul  um  (X-mode)  16  16  4 
(  4Bh  ) 
X-mode  (10h)  80  16 
X-mode  (24h)  16  4  g 
X-mode  (48h)  16  8  8 
X-mode  (72h)  16  16  8 
C-mode  (10h)  00  0 
C-mode  (24h)  00  0 
C-mode  (48h)  00  0 
C-mode  (72h)  00  0 
reciprocal  of  highest  dilution  of  samples  showing 
complete  agglutination  of  the  erythrocytes. 132 
Figure  22  :  Changes  in  agglutinability  with 
unabsorbed  antisera 
A  10%  (v/v)  inoculum  from  a  48h 
X-mode  culture  of  B.  pertussis 
strain  18334  was  used  in  the 
growth  experiment 
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With  the  unabsorbed  anti-C  serum  against  X-mode  cells,  the 
titres  showed  a  slight  but  not  significant  increase  from 
64  to  128  by  10h,  then  decreased  to  32  by  24h  and 
thereafter  remained  relatively  constant.  However  the  titres 
of  unabsorbed  anti-C  serum  against  C-mode  cells  increased 
from  64  to  256  by  10h  and  further  increased  to  4096  by  24h 
and  stayed  relatively  unchanged. 
Results  obtained  using  specific  antisera  are  shown  in 
Figure  23.  The  titre  of  specific  anti-X  serum  against 
X-mode  cells  stayed  relatively  constant  at  4096  throughout 
growth.  However,  the  titre  of  specific  anti-X  serum  against 
C-mode  cells  decreased  from  2048  to  1024  by  10h  and  further 
decreased  to  64  by  24h  after  which  it  stayed  relatively 
constant.  With  the  specific  anti-C  serum  against  C-mode 
cells,  the  titres  increased  from  4  to  64  by  10h,  increased 
further  to  256  by  24h  and  remained  relatively  unchanged. 
On  the  other  hand,  the  titres  of  the  specific  anti-C  serum 
against  X-mode  cells  showed  a  slight  increase  from  4  to  8 
by  10h,  then  dropped  to  4  by  24h  and  remained  constant. 
These  results  indicated  that  after  10h  of  growth  of 
X-mode  cells  in  C-medium,  there  was  no  appreciable  change 
in  the  surface  agglutinogens  but  by  24h,  the  X-specific 
agglutinogens  appeared  to  have  been  lost. 
3.  Envelope  proteins 
J.  Changes  in  electrophoretic  profiles 
The  various  immunological  and  pathophysiological 
activities  of  B.  Pertussis,  except  the  heat-labile  toxicity, 134 
Figure  23  Changes  in  agglutinability  with 
specific  (absorbed)  antisera 
A  10%  (v/v)  inoculum  from  a  48h 
X-mode  culture  of  B.  pertussis 
strain  18334  was  used  in  the  growth 
experiment 
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have  been  reported  to  be  associated  with  the  cell 
envelope  proteins  of  the  bacterium  (Munoz,  Ribi  and  Larson, 
1959;  Morse  and  Morse,  1970;  and  Munoz,  1971).  The 
presence  of  two  major  gel  lines  appeared  to  correlate  with 
the  presence  of  various  activities  such  as  the  PA  and  the 
HSF  activities  (Wardlaw,  Parton  and  Hooker,  1976). 
Therefore,  polyacrylamide  gel  electrophoresis  of  envelope 
polypeptides  was  used  to  follow  the  modulation  process 
in  this  study.  In  initial  experiments  X-  and  C-  mode  whole 
cell  suspensions  were  compared  and  it  was  found  that  the 
difference  in  the  two  major  envelope  polypeptide  bands  were 
clearly  visible  in  whole-cell  preparations.  Since  the 
preparation  of  cell-envelopes  was  time  consuming,  whole- 
cell  suspensions  were  used  in  all  subsequent  experiments. 
Comparison  of  X-  and  C-mode  cells,  obtained  from  more 
than  twelve  growth  experiments,  in  which  strainsl8334  and  134 
were  used,  revealed  that  the  electrophoretic  patterns  of  the 
polypeptide  bands  were  consistently  similar  except  that 
three  polypeptide  bands  which  were  present  in  the  all  the 
X-mode  samples  were  absent  in  the  C-mode  samples  (Plate  1). 
From  the  molecular  weights  of  marker  proteins  run  side  by 
side  with  the  samples,  the  molecular  weights  of  the  three 
bands  missing  in  the  C-mode  cells  were  estimated  at  about 
28,000,30,000  and  '100,0001  daltons. 
The  absence  or  reduction  of  the  three  bands  in  the  10h 
C-mode  cells,  suggest  that  these  polypeptides  were  lost  in 
parallel  with  the  various  activities,  i.  e.  by  degradation 
and  not  by  simple  growth-dilution. 136 
Plate  I.  SDS-polyacrylamide  gel  electrophoresis 
of  envelope  polypeptides  of  B.  pertussis 
grown  in  X-  and  C-  media.  (X  -i: 
modulation), 
a.  XIOh 
b.  X24h 
C,  X48h 
d.  X72h 
e,  CIOh 
f.  C24h 
g.  C48h 
h.  C72h 1OOk-º 
30k-º 
28k-º 
..  k..:  -:..  _ 137 
ii.  Time  of  onset  of  synthesis  of  28k  and  30k  polypeptides 
As  earlier  stated  the  presence  of  the  28k  and  30k 
polypeptide  bands  in  the  X-mode  cells  were  correlated  with 
the  presence  of  PA  and  HSF  activities  (Wardlaw  et  al.,  1976). 
In  the  present  study  it  was  observed  that  as  early  as  10h 
,d  ur  , rig  growth  of  X-mode  cells  in  C-medium  the  two  polypeptide 
bands  had  either  been  greatly  reduced  or  had  disappeared  in 
parallel  with  various  activities.  These  findings  stimulated 
efforts  to  determine  if  there  was  a  transient  synthesis  of 
the  two  polypeptides  in  C-medium  or  whether  the  synthesis 
of  the  polypeptides  was  switched  off  immediately  upon 
inoculation. 
Initially  the  experimental  approach  was  to  grow  X-mode 
cells  in  X-  and  C-  Hornibrook  media  with  added 
14C 
glutamate. 
The  estimation  of  the  incorporation  of  labelled  glutamate 
into  the  different  protein  components  of  the  cells  involved 
electrophoretic  separation  of  proteins  in  the  samples, 
densitometry  of  stained  gels,  slicing  of  gels  and  radio- 
active  counting.  However,  there  was  very  little  or  no 
uptake  of  labelled  glutamate  by  the  cells.  This  probably 
was  due  to  the  fact  that  the  casamino  acids  in  Hornibrook 
medium  contained  high  levels  of  glutamate  which  competed 
with  the 
14C 
glutamate.  Thus  in  later  experiments,  X- 
and  C-  Stainer  and  Scholte  defined  media  were  used.  Since 
B.  Pertussis  is  known  to  prefer  glutamate  to  other  amino 
acids  as  a  source  of  nitrogen,  the  original  level  of 
glutamate  in  Stainer  and  Scholte  X-  and  C-media  was  reduced 
and  an  increased  amount  of 
14C 
glutamate  was  added  to  ensure 138 
an  adequate  uptake  of  the  label.  Also,  the  original 
level  of  proline  in  the  media  was  increased  as  a  secondary 
source  of  nitrogen.  With  this  modification  much  better 
uptake  of  labelled  glutamate  by  the  X-  and  C-mode  cells 
was  obtained. 
Figures  25A  and  25C  respectively  show  the  densitometer 
traces  of  stained  gels  and  the  graph  of  the  uptake  of 
labelled  glutamate  in  the  X-mode  cells;  Figures  25B  and 
25D  show  the  results  for  the  C-mode  cells.  Comparing  the 
densitometer  traces  of  X-  and  C-mode  gels  (Figure  24)  it 
was  observed  that  while  the  28k  and  30k  bands  were  present 
in  the  X-mode  samples  only  remnants  of  these  bands  were 
present  in  the  C-mode.  In  addition,  one  other  band  with 
a  molecular  weight  of  approximately  100k  which  was  present 
in  the  X-mode  gels  was  found  to  be  greatly  reduced  in  the 
C-mode  gels. 
When  the  densitometer  traces  and  the  graphs  of  the 
glutamate  uptake  were  compared,  the  labelled  glutamate  was 
found  to  be  incorporated  into  nearly  all  the  polypeptide 
components  of  X-mode  cell  in  proportion  to  their  protein 
content.  However,  there  was  a  protein  component  with  a 
molecular  weight  of  approximately  25,000  where  there  was 
little  or  no  uptake  of  labelled  glutamate  (arrow,  Figure  25A). 
With  the  C-mode  cells,  the  labelled  glutamate,  in  general, 
was  incorporated  into  the  bands  in  proportion  to  their 
protein  contents  as  shown  by  the  densitometer  traces. 
However,  in  the  region  of  the  28k  and  30k  polypeptides  there 139 
Figure  24  Comparison  of  densitometer  traces 
of  protein  profiles  of 
B.  pertussis  strain  18334  grown 
in  Stainer  and  Scholte  X-medium 
(top)  and  Stainer  and  Scholte 
C-medium  (bottom) TOP  OF  GEL 
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Figure  25  :  Comparison  of  densitometer  traces 
of  protein  profiles  and  incorporation 
of 
14C 
glutamate  into  cell  proteins 
of  B.  pertussis  strain  18334  grown  in 
Stainer  and  Scholte  X-  and  C-media. 
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was  very  little  uptake  of  labelled  glutamate  even  though 
remnants,  of  these  bands  were  clearly  visible  in  the 
densitometer  traces.  Also  there  was  no  glutamate  uptake 
in  the  region  of  one  of  the  minor  high  molecular  weight 
polypeptides  (arrow,  Figure  25B).  This  is  not  the  same 
band  as  the  100k  band  which  is  major  in  X  and  minor  in  C. 
There  appeared  to  be  incorporation  of 
14C_into 
the  100k 
band  in  proportion  to  its  peak  height;  even  though  it  is 
a  minor  component  in  C-mode. 
4.  Correlation  of  changes  in  the 
immunological  and  pathophysiological 
activities  during  growth 
One  of  the  main  aims  of  this  project  was  to  determine 
if  the  various  activities  were  lost  at  the  same  or  at 
different  rates  during  modulation.  Thus  having  followed 
changes  in  the  levels  of  the  individual  activities  during 
growth  of  X-mode  cells  in  X-  and  C-  media,  attempts  were 
made  to  correlate  the  loss  of  some  of  these  activities. 
Samples  obtained  at  various  intervals  during  growth  of 
X-mode  cells  in  X-  and  C-media  were  assayed  for  a  number 
of  activities. 
Results  from  a  number  of  similar  experiments  did  not 
differ  significantly  and  Figures  26A,  26B  and  26C  show 
the  levels  of  HSF,  LPF  and  HLT  activities  in  whole  culture 
samples  obtained  from  a  typical  growth  experiment.  The 
total  levels  of  these  activities  in  the  X-mode  cultures 
-.  increased  simultaneously  with  cell  numbers  reaching  a  peak 142 
Figure  26  Correlation  of  changes  in  the  levels 
of  histamine-sensitizing  activity, 
leukocytosis-promoting  activity  and 
heat-labile  toxicity. 
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Figure  26C  -Changes  in  HLT  activity  in 
whole  cultures 
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between  24h-48h  and  then  started  to  decline.  However,  the 
levels  of  these  activities  in  the  C-mode  whole  cultures 
decreased  gradually  from  the  time  of  inoculation.  With 
the  levels  of  HSF  and  LPF  activities  in  the  cell  suspensions, 
Figures  26D  and  26E  show  that  the  level  of  these  activities 
in  X-mode  cells  remained  relatively  constant  during  growth 
but  decreased  gradually  from  time  of  inoculation  in  the 
C-mode  cells.  The  results  indicated  that  during  growth  of 
X-mode  cells  in  C-medium,  the  loss  of  the  HSF,  LPF  and  HLT 
activities  in  whole  cultures,  and  the  HSF  and  LPF  activities 
in  cell  suspensions,  appeared  to  follow  the  same  pattern. 
This  suggested  that  these  activities  were  apparently  lost 
at  about  the  same  rate  during  modulation. 
The  best-estimated  potency  values  for  the  various 
activities,  obtained  from  between  four  to  a  dozen  experiments 
done  under  the  same  conditions,  were  calculated  for  X-  and 
C-mode  samples.  The  percentage  loss  of  the  HSF,  LPF  and 
HLT  activities  in  the  C-mode  cells  and  whole  cultures  are 
shown  in  Tables  12A  and  12B.  At  10h  there  was  a  two-fold 
difference  between  the  levels  of  the  LPF  and  HSF  activities 
in  the  C-mode  cells. 
However,  with  the  best-estimated  potency  values  from 
four  independent  mouse  protection  tests,  the  percentage 
loss  of  the  protective  activity  in  the  C-mode  cells  at 
different  stages  of  growth,  was  greater  than  the  values 
for  the  other  three  mentioned  activities.  These  observations 
suggested  that  while  the  two  (HSF  and  LPF)  activities  were 
lost  at  about  the  same  rate  during  modulation,  the  mouse 145 
Figure  26D  Changes  in  HSF  activity  in  cells 
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protective  activity  appeared  to  be  lost  much  more  rapidly. 
Furthermore,  the  residual  activities  still  present  in  the 
C-mode  cells  by  72h  indicated  that  the  HSF  and  LPF 
activities  were  not  completely  lost  during  a  single 
subculture  of  X-mode  cells  in  C-medium  with  5%-10% 
inoculum. 
5.  Distribution  of  the  HSF  and  LPF 
activities  between  cells  and 
culture  supernatants. 
A  number  of  experiments  were  performed  to  determine 
the  distribution  of  the  HSF  and  LPF  activities  between  the 
cells  and  the  culture  supernatants  during  growth.  These 
experiments  were  carried  out  with  a  view  to  determining 
if  the  loss  of  activities  in  the  C-mode  cells  was  due  to 
liberation  of  the  activities  into  the  culture  supernatant 
and,  if  so,  to  further  ascertain  if  activities  in  the 
supernatant  were  degraded  faster  than  in  the  cells  or  vice 
versa.  At  various  intervals  during  growth,  aliquots  of 
X-  and  C-mode  cultures  were  centrifuged,  the  supernatant 
fluid  was  decanted  and  the  cell  pellets  obtained  were 
resuspended  in  saline  to  the  original  volume.  The  super- 
natant  fluids,  cell  suspensions  and  unfractionated  culture 
samples  were  detoxified  by  heating  and  assayed  for  LPF  and 
HSF  activities. 
Results  from  the  various  experiments  were  similar  and 
a  typical  LPF  result  is  shown  in  Figures  27A  and  27B. 
With  the  X-mode  samples,  most  of  the  LPF  activity  in  early 149 
Figure  27  Distribution  of  LPF  activity  between 
cells  and  culture  supernatant  during 
growth  of  X-mode  B.  pertussis  strain 
18334  in  X-  and  C-media 
A.  Growth  in  X-medium 
0---0  whole  culture 
q  ýp  supernatant 
-Z;  ce11s 
B.  Growth  in  C-medium 
whole  culture 
----ý  supernatant 
`  _;  cells A  4*9 
4.7 
4.5 
El 
U 
Pq 
4.3 
0 
U 
0 
r1 
0 
401 
'j%ALXNE(p  VIBO-0  QN 
3.9L',   IIIII  -1 
' 
0  20  40  60  80 
AGE  OF  CULTURE  (h) 
B 
M 
El 
El 
1-1 
U 
Pal 
z 
0 U 
0 
C7 
0 
z 
4.6 
4.4 
4.2 
4.0 
3.8  II1t7 i" 
0  20  40  60  80 
AGE  OF  CULTURE  (h) 150 
stages  of  growth  was  associated  with  the  cells,  with  little 
activity  in  the  culture  supernatant.  However,  after  10h 
of  growth  the  level  of  activity  began  to  increase  in  the 
supernatant  but  decreased  in  the  cells  after  an  apparent 
initial  increase.  This  suggested  that  during  the  log 
phase  of  growth,  LPF  was  liberated  from  the  cells  into 
the  culture  supernatant.  The  total  level  of  activity  in 
the  whole  culture  samples  increased  steadily,  reached  a 
peak  at  about  the  end  of  log  phase  and  started  to  decline 
as  found  previously  (Figures  1$A,  19A  and  26B).  With  the 
C-mode  samples,  the  levels  of  LPF  activity  in  the  whole 
cultures,  cell  suspensions  and  culture  supernatants  showed 
a  progressive  decline  from  the  time  of  inoculation 
(Figure  27B).  By  24h,  activity  in  the  cells  had  been 
greatly  decreased  and  'there  was  no  evidence  that  the  LPF 
was  released  into  the  supernatant  since  the  total  level  of 
activity  in  the  whole  culture  and  supernatant  also  showed 
a  decline. 
With  the  HSF 
..  aJ  typical  result  (Figures  28A  and  28B) 
showed  that  the  level  of  activity  in  the  cell  suspensions 
was  only  slightly  higher  than  the  levels  in  the  culture 
supernatant  by  10h  of  growth  of  X-mode  cells  in  X-medium. 
But  at  the  later  stages  of  growth,  most  of  the  activity 
was  present  in  the  supernatant  while  the  levels  in  the  cells 
declined  after  an  initial  increase.  This  indicated  that, 
like  the  LPF  the  HSF  was  excreted  by  the  cells  into  the 
extracellular  fluid  during  the  log  phase  of  growth. 151 
Figure  28  Distribution  of  histamine- 
sensitizing  activity  between  cells 
and  culture  supernatant  during 
growth  of  X-mode  B.  pertussis  strain 
18334  in  X-  and  C-media 
HSD50  values  are  given  as  ml  of 
whole  cultures,  supernatants  and  cell 
suspensions 
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The  total  level  of  HSF  activity  in  the  whole  culture 
increased  in  parallel  with  cell  numbers  (Figure  28A). 
With  the  C-mode  samples  the  original  activity  from  the 
inoculum  was  detected  initially  in  the  cells  and  whole 
cultures.  But  this  activity  was  lost  gradually  in  the 
whole  culture,  cell  suspension  and  supernatant  during 
growth  (Figure  28B). 
One  discrepancy  observed  in  the  results  was  that  the 
levels  of  both  the  HSF  and  LPF  activities  in  the  X-mode 
cell  suspensions  showed  an  initial  increase  by  10h  then 
decreased  thereafter.  Previous  experiments  had  shown 
that  the  level  of  activities  in  the  cell  suspensions,  of 
equal  opacity  units,  but  harvested  at  various  times  during 
growth,  was  constant.  (e.  g.  Figures  13A,  14A,  18B  and  19B). 
Thus-'since  at  every  sampling  time,,  the  number  of  cells 
increased,  the  levels  of  activities  in  the  cell  suspensions 
were  expected  to  increase  in  parallel  with  cell  number. 
However,  an  initial  increase  then  a  decrease  in  the  level 
of,  activities  in  the  cell  suspensions  was  found.  A  possible 
explanation  for  this  could  be  that  the  samples  were  stored 
frozen.  before  thawing  and  heating  at  56°C  for  30  minutes. 
There  may  have  been  some  loss  of  activities  either  due  to 
direct  denaturation  or  possibly  due  to  proteolysis  by 
intracellular  enzymes  released  by  freezing  and  thawing  and 
active  during  the  thawing  period  prior  to  heating. 
To  investigate  the  possible  effect  of  freezing  and 
thawing  prior  to  heating,  the  experiment  was  repeated. 
Samples  of  whole  culture,  supernatant,  and  cell  suspensions 153 
obtained  in  this  experiment  were  heated  immediately  after 
sampling,  preserved  by  the  addition  of  0.  lmg/ml  thiomersal 
and  stored  at  4°C.  A  week  later,  X-mode  samples  were 
assayed  for  their  HSF.  activities. 
Results  for  the  whole  culture  and  supernatant  samples 
were  similar  to  those  obtained  in  previous  experiments. 
Figure  28C  shows  that  the  total  level  of  HSF  activity  in 
the  culture  increased  in  parallel  with  cell  numbers. 
The  level  of  activity  in  the  supernatant  was  relatively 
low  at  10h  but  thereafter  it  increased  rapidly  up  to  48h. 
However,  with  the  cell  suspensions  there  was  a  steady 
increase  in  the  level  of  activity  during  growth.  This 
differed  markedly  from  the  previous  results  where  the  levels 
of  activity  in  the  cell  suspensions  at  first  increased  then 
decreased  (Figure  2$A). 
The  level  of  activities  in  whole  cultures,  supernatant 
samples  and  cell  suspensions  in  this  experiment  were  higher 
than  the  levels  of  activity  obtained  in  the  previous 
experiments  (Figures  28A).  This  suggested  that  freezing 
and  thawing  of  the  samples  prior  to  heating  allowed  some 
degrading  or  denaturing  effect  on  the  B.  pertussis  components 
responsible  for  its  pathophysiological  activities. 
In  conclusion,  it  has  been  shown  that  during  growth 
in  X-medium,  cells  synthesized  LPF  and  HSF.  Initially 
these  factors  were  bound  to  the  cell  but  as  growth  progressed 
a  proportion  of  the  activity  was  liberated  into  the 
extracellular  fluid  where  it  accumulated  and  accounted 
for  most  of  the  activity  in  the  culture. 154 
Figure  28  :  Distribution  of  histamine- 
sensitizing  activity  between  cells 
and  culture  supernatant  during 
growth  of  X-mode  B.  pertussis  strain 
18334  in  X-  and  C-media 
HSD50  values  are  given  as  ml  of 
whole  cultures,  supernatants  and  cell 
suspensions 
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The-LPF  was  apparently  not  synthesized  during  growth  in  C- 
medium  but  there  appeared  to  be  a  transient  increase  in  the 
histamine  sensitizing  ability  of  the  whole  culture  during 
the  early  stages  of  growth.  Evidence  suggested  that  the 
loss  of  activities  in  the  C-mode  cells  was  not  due  solely  to 
liberation  of  activities  into  the  extracellular  fluid  but  also 
to  the  denaturation  or  degradation  of  the  activities  present 
initially  in  both  the  cells  and  the  extracellular  fluid. 
Subsection  BC  to  X  modulation 
Towards  the  end  of  this  study,  the  reverse  process  of 
modulation  (i.  e.  C  to  X),  was  examined  to  check  if  modulation 
is.  freely  reversible  as  stated  by  Lacy  (1960).  However  this 
was-not  examined  in  the  same  detail  as  for  the  X  to  C  modulation. 
X-  and  C-media  were'  inoculated  with  cells  grown  for  48h 
in  C-medium  (C-mode  cells).  As  a  control,  another  set  of 
flasks  with  X-  and  C-media  were  inoculated  with  cells  grown 
for,  48h  in  X-medium  (X-mode  cells).  Cultures  were  harvested 
after  48h  and  the  cell  suspensions  obtained  were  assayed  for 
the  levels  of  LPF,  HSF  and  HLT  activities.  Changes  in  surface 
agglutinogens  and  envelope  polypeptides  were  also  examined. 
The.  experiment  was  repeated  three  times. 
t,  1  1.  Growth  characteristics 
-  The  optical  densities  of  culture  samples  obtained  from 
the  above  experiments  were  monitored  at  various  intervals 
during  growth.  The  changes  in  optical  densities  observed 
in  the  three  different  experiments  were  similar.  One  set  of 156 
results  is  shown  in  Figure  29.  The  growth  of  X-  or  C-mode 
cells  in  C-medium  had  a  consistently  higher  optical  density 
than  the  growth  of  X-  or  C-mode  cells  in  X-medium.  These 
results  were  similar  to  the  previous  observations  with  the 
X  to  C  modulation. 
2.  Immunological  and  pathophysiological 
activities 
i.  Histamine-sensitizing  activity,  leukocytosis- 
promoting  activity  and  heat-labile  toxicity 
Cell  suspensions  obtained  from  4$h  cultures  of  C-mode 
cells  inoculated  into  X-  and  C-media  and  of  X-mode  cells 
inoculated  into  X-  and  C-media,  were  assayed  for  the  above 
activities.  Assay  methods  and  analysis  of'results  were 
done  as  in  previous  experiments. 
The  best-estimated  values  of  the  histamine-sensitizing 
potencies  from  two  similar  experiments  are  given  in  Table  13. 
After  48h,  C-mode  cells  grown  in  X-medium  had  66%  of  the 
activity  of  X-mode  cells  grown  in  X-medium  whereas  C-mode 
cells  grown  in  C-medium  had  only  2.4%  of  the  activity  of  X-mode 
cells  grown  in  X-medium.  (Table  13).  Thus  C-mode  cells 
appeared  to  regain  HSF  activity  when  grown  in  X-medium; 
though  the  regain  of  this  activity  was  apparently  slower 
than  the  loss  in  X  to  C  modulation  (Figures  13A  and  14A  and 
Tables  9A  and  9B).  In  X  to  C  modulation,  activities  were 
lost  faster  than  can  be  explained  by  dilution  effect 
presumably  because  denaturation  or  degradation  was  occurring. 157 
Figure  29  :  Changes  in  optical  density  during 
growth  of  B.  pertussis  strain  18334 
in  X-  and  C-media. 
10%  (v/v)  inocula  of  48h  X-  and 
C-mode  cultures  were  used. 
0--o  XºX  culture 
ý-ýý  C  -10ýX  culture 
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Table  13:  Histamine-sensitizing  activity 
in  cells  during  X  to  C  and 
C  to  X  modulation. 
Sample  Relative  potencies  (and  95%  Best-estimate 
confidence  limits)  relative  potency 
-values 
Experiment  1  Experiment  2 
Standard  pertussis  1.00  1.00  1.00 
vaccine 
X  OX  cells 
.  (4  h) 
XºC  cells 
(4$h) 
C  ºC  cells 
(48h) 
c  ----*X  cells 
(4ah) 
1.4  0.63  0.81 
(0.63-3.6)  (0.37-1.1)  (0.51-1.3) 
0.007  0.02  0.01 
(0.000-0.05)  (0.002-0.08)  (0.003-0.06) 
0.02  0.02  0.02 
(0.004-0.05)  (  0.002-0.08)  (0.007-0.06) 
0.63  0.50  0.53 
(0.27-1.3)  (0.28-0.84)  (0.34-0.83) 159 
Results  of  the  LPF  assay  showed  that  X-  or  C-mode  cells 
grown  in  C-medium  had  very  low  levels  of  detectable  activity 
compared  to  X-mode  cells  grown  in  X-medium.  On  the  other 
hand,  C-mode  cells  grown  in  X-medium  had  almost  as  high  a 
level  of  activity  as  X-mode  cells  grown  in  X-medium  (Figure  30). 
This  again  suggested  that  the  LPF  activity  was  regained  when 
C-mode  cells  were  grown  in  X-medium  and  that  modulation  was 
freely  reversible.  The  actual  leukocyte  counts  obtained 
are  tabulated  in  Appendix  7. 
The  same  trend  of  results  as  for  the  HSF  and  LPF 
assays  were  obtained  when  samples  were  assayed  for  heat- 
labile  toxicity.  The  potency  values  obtained  from  a  typical 
experiment  (Table  14)  indicated  that  X-  or  C-mode  cells 
grown  in  C-medium  had  22%  and  16%  respectively  of  the 
levels  of  activity  of  X-mode  cells  grown  in  X-medium. 
Also  C-mode  cells  grown  in  X-medium  regained  TILT  activity 
and  had  77%  of  the  activity  of  X-mode  cells  grown  in  X-medium. 
As  with  the  HSF,  the  potency  values  and  95%  confidence  limits 
indicated  no  significant  difference  in  the  level  of  toxicity 
when  either  C-mode  or  X-mode  cells  were  grown  in  X-medium 
for  48h. 
These  results  suggested  that  the  HSF,  LPF  and  HLT  were 
regained  and  restored  to  almost  normal  levels  after  a 
single  subculture  of  C-mode  cells  in  X-medium. 
ii.  Ap,  glutinability 
Cell  suspensions  harvested  at  various  intervals  during 
growth  of  C-mode  cells  in  X-medium  were  tested  for  possible 160 
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Figure  30  Levels  of  LPF  activity  in  X-  and 
C-mode  cells 
Cells  were  harvested  after  48h  growth 
of  B.  pertussis  strain  18334  in  X-  and 
C-media  (10%  (v/v)  inoculum). 
8  ou.  ml  of  each  cell  suspension  was 
injected  per  mouse. 4.6 
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Table  14:  Heat-labile  toxicity  in  cells 
during  X  to  C  and  C  to  X 
modulation 
Sample  Relative  potency  LD50(ou.  ml) 
(and  95%  confidence  limits) 
Inoculum  (X-mode)  1.00  0.38 
v(48h) 
X  ---ºX  0.74  0.52 
(4Sh)  (0.42  -  1.3) 
X  --ºC  0.16  2.4 
(48h)  (0.093  -  0.28) 
C  -ºC  0.12  3.2 
(4$h)  (0.067  -  0.21) 
C-  X.  0.57 
. 
67 
(48h)  (0.32  -  0.99) 
.  ýý  :  ýý_  , 
...  ýýý 162 
changes  in  their  surface  agglutinogens.  Samples  from  two 
similar  experiments  were  tested  against  specific  and 
unabsorbed  X-  and  C-mode  antisera  for  their  agglutinability. 
Results  from  the  two  experiments  were  not  significantly 
different. 
Figure  31A  shows  the  results  of  one  of  the  assays  using 
unabsorbed  antisera.  The  titre  of  anti-X  serum  against 
the  inoculum  cells  (C-mode  cells)  was  initially  low  but 
as  the  C-mode  cells  grew  in  X-medium  the  titre  increased 
gradually  ffit 
.  about  24h  after  which  it  stayed  constant. 
On  the  other  hand,  the  titre  of  anti-C  serum  against  the 
inoculum  cells  (C-mode  cells)  was  high  but  as  the  cells 
grew  in  X-medium,  it  decreased  and  remained  relatively 
constant  after  24h. 
With  the  specific  antisera  (Figure  31B),, 
-the'-titre  of  the 
anti-X  serum  against  C  to  X  cells  showed  only  a  slight 
increase  for  up  to  48h  and  remained  unchanged.  However, 
the  titre  of  the  anti-C  serum  against  C  to  X  cells  decreased 
significantly  within  24h  and  stayed  constant. 
The  increase  in  the  titres  of  specific  and  unabsorbed 
anti-X  sera  for  C  to  X  cells  and  the  decrease  of  the  titre  of 
the  anti-C  sera  for  C  to  X  cells  during  growth  indicated 
that  surface  agglutinogens  were  regained.  This  appeared  to 
have  occurred  within  24h  of  inoculation  of  C-mode  cells  into 
X-medium.  In  previous  results,  the  loss  of  the  agglutinogens 
during  X  to  C  modulation  was  also  observed  to  occur  within 
24h  of  growth  of  X-mode  cells  in  C-medium. 163 
Figure  31  Changes  in  agglutinability  with 
unabsorbed  and  absorbed  antisera. 
A  10%  (v/v)  inoculum  from  a  4Bh 
C-mode  culture  of  B.  pertussis  strain 
18334  was  used  in  the  growth  experiment. 
A.  Agglutination  with  unabsorbed  antisera. 
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3.  Changes  in  cell-envelope 
proteins 
During  the  growth,  of  C-mode  cells  in  X-medium  and 
X-mode  cells  in  C-medium,  the  protein  profiles  of  cell 
suspensions  obtained  were  analysed  by  'the-SDS-polyacrylamide 
electrophoretic  method.  Results  revealed  that 
polypeptides  with  molecular  weights  of  28k,  30k  and  100k 
were  absent  in  X-mode  cells  grown  in  C-medium.  These 
polypeptides  however  were  present  in  C-mode  cells  grown 
in  X-medium  (Plate  2).  Thus  these  polypeptides  were 
regained  during  the  reverse  process  of  modulation.  This 
gain  of  envelope  proteins  correlated  with  the  gain  of 
other  immunological  and  pathophysiological  activities 
during  C  to  X  modulation. 
SECTION  3:  MECHANISMS  OF  ANTIGENIC 
MODULATION 
During  modulation  from  the  X-mode  to  the  C-mode,  the 
various  immunological  and  pathophysiological  activities 
associated  with  the  X-mode  cells  were  lost  and  during  the 
change  from  C-mode  to  X-mode  these  activities  were  regained. 
In  an  attempt  to  explain  the  mechanism  of  these  changes  the 
roles  of  a  number  of  different  factors  in  modulation  were 
examined. 165 
Plate  2.  SDS-polyacrylamide  gel  electrophoresis 
of  envelope  polypeptides-of  B.  pertussis 
grown  in  X-  and  C-media  (X-ºC  and 
C  -)p-X  modulation). 
a.  standard  proteins 
b.  inoculum 
c.  X10h 
d.  X24h 
e.  X48h 
f.  X72h 
g.  C10h 
h.  C24h 
i.  C48h 
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1.  Specificity  of  the  magnesium 
sulphate  requirement 
In  the  present  study,  X  to  C  modulation  was  induced 
by  replacing  the  NaCl  content  of  the  growth  medium  with  an 
equivalent  amount  bf  MgSO4.7H20.  In  order  to  understand 
the  mechanism  of  modulation,  it  was  necessary  to  examine 
the  possible  roles  of  NaCl  and  MgSO4.7H20  in  modulation. 
Preliminary  experiments  involved  growing  X-mode  cells 
in  X-medium  and  in  Hornibrook  medium  with  neither  NaCl 
nor,  MgSO4.7H20  as  an  added  ingredient.  In  later  experiments, 
,  growth  of  X-mode  cells  in  C-medium  was  included  as  a  further 
control.  Two  phase  I  strains  of  B.  pertussis,  18334  and 
D30042  were  used.  Both  strains  grew  well  in  the  medium 
with  neither  added  NaCl  nor  MgSO4.7H20.  In  all  the 
experiments,  cells  were  harvested  after  48h  and  both  cell 
suspensions  and  whole  culture  samples  were  assayed  for  their 
HSF  activity. 
Tables  15A  and  15B  show  the  HSD50  values  obtained. 
With  strain  18334,  there  was  a  significant  drop  in  the  level 
of  HSF  activity  in  both  the  cell  suspensions  and  whole 
culture  samples  of  cells  grown  in  Hornibrook  medium  with 
neither  added  NaCl  nor  MgS04.7H20.  The  percentage  levels 
of  activity  in  the  cultures  and  cell  suspensions  relative 
to  the  level  of  activity  in  X-mode  cultures  and  cell 
suspensions  was  31%  and  22%  respectively.  The  loss  of 
activity  represented  a  three-fold  and  four-fold  difference 
in  the  whole  cultures  and  cell  suspensions  respectively. 
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Table  15A: 
ý  "s  ` 
Histamine-sensitizing  activity  in 
whole  culture  and  cell  suspensions 
of  B.  pertussis  strain  18334  grown  in 
medium  without  added  NaCl  or  MgSO4. 
Growth--medium  Whole  culture  Cell  suspensions 
HSD50  %  activity  HSD  %  activity 
(in  ml)  relative  to  (in  12) 
relative  to 
X-mode  X-mode 
X-medium  0.27  100  0.41  100 
Hornibrook  medium 
-  no  added  NaCl  0.82  31  1.90  22 
or  MgSO4 
Table  15B:  Histamine-sensitizing  activity  in 
cell  suspensions  of  B.  pertussis 
strain  D300421  grown  in  medium 
without  added  NaCl  or  MgSO4 
Growth  medium  Cell  suspensions 
HSD50  %  activity  relative 
(in  ou.  ml)  to  X-mode 
X-medium  0.30  100 
C-medium  2.38  13 
Hornibrook  medium 
without  added  NaCl  0.62  48 
or  MgS  04 168 
With  strain  D30042,  only  the  cell  suspensions  were 
assayed  for  activity.  However,  similar  results  were 
obtained  as  with  strain  18334.  Cells  grown  in  Hornibrook 
medium  with  neither  added  NaCl  nor  MgSO4.7H20,  had  only  48% 
of  the  activity  of  cells  grown  in  X-medium.  This  indicated 
a  two-fold  difference  in  activity. 
Cells  grown  in  C-medium  had  only  13%  of  the  activity 
of  cells  grown  in  X-medium. 
In  both  strains,  growth  in  Hornibrook  medium  with 
neither  added  NaCl  nor  MgSO4.7H20  resulted  in  a  decrease 
in-the  level  of  HSF  activity,  though  not  to  the  same  level 
as  when  cells  were  grown  in  C-medium.  This  suggested  that 
although  high  levels  of  MgSO4.7H20  plays  a  major  role  in 
the  induction  of  modulation,  the  lack  of  NaCl  also  may  be 
important. 
2.  Proteolytic  activities  of  X-  and 
C-mode  cultures 
During  X  to  C  modulation,  activities  decreased  faster 
than  could  be  explained  by  dilution  amongst  the  progeny 
cells.  One  possible  explanation  was  that  the  protein 
components  responsible  for  these  activities  were  degraded 
by  proteolytic  enzymes  released  from  the  cells. 
Therefore  the  proteolytic  activities  present  in  X-  and 
C-mode  cultures  were  estimated.  In  the  assay,  azocoll  and 
azocaesin  were  used  as  substrates  while  pronase  and 
subtilisn  respectively  were  used  as  standard  proteolytic 
enzymes. 169 
Assays  were  done  on  samples  of  X-  and  C-mode  whole 
cultures  and  culture  supernatants  obtained  at  various 
intervals  during  growth.  As  controls,  heated  (1000C 
for  30  mins.  )  whole  cultures  and  supernatants  as  well 
as  samples  of  uninoculated  X-  and  C-media  were  tested. 
Concentration  of  proteases  in  the  samples  were  to  be 
estimated  from  standard  curves  obtained  with  pronase  and 
subtilisn  and  their  respective  substrates  (Figures  32A  and 
32B).  However,  there  was  no  significant  difference 
between  the  values  obtained  for  any  of  the  test  samples 
and  the  controls.  Thus  it  was  concluded  that  proteolytic 
activity  was  not  detectable  in  either  the  X-  or  C-mode  cultures. 
Later  attempts  to  estimate  the  intracellular  levels  of 
activity  using  X-pressed  cells  also  showed  no  detectable 
activity.  In  conclusion,  it  appeared  that  the  loss  of 
activities  during  modulation  was  probably  not  due  to 
proteolytic  degradation  of  envelope  components  or  cell 
components  released  into  the  culture  medium. 
3,  Cyclic  AMP  levels  during 
modulation 
Recently,  Parton  and  Durham  (1978)  reported  the 
absence  of  adenylate  cyclase  activity  and  cyclic  AMP  in 
C-mode  cultures  of  B.  pertussis.  The  role  of  cyclic 
AMP  in  the  regulation  of  gene  expression  in  some  micro- 
organisms  has  been  clearly  established.  Thus  efforts  were 
directed  towards  investigating  the  possible  role  of  cyclic 
AMP  in  antigenic  modulation  in  B.  pertussis. 170 
Figure  32  :  Estimation  of  proteolytic  activity. 
(Standard  curves). 
A.  Digestion  of  azocasein  by  subtilisn. 
B.  Digestion  of  azocoll  by,  pronase. 
Arrow  in  both  graphs  indicate  value 
obtained  for  the  X-  and  C-mode 
samples. cG 
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Total  cyclic  AMP  in  X-  and  C-mode  cultures  harvested 
at  various  intervals  were  estimated. 
Figure  33  shows  the  levels  of  CAMP  in  X-mode  cultures 
obtained  from  five  similar  experiments.  In  all  the 
experiments,  there  was  a  steady  increase  in  CAMP  during 
growth.  In  the  three  experiments  where  the  sampling 
time  was  extended  to  96h,  it  was  observed  that  the  increase 
in  CAMP  reached  a  peak  at  about  72h  and  thereafter  declined. 
In  two  other  experiments  where  samples  were  taken  earlier 
than  10h  during  growth,  it  was  observed  that  the  levels 
of  CAMP  in  the  cultures  did  not  show  any  marked  increase 
until  after  about  8h  a_9£r  incubation,  although  these 
low  levels  were  at  the  limits  of  detection.  Strains  134 
and  D30042  produced  higher  levels  of  CAMP  than  strain 
18334  though  the  significance  of  this  observation  is 
unknown.  In  all  the  experiments,  there  was  no  detectable 
CAMP  (<  2.5pmol/ml  of  undiluted  culture)  in  any  of  the 
samples  taken  from  C-mode  cultures  of  the  three  strains 
after  10h  of  incubation. 
Thus,  during  growth  in  X-medium  cAMP  was  synthesized 
by  the  cells  whereas  there  appeared  to  be  no  synthesis  at 
any  time  during  growth  in  C-medium.  Also  the  initial 
cAMP  content  of  the  X-mode  inoculum  appeared  to  be  rapidly 
destroyed  by  growth  in  the  C-medium. 
In  later  experiments,  X-mode  cells  were  grown  in  X- 
and  C-media  to  which  was  added  54g/ml  of  bovine  liver 
catalase,  known  to  contain  an  activator  of  B.  Pertussis 172 
Figure  33  :  Changes  in  cyclic  AMP  levels  in 
whole  cultures  during  growth  of 
B.  pertussis  strains  in  X-medium. 
experiment  1.  (18334) 
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adenylate  cyclase.  Samples  of  whole  cultures  were  obtained 
at,  various  intervals  during  growth  and  assayed  for  their 
cAMP  levels.  With  the  X-mode  culture  samples,  there  was 
eý,  an  approximately  two-fold  increase  in  the  levels  of  cAMP 
formed  when  compared  to  the  levels  in  cultures  grown  in 
X-medium  without  added  catalase.  On  the  other  hand,  even 
with'a  source  of  adenylate  cyclase  activator,  there  was 
.  still  no  detectable  cAMP  in  the  C-mode  samples  (Table  16). 
.  This  result  further  suggested  that  there  was  apparently 
no  synthesis  of  cAMP  by  the  C-mode  cells.  If  there  had 
been  even  low  activity  of  adenylate  cyclase,  it  is  possible 
-'that  the  presence  of  catalase  might  have  enhanced  cAMP 
formation  to  detectable  levels. 
Samples  obtained  from  these  experiments  were  further 
assayed  for  their  HSF  activity.  It  was  observed  that 
despite  the  two-fold  enhancement  in  the  levels  of  cAMP 
in  the  X-mode  cultures,  the  levels  of  HSF  activities  in 
cultures  grown  in  the  presence  or  absence  of  catalase  did 
not  alter  significantly  (Table  16).  Thus  it  appeared  that 
the:  level  of  HSF  activity  was  not  directly  related  to  the 
level  of  cAMP  in  the  X-mode  cultures.  In  both  the  C-mode 
cultures  grown  in  the  presence  or  absence  of  catalase, 
there  was  a  rapid  decrease  with  time  in  the  levels  of 
HSF  activity. 
Changes  in  cAMP  levels  during  the  reverse  process  of 
C  to  X  modulation  were  also  investigated.  X-  and  C-media 
were  inoculated  with  48h  C-mode  liquid  culture  of  strain 
D30042  containing  no  detectable  cAMP.  Growth  of  X-mode 174 
Table  16:  Effect  of  catalase  on  cyclic  AMP 
levels  and  histamine-sensitizing 
activity  in  cultures  of  B.  pertussis 
_'"  strain  1$334  grown  in  X-  and  C-media 
Sample  Total  cyclic  AMP 
pmol/ml  culture 
HSD50(mi) 
Inoculum  51.0  0.41 
(X-mode,  48h) 
X-+X  24h  30.6  0.47 
X-ºX  +  catalase  24h  53.5  0.53 
X-*C  24h  <  2.5  *  2.20 
X-ºC 
.+ 
catalase  24h  <  2.5  *  2.64 
X-ºX.  48h  45.9  0.41 
X--Jo,  -X+  catalase  48h  76.5  0.35 
X--+C-  48h  <  2.5  *  5.58 
X---O-C-+  catalase  48h  <  2.5  *  5.58 
*'limit  of  detection 175 
cells  in  X-medium  was  set  up  in  parallel  as  control. 
Results  depicted  in  Figure  34  shows  that  the  levels 
of  cAMP  in  cultures  of  X-mode  cells  grown  in  X-medium 
increased  rapidly  between  10h  and  24h  and  thereafter 
showed  only  a  further  slight  increase  to  48h. 
With  growth  of  C-mode  cells  in  X-medium  the  level 
of  cAMP  showed  a  similar  pattern  of  a  steady  increase 
during  growth,  though  there  was  an  initial  lag  period 
during  which  cAMP  was  undetectable  in  the  culture. 
There  was  no  cAMP  detected  at  any  time  during  growth  of 
C-mode  cells  in  C-medium. 
Results  from  earlier  experiments  indicated  that  lost 
immunological  and  pathophysiological  activities  were  regained 
during  C  to  X  modulation.  These  observations  coupled  with 
the  fact  that  cAMP  was  also  regained  during  the  reverse 
process  of  modulation,  prompted  attempts  to  determine  the 
possibility  of  stimulating  a  faster  restoration  of  the 
activities  by  enhancing  the  cAMP  levels  during  C  to  X  modu- 
lation.  C-mode  cells  were  grown  in  normal  X-  and  C-media 
and  in  X-  and  C-media  with  added  catalase  (5µg/m1).  As  a 
control  X-mode  cells  were  also  grown  in  normal  X-medium  and 
X-medium  with  added  catalase.  Whole  culture  samples  obtained 
at  various  intervals  during  growth  were  assayed  for  their  CAMP 
content  and  HSF  activities.  Table  17  shows  that  there  was  no 
detectable  cAMP  in  any  whole  culture  samples  of  C-mode  cells 
grown  in  C-medium  and  correspondingly,  there  were  very  low  levels 
of  HSF  activities.  When  C-mode  cells  were  grown  in  normal 
X-medium  for  $h,  there  was  no  detectable  c  AMP  though  there 176 
Figure  34  :  Changes  in  cyclic  AMP  levels  in 
whole  cultures  during  growth  of 
X-mode  and  C-mode  B.  pertussis 
strain  18334  in  X-medium. 
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Table  17:  Effect  of  catalase  on  the  levels  of 
cyclic  AMP  and  histamine-sensitizing 
activity  in  cultures  of  B.  pertussis 
strain  D300421  in  X-  and  C-media 
Sample  Total  cyclic  AMP  HSD50(ml) 
pmol/ml  culture 
Inoculum 
(C-mode,  48h)  <  2.5  *  6.08 
C  -ºC  $h  <  2.5  *  6.42 
C-->C  +  catalase  8h  <  2.5  *  6.01 
C-->C  24h  <  2.5  *  5.98 
c-->C  +  catalase  24h  <  2.5  *  5.98 
c-->X  8h  <  2.5  *  4.64 
c-->X,  +  catalase  $h  5.1  2.18 
C->X  24h  68.25  0.84 
c,  --->X  +  catalase  24h  112.4  0.31 
Inoculum 
(X-mode,  48h)  7.12  +  0.61 
X--->X  8h  10.25  0.49 
x  --*X  +  catalase  8h  27.5  0.26 
X  -*X  24h  97.6  0.28 
X-  *X  +  catalase  24h  163.0  0.16 
iß,  riit  of-L-detection 
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was  a  slight  but  insignificant  increase  in  the  level  of 
HSF  activity  when  compared  to  the  level  of  activity  in  the 
C-mode  inoculum..  On  the  other  hand,  when  C-mode  cells 
were  grown  in  X-medium  with  added  catalse  for  8h,  low 
levels  of  cAMP  were  detected  and  there  was  a  corresponding 
increase  in  the  levels  of  HSF  activity.  Thus  there 
appeared  to  be  some  relationship  between  the  level  of  cAMP 
and  the  rate  at  which  the  HSF  activity  was  regained. 
In  conclusion  the  synthesis  of  cAMP  during  the  log 
phase  of  growth  of  X-  or  C-mode  cells  in  X-medium  appeared 
to  parallel  the  increase  in  the  levels  of  various  activities. 
The  lack  of  cAMP  in  C-mode  cultures  accompanied  the 
lack  of  these  activities.  Furthermore,  when  formation  of 
cAMP  was  enhanced  by  the  addition  of  an  activator,  restoration 
of  HSF  activity  also  appeared  to  be  enhanced.  The  enhance- 
ment  of  cAMP  levels  in  cultures  may  have  accelerated  the 
gain  in  HSF  activity  during  the  C  to  X  change. DISCUSSION 179 
SECTION  1:  DEVELOPMENT  OF  AN  LPF 
ASSAY  METHOD 
,  f"  Recent  fractionation  studies  have  provided  substantial 
evidence  for  the  relationship  between  certain  of  the 
immunological  and  pathophysiological  activities  associated 
with  X-mode  B.  pertussis.  For  example,  Morse  and  Morse 
(1976)  and  Lehrer  et  al.,  (1976)  reported  that  the 
histamine-sensitizing  ability  and  lymphocytosis-promoting 
ability  were  different  manifestationsof  a  single  protein 
component  of  the  cell.  The  loss  of  HSF  in  C-mode  cells 
was.  reported  by  Wardlaw  et  al.,  (1976).  If  a  single 
component  were  responsible  for  the  HSF  and  LPF  activities 
then.  the  LPF  would  also  be  lost  in  C-mode  cells.  Since 
there  was  no  previous  report  on  whether  the  LPF  was  present 
or  absent  in  C-mode  cells,  this  was  investigated  in  the 
present  work.  Results  indicated  clearly  that  the  LPF 
activity  was  lost  from  C-mode  cells  during  modulation. 
:  -In  order  to  determine  more  precisely  the  time  sequence 
of  loss  of  each  of  the  immunological  and  pathophysiological 
activities  during  modulation  and  to  further  elucidate  the 
relationship,  if  any,  between  them,  it  was  necessary  to 
quantitate  the  potencies  of  these  activities  associated 
with  the  cells  at  various  intervals  during  growth. 
-.  At  the  beginning  of  the  present  study,  suitable  assay 
methods  were  available  for  determining  the  potencies  of  the 
PA,  -HSF  and  HLT;  but  there  was  no  method  available  for 
measuring  the  LPF  potency  of  B.  pertussis  preparations. 180 
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In  LPF  studies  by  various  workers,  male  or  female 
mice  of  different  strains  have  been  used.  There  has  been 
no,  report  of  any  work  done  to  compare  the  effect  of  seg. 
of  mouse  or  strain  of  mouse  on  LPF  response.  Since 
different  strains  of  mice  vary  greatly  in  their  response 
to  HSF  (Munoz  and  Bergman,  1968),  the  possible  effect  of 
,  sex  and  strain  of  mouse  on  LPF  response  was  investigated 
in,  the  present  study.  Male  mice  were  found  to  be 
.,  slightly  more  responsive  to  LPF  than  female  mice.  This 
was  an  unexpected  result  since  the  female  mice  were 
smaller  and  weighed  less  than  male  mice  of  the  same  age. 
It  would  have  been  expected  therefore  that  the  females 
getting  a  greater  dose  per  unit  weight,  would  have  had  a 
greater  response  than  the  males. 
P1ith  regards  to  mouse  strain  there  was  no  significant 
difference  between  the  responses  of  Häm/ICR  and  NIH  mice 
to,  LPF.  These  were  the  only  mice  conveniently  available 
for  the  present  work.  It  is  possible  that  differences 
would  have  been  detected  if  more  strains  of  mice  had  been 
, 
investigated. 
Further  experiments  were  performed  to  examine  the 
LPF  response  in  mice  of  different  ages  since  it  has  been 
:  reported  that  age  was  an  important  factor  in  histamine- 
sensitization.  In  certain  strains  of  mice,  such  as  the 
'CFW,  age  does  not  seem  to  play  a  marked  role  in  histamine- 
sensitization  but  in  other  strains  it  has  a  profound  effect 
..  on,  the  response  (Bergman  and  Munoz,  1964).  In  this 
project  there  was  no  significant  difference  observed  in 181 
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the  LPF  responses  of  the  various  ages  (3  weeks  to  20  weeks) 
of  Ham/ICR  and  NIH  mice  tested.  This  was  also  an  unexpected 
result  for  the  smaller  3-week  old  mice,  received  a  much  higher 
dose  per  unit  body  weight  than  the  20  week  old  mice.  Doubling 
of  the  dose  of  B.  pertussis  preparations  significantly  increased 
the  leukocytosis  in  mice  of  the  same  age.  However,  an 
approximately  two-fold  difference  in  body  weight,  as  found 
in  mice  of  the  different  ages,  appeared  not  to  have  any 
significant  effect  on  LPF  response. 
Another  factor  of  considerable  importance  in  the  LPF 
response  in  mice  is  the  route  of  inoculation  of  the  pertussis 
sample.  Both  the  intraperitoneal  and  intravenous  routes  of 
inoculation  have  been  used  by  various  workers.  Morse  (1965) 
and  Finger,  Emmerling  and  Plager  (1972)  reported  that  the 
intravenous  route  of  inoculation  stimulated  leukocytosis 
more  rapidly  and  to  a  greater  extent  than  the  intraperitoneal 
route.  °  The  subcutaneous  route  was  reported  to  be  ineffective. 
T  heifinding  in  this  study  comparing  the  intravenous  and 
intraperitoneal  routes  of  inoculation  agreed  with  the  views 
of-,  ",  these  workers.  However,  whereas  Morse  (1965)  reported 
a-two-fold  difference  in  LPF  response  between  the  two  routes 
of  inoculation,  a  four-fold  difference  was  obtained  in  the 
present  work.  This  discrepancy  may  not  be  significant 
because  of  the  differences  in  the  doses  of  samples,  strains 
o£-,  mice  and  assay  methods  used. 
Having  determined  the  optimal  conditions  for  an  LPF 
assay,  later  experiments  were  directed  towards  quantitating  the 182 
LPF,  potency  of  the  X-  and  C-mode  samples.  Earlier  workers 
had:  quantitated  the  LPF  potency  of  B.  pertussis  in  different 
ways.  '  Ishida  (1968)  based  his  measurements  of  LPF  potency 
on'4the  effect  of  LPF  on  body  weight  of  mice.  He  stated 
that  after  intraperitoneal  injection  with  B.  pertussis 
samples,  the  effect  of  endotoxin/heat-labile  toxin  on 
decrease  in  body  weight  was  observed  on  the  second  day 
after  inoculation  while  the  effect  of  LPF  on  further  decrease 
in.  body  weight  was  manifested  from  the  third  or  fourth  day 
after  inoculation.  He  therefore  proposed  D0D4  as  an 
absolute  unit  of  LPF  for  the  body  weight-decreasing  toxicity. 
This  stood  for  the  dose  with  which-the  body  weight  of  mice 
-did"  not  increase  nor  decrease  during  a  time  period  from 
the  second  to  the  fourth  day  after  intraperitoneal  injection. 
{  Sato  and  Arai  (1972)  arbitrarily  defined  one  unit  of 
LPF  activity  as  the  amount  of  a  sample  which  when  injected 
into  mice  gave  rise  to  a  total  leukocyte  population  of 
3 
32,000/mm.  They  showed  a  linear  relationship  between 
the.  logarithmic  leukocyte  count  and  logarithmic  LPF  dose 
and  further  added  that  the  magnitudes  of  variance  of 
logarithmic  numbers  of  leukocyte  counts  at  different  doses 
were  on  the  same  level.  However,  Kurokawa,  Ishida, 
Asakawa  and  Iwasa  (1978),  did  not  accept  this  LPF  unitage 
proposed  by  Sato  and  Arai  (1972)  on  the  basis  that  it  was 
an.  -arbitrary  potency  unit.  Instead,  these  workers 
proposed  the  applicability  of  the  parallel  line  assay 
method  for  the  determination  of  LPF  potency,  based  on 
total  peripheral  leukocyte  count.  They  tentatively 183 
proposed  one  LPF  unit  as  the  amount  of  a  reference 
diphtheria-pertussis-tetanus  combined  vaccine  equivalent 
to  one  histamine-sensitizing  unit.  The  histamine-sensitizing 
potency  ,  of  this  vaccine  had  earlier  been  estimated  at  5HSU/ 
ml.  'r=..  They  estimated  the  LPF  potency  of  other  samples  by 
comparing  them  against  the  standard  vaccine  using  a  6-point 
assay  method. 
The  method  used  in  the  quantitation  of  LPF  potency  in 
this  study  was  similar  in  many  respects  to  that  used  by 
Kurokawa  et  al.,  (1978).  Using  the  cumulative  percentage 
frequency  of  the  leukocyte  counts,  these  workers  showed 
that  the  arithmetic  leukocyte  counts  were  not  normally 
distributed  but  that  logarithmically  transformed  leukocyte 
counts  were  normally  distributed.  However,  in  this  project, 
both'the  arithmetic  and  logarithmic  leukocyte  counts  were 
shown  to  be  at  least  approximately  normally  distributed  by 
the  rankit  method.  Further  analysis  on  the  homogeneity 
of  the  variances  obtained  for  arithmetic  and  logarithmic 
leukocyte  counts  revealed  a  high  degree  of  heterogeneity 
in-the  variances  of  the  arithmetic  leukocyte  counts  whereas 
a.  satisfactory  degree  of  homogeneity  was  obtained  with 
logarithmically  transformed  leukocyte  counts.  This  result 
was°in  accord  with  the  findings  of  Sato  and  Arai  (1972) 
and  Kurokawa  et  a1.,  (1978)  who  stated  that  the  deviations 
from  variance  homoscedasticity  were  insignificant  only 
after  the  logarithmic  transformation  of  leukocyte  counts. 
Using  the  6-point  assay  method  attempts  were  made,  in 
this  study,  to  estimate  the  LPF  potency  of  the  C-mode 184 
samples  relative  to  their  X-mode  counterparts.  These 
attempts  did  not  succeed  because  of  the  very  low  potency 
of`the  C-mode  preparations  leading  to  non-parallelism  of 
the  dose-response  curves.  However,  with  the  6-point 
assay,  there  was  parallelism  between  the  LPF  dose-responses 
of  .  the  various  X-mode  samples  when  they  were  compared 
to  the  LPF  dose-response  of  a  standard  X-mode  preparation. 
These  X-mode  samples  had  very  high  levels  of  LPF  activity. 
Thus  the  6-point  assay  appeared  to  be  valid  only  when  the 
LPF  potency  of  preparations  with  high  levels  of  activity 
were-being  estimated.  Estimation  of  the  potency  of 
preparations  containing  low  levels  of  LPF  activity  by  the 
6-point  assay  method  were  found  to  be  invalid.  Although 
Kurokawa  et  al.,  (1978)  did  not  attempt  to  quantitate  the 
LPF  potency  of  preparations  with  very  low  levels  of  activity, 
they  found  the  6-point  assay  was  valid  when  they  estimated 
the  LPF  potency  in  preparations  with  apparently  high  levels 
of  activity. 
As  a  further  attempt  to  quantitate  the  LPF  potency  of 
C-mode  samples,  the  4-point  assay  method  was  used.  It  was 
observed  that  only  the  10h  C-mode  samples  which  still 
retained  moderate  levels  of  LPF  activity,  showed  parallelism 
to,  the  10h  X-mode  sample. 
There  was  no  parallelism  between  the  dose-responses 
of-the  older  C-mode  samples  and  those  of  their  X-mode 
counterparts.  Again  the  4-point  assay  appeared  not  to  be 
suitable  for  estimating  the  LPF  potency  of  preparations 
with  very  low  levels  of  activity.  However,  if  in  future 185 
work,  the  LPF  potency 
were  reduced,  it  migh 
6-point  assay  methods 
older  C-mode  samples. 
SECTION  2 
of  the  standard  X-mode  preparations 
t  be  possible  to  use  the  4-point  and 
to  estimate  the  LPF  potency  of  the 
CULTURAL  CHANGES  DURING 
MODULATION 
The  growth  ratesof  B.  pertussis  in  different  culture 
media  have  been  examined  by  several  workers.  Rowatt  (1957) 
stated  that  the  mean  generation  time,  measured  turbidmetrically) 
fora  number  of  virulent  strains  of  B.  pertussis  grown  in 
Cohen  and  Wheeler's  medium  was  between  2.3-2.  $h.  She  also 
reported  that  alteration  of  the  concentration  of  some  of 
the  medium  constituents  led  to  an  increase  or  decrease  in 
the  mean  generation  time.  With  0.5%  (w/v)  glutamate  the 
mean  generation  time  was  approximately  5h  ;  with  1%  (w/v) 
glutamate  the  mean  generation  time  was  increased  to  8h  or 
more. 
In  stationary  cultures  of  B.  pertussis  18323  in  Cohen 
and  Wheeler's  mediu  m,  the  generation  time  was  18.5h  but  with 
shaking,  the  generation  time  was  reduced  to  5h  (Csizer, 
Pusztai  and  Joö,  1970).  Other  workers  (Csizer,  Szammet, 
Niedermager,  Zsidai,  Auber  and  Joo,  1977)  further  reported 
that  the  doubling  time  of  their  cultures  in  modified  Cohen 
and  Wheeler  medium  was  5h.  However,  their  estimations  were 
made  from  photometric  measurements.  By  plate  counts  of 
viable  cell  numbers  at  various  intervals  during  growth  of 
B.  ertussis  strain  18334,  in  modified  Hornibrook  medium, 186 
the  generation  time  for  X-  and  C-mode  cultures  obtained 
in,  this  study  was  approximately  6-7h.  Although  there  were 
differences  in  the  culture  medium  used  and  the  method  of 
"  estimation  of  cell  numbers,  the  result  is  comparable  with 
those  of  the  latter  two  groups  of  workers.  It  also  falls 
within  the  range  of  values  reported  by  Rowatt  (1957)  when 
-.  different  concentrations  of  glutamate  were  used. 
The  growth  pattern  observed  in  this  study  indicated 
that  despite  a  slight  lag  which  occurred  when  X-mode  cells 
were  inoculated  into  C-medium,  the  logarithmic  phase  of 
growth  in  both  X-  and  C-media  occurred  between  10h  and  48h 
after  inoculation.  There  was  no  significant  difference 
ýin  this  pattern  of  growth  when  either  a  10%  (v/v)  or  5%  (v/v) 
-inoculum  was  used,  though  growth  of  cultures  with  10%  (v/v) 
inocula  was  sometimes  faster. 
Although  both  the  X-  and  C-mode  cultures  were  found 
to  grow  at  about  the  same  rate,  the  viable  counts  of  the 
C-mode  cultures  were  consistently  slightly  less  than  those 
of  the  X-mode  culture  at  any  time  during  growth.  Although 
the  difference  wasnot  very  significant  in  this  study, 
Lacey  (1960)  reported  a  similar  observation,  that  the 
number  of  viable  cells  of  B.  pertussis  was  slightly  but 
-significantly 
less  on  the  medium  with  magnesium  sulphate. 
Despite  the  slightly  lower  viable  counts,  it  was 
observed  in  this  study  that  the  C-mode  cultures  consistently 
had  a  higher  optical  density  than  their  corresponding  X-mode 
cultures  at  all  sampling  times  during  growth. 187 
When  C-mode  cultures  were  inoculated  into  X-  and  C- 
media,  it  was  observed  that  the  resulting  X-culture  had  a 
lower  optical  density  than  the  corresponding  C-cultures. 
This  suggested  that  the  C-medium  might  be  responsible  for  this 
increase  in  optical  density.  Davis,  Dulbecco,  Eisen, 
Ginsberg  and  Wood  (1967)  stated  that  growth  of  some  bacteria 
in  the  presence  of  high  levels  of  certain  salts  or  sugars 
resulted  in  the  shrinkage  of  the  cells  and  an  increase  in 
their  refractive  index  which  lead  ultimately  to  an  increased 
light  scattering.  Thus  it  is  possible  that  transfer  of 
X-mode  cells  to  C-medium  led  to  shrinkage  of  the  cells 
although  it  might  be  expected  that  this  would  occur  instantly. 
Another  possible  explanation  for  the  higher  optical  density 
of  the  C-mode  cultures  could  be  due  to  the  fact  that  bacterial 
cell  walls  may  undergo  radical  changes  in  response  to 
relatively  small  changes  in  the  growth  environment  (Ellwood 
and  Tempest,  1972).  During  modulation  changes  are  known  to 
occur  in  the  cell  envelope  proteins  (Parton  and  Wardlaw,  1975). 
It  is  possible  that  these  changes  or  other  alterations  in  the 
cell  wall  composition  could  alter  the  light  scattering 
properties  of  the  cell. 
The  loss,  during  antigenic  modulation  of  the  protective 
antigen  (PA)  the  histamine-sensitizing  factor  (HSF),  the  heat- 
labile  agglutinogens,  the  heat-labile  toxin  (HLT)  and 
adenylate  cyclase  activity  has  been  well  documented.  In 
addition  the  present  study  showed  that  the  leukocytosis- 
promoting  factor  (LPF)  was  also  lost. 188 
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One  of  the  primary  aims  of  this  investigation  was  to 
determine  the  time  sequence  of  the  loss  of  these  activities. 
-.  Thus,  it  was  necessary  to  monitor  the  levels  of  activities 
in  the  X-  and  C-mode  samples  at  various  intervals  during 
growth. 
Comparing  the  potency  values  obtained  in  this  study, 
for  the  various  C-mode  cells  with  their  X-mode  counterparts, 
it-'was  observed  that  by  10h  and  48h  during  modulation  of 
B.  --pertussis  strain  18334,  the  C-mode  cells  had  only  2%  and 
0.5%  respectively  of  the  mouse  protective  activity  present 
in'the  X-mode  cells.  These  results,  obtained  in  the  present 
investigation,  were  not  significantly  different  from  the 
findings  of  Wardlaw  et  al.,  (1976)  who  also  induced 
modulation  by  the  use  of  magnesium  sulphate  and  reported 
that  after  4th,  C-mode  cells  of  strain  18334  had  only  4%  of 
the  mouse-protective  activity  of  their  X-mode  counterparts. 
These  workers  further  examined  modulation  in  four  other 
strains  of  B.  Pertussis  and  reported  that  48h  C-mode 
cells  had  between  1.6%-16%  of  the  mouse  protective  activity 
of  the  4$h  X-mode  cells. 
Holt  and  Spasojevic  (1968)  also  grew  B.  pertussis  in 
the  presence  of  high  concentrations  of  magnesium  sulphate 
and  reported  that  the  C-mode  cultures  they  obtained  had 
less  mouse-protective  activity  than  the  X-mode  cultures 
although  data  suitable  for  calculating  relative  potencies 
were  not  reported. 189 
Wardlaw  et  al.,  (1976)  also  investigated  the  loss  of  the 
HSF"activity  in  the  C-mode  cells  of  B.  pertussis  strain  18334. 
They  showed  that  by  4$h  during  modulation  C-mode  cells  had 
only  3%  of  the  HSF  activity  present  in  48h  X-mode  cells. 
Livey,  Parton  and  Wardlaw  (1978)  reported  that  growth  of 
B.  -  pertussis  in  the  presence  of  magnesium  sulphate  led  to  a 
'decrease  in  the  amounts  of  HSF  activity  of  the  cells.  From 
a  number  of  experiments,  they  stated  that  their  65h  C-mode 
cells  had  only  0.4%-2%  of  the  level  of  activity  present  in 
65h  X-mode  cells.  In  the  present  investigation,  using  5% 
(v/v)  or  10%  (v/v)  inocula,  it  was  found  that  48h  C-mode  cells 
had  only  about  2%  of  the  HSF  activity  of  their  X-mode  counter- 
parts.  Though  the  previous  workers  used  a  1%  (v/v)inoculum 
of  the  same  age  of  culture  and  strain  as  used  in  this  study, 
the  results  obtained  from  the  three  investigations  did  not 
differ  significantly.  The  present  study  also  revealed  that 
the  loss  of  HSF  activity  from  the  C-mode  whole  culture  was 
slower  than  the  rate  of  loss  of  the  activity  in  the  cells. 
The  activity  in  10h  C-mode  whole  culture  was  23%  of  the  level  of 
activity  in  the  10h  X-mode  culture  whereas  the  C-mode  cells, 
after  10h,  contained  about  11%  of  the  activity  in  X-mode  cells. 
This  suggests  that  the  HSF  activity  in  the  supernatant  persists 
longer  than  the  activity  associated  with  the  cells.  The  HSD50 
of  10h  C-mode  whole  culture  showed  an  initial  increase  from  the 
HSD50  of  the  original  inoculum,  thus  suggesting  that  the  HSF 
may  be  transiently  synthesized  by  the  C-mode  cells  in  the 
initial  stages  of  growth  and  released  into  the  medium.  However, 
there  was  evidence  from  other  experiments  to  show  that  envelope 190 
components  which  seem  to  be  associated  with  the  pathophysio- 
logical  activities  were  not  synthesized  or  not  incorporated 
into--  the  cells  during  modulation.  The  initial  increse  in 
the'-level  of  HSF  activity  in  10h  C-mode  whole  culture  could 
be  explained  by  the  fact  that  HSF  might  be  synthesized  and 
liberated  into  the  extracellular  fluid  rather  than  be 
incorporated  into  the  cellular  substance.  This  liberation 
of  HSF  into  the  extracellular  fluid  explains  the  slower  loss 
of  the  HSF  activity  from  the  whole  culture  than  from  the  cells 
alone. 
Although  it  was  not  possible  to  estimate  the  LPF  potency 
of  older  C-mode  cells,  it  was  shown  that  at  10h  during 
modulation,  the  C-mode  cells  had  only  about  20%  of  the  LPF 
activity  present  in  the  10h  X-mode  cells. 
When  the  loss  of  the  HLT  activity  was  examined  in  this 
study,  it  was  observed  that  by  10h  and  48h  during  modulation 
C-mode  whole  cultures  had  only  16%  and  1%  respectively  of 
the  level  of  toxicity  present  in  10h  and  48h  X-mode  whole 
cultures.  Although  the  loss  of  the  HLT  activity  in  the 
C-mode  cells  was  not  examined  in  as  much  detail  as  for  the 
whole-cultures,  results  showed  that  at  48h  during  modulation, 
theýC-mode  cells  had  22%  of  the  level  of  toxicity  contained 
in'-the  X-mode  cells  of  the  same  age.  Thus,  there  appeared  to 
be  a  faster  rate  of  loss  of  toxicity  in  the  whole  cultures 
than  in  the  cell  suspensions.  Since  these  results  were 
obtained  from  two  different  experiments,  and  little  is  known 
about  the  distribution  of  toxicity  between  cells  and  culture 
supernatant  at  various  stages  during  growth,  it  will  be 191 
necessary  to  repeat  these  experiments  to  ascertain  the 
significance  of  this  difference.  Other  workers  who  looked 
at  the  loss  of  HLT  activity  during  modulation  reported  that 
after  65h,  the  average  toxicity  of  C-mode  lysates  was  4.9% 
of  . that  in  X-mode  lysates  (Livey  et  al.,  1978). 
The  exact  location  of  the  HLT  in  the  cell  is  still  not 
clear.  -  Some  reports  claimed  that  it  was  located  in  the 
cytoplasm  (Munoz,  Ribi  and  Larson,  1959)  while  others 
reported  that  it  was  a  cell  envelope  constituent  (Yoshida 
et  a1.,  1955  cited  by  Billaudelle  et  al.,  1960).  The  majority 
of  opinion  presently  appears  to  support  the  cytoplasmic 
location  of  the  toxin.  If  this  is  true,  then  evidence  from 
this  study  indicated  that  the  process  of  modulation  in 
B.  Pertussis  produced  changes  in  the  cell  which  were  not 
restricted  to  the  cell  envelope.  This  was  earlier  discussed 
by  Livey  et  a1.,  (1978). 
The  toxicity  of  the  X-  and  C-mode  cells  as  measured  by 
the  mouse  weight-gain  test  was  also  examined  in  this  study. 
Mice  inoculated  with  X-  or  C-mode  cells  showed  a  similar 
initial  weight  loss.  However,  the  subsequent  weight  gain 
was  faster  in  mice  inoculated  with  the  older  C-mode  cells 
than  in  mice  inoculated  with  the  X-mode  and  10h  C-mode  cells. 
These  observations  indicated  the  presence  of  a  common  toxic 
factor  in  both  the  X-  and  C-mode  cells  which  was  responsible 
for  the  similar  initial  weight  loss.  Kurokawa  et  al.,  (1978) 
reported  that  early  appearing  toxicity  resulting  in  weight 
loss  in  mice  inoculated  with  B.  pertussis  samples  was 
attributable  to  endotoxin  or  HLT.  However,  since  heated  cell 192 
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ýý  ýý  suspensions  were  used  in  this  investigation,  the  effect  of 
HLT  would  have  been  eliminated.  The  indication  therefore 
was  that  the  endotoxin  present  in  both  X-  and  C-mode  cells 
was  responsible  for  the  initial  weight  loss.  Also  some 
workers  have  reported  the  presence  of  a  factor  in  B.  pertussis 
which  was  responsible  for  slow  weight-gain  in  mice  inoculated 
with  B.  Pertussis.  Pittman  and  Cox  (1965)  reported  that  this 
slow  weight-gain  factor  was  the  same  as  the  LPF  while  Iwasa 
et  al.,  (1966)  referred  to  the  factor  as  late-appearing 
toxicity  (LAT).  On  further  purification,  these  latter  workers 
showed  that  the  LAT  had  properties  similar  to  LPF. 
Thus  it  appears  that  the  X-  and  C-mode  cells  had  similar 
levels  of  lipopolysaccharide  which  were  responsible  for  the 
initial  weight  loss  when  injected  into  mice.  However,  in 
addition  to  LPS,  it  appears  that  the  X-mode  cells  and  10h 
C-mode  cells  had  the  factor  responsible  for  late-appearing 
toxicity.  This  was  absent  in  the  older  C-mode  cells  and 
resulted  in  a  faster  weight-gain  in  mice  inoculated  with  these 
cells.  The  10h  C-mode  cells  still  had  about  20%  of  the  LPF 
activity  of  10h  X-mode  cells  and  this  was  presumably  responsible 
for  the  slower  weight-gain  in  mice  inoculated  with  these  samples. 
Lacey  (1960)  followed  modulation  by  monitoring  changes 
in  surface  agglutinogens  during  growth  of  X-mode  cells  in 
C_medium.  He  determined  the  slide-agglutination  titres  of 
rabbit  X-  and  C-antisera  against  C-mode  cells  of  various  ages. 
His  results  showed  that  the  titre  of  specific  X-antiserum 
against  X-cells  inoculated  into  C-medium  decreased  from  5120 
initially  to  about  2560  after  12h  of  growth.  The  titre 193 
further  decreased  to  1280  by  18h  and  dropped  to  below  5  by 
24h.  He  also  showed  that  the  titre  of  unabsorbed  C-mode 
antiserum  against  X-mode  cells  grown  on  C-medium  stayed 
constant  at  20  for  12h  then  increased  slightly  to  about  60 
by'l8h  then  increased  rapidly  to  1280  by  24h  and  thereafter 
stayed  constant.  He  did  not  give  any  data  to  show  possible 
changes  in  the  agglutination  titres  of  X-  or  C-antisera  against 
X-mode  cells  grown  in  X-medium.  However,  his  results  4  ., 
suggested  that  the  loss  of  some  surface  agglutinogens 
associated  with  X-mode  cells  occurred  within  24h  of  growth 
in  C-medium. 
It  was  shown  in  the  present  investigation  that  while 
the  tiitres  of  specific  and  unabsorbed  X-antisera  against  X-cells 
stayed  relatively  constant  at  4096  throughout  growth,  the  titres 
of  these  antisera  against  C-mode  cells  decreased  from  2048  and 
4096..  to  64  and  512  respectively  by  24h  and  thereafter  remained 
relatively  unchanged.  Furthermore,  the  titres  of  the 
specific  and  unabsorbed  C-antisera  against  C-mode  cells 
increased  from  4  and  64  to  256  and  4096  respectively  by  24h 
and  stayed  relatively  constant  while  the  titres  of  these 
antisera  against  X-mode  cells  stayed  relatively  constant  at 
4  and  32  respectively  throughout  growth.  The  results 
provided  some  evidence  that  the  surface  X-specific  agglutino- 
gens-were  lost  by  24h  during  modulation.  This  observation 
agrees  with  the  earlier  finding  by  Lacey  (1960).  However, 
one  discrepancy  was  that  Lacey  showedthat  the  titre  of  specific 
anti-X  serum  against  C-mode  cells  dropped  to  less  than  5 
after  24h  but  in  the  present  project  the  titre  of  the  specific 194 
anti-X  serum  against  C-mode  cells  decreased  only  to  64  by 
24h'.  This  apparent  difference  in  titres  may  be  accounted 
for  by  the  fact  that  the  anti-X  serum  may  not  have  been 
completely  absorbed  by  the  C-mode  cells  and  thus  there  was 
still  some  C-mode  specificity  in  the  serum. 
Investigation  of  the  level  of  the  HA  activity  in 
C-mode  cultures  during  modulation  revealed  that  activity  was 
not  detectable  in  any  samples  of  C-mode  cultures  or  cell 
suspensions  obtained  after  10h  during  modulation.  On  the 
other  hand,  appreciable  levels  of  activity  were  detected 
in  all  X-mode  cultures  and  cell  suspensions.  It  is 
possible  that  if  C-mode  samples  were  obtained  earlier  than 
l0h  during  modulation,  some  activity  would  have  been  detected. 
However,  very  similar  results  were  obtained  by  Lacey  (1960) 
when  he  examined  the  HA  activity  of  C-mode  cells  against  sheep 
red  blood  cells.  He  was  unable  to  detect  any  activity  in 
C-made  cells  obtained  2h  after  inoculation  of  X-mode  cells 
onto  C-medium.  He  therefore  concluded  that  under  pro-C- 
mode  conditions,  the  HA  of  X-mode  cells  disappeared  long 
before  the  X-agglutinogens  were  lost.  Since  this 
investigation  showed  that  by  10h  during  modulation,  C-mode 
cells  still  had  10%-20%  of  the  other  pathophysiological 
activities  present  in  10h  X-mode  cells  and  no  HA  activity, 
it  appeared  that  the  HA  activity  was  more  labile  and  was 
lost-faster  than  the  other  pathophysiological  activities 
during  modulation  in  liquid  medium. 195 
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Although  initial  experiments  showed  the  loss  of  the 
various  activities  during  modulation,  there  was  no  clear 
, 
evidence  to  show  whether  loss  of  activities  was  due  to 
denaturation  or  degradation  in  situ  of  the  cell  components 
responsible  or  if  the  loss  from  the  cells  was  due  to 
liberation  of  the  components  into  the  growth  medium.  It 
was  known  that  these  components  were  liberated  into  the 
surrounding  medium  during  normal  X-mode  growth.  However, 
later  investigations  revealed  that  the  HSF,  LPF  and  HA 
activities  were  also  lost  in  C-mode  whole  cultures  and 
culture  supernatants.  This  loss  followed  a  similar 
pattern  to  that  observed  for  the  cell  suspensions.  Thus 
it:  was  concluded  that  the  loss  of  activities  from  C-mode 
cells  during  modulation  could  not  be  due  solely  to  the 
liberation  of  activities  into  the  extracellular  medium  but 
,  was  probably  due  to  denaturation  or  degradation  of  the  cell 
components  in  situ. 
Wardlaw  et  al.,  (1976)  correlated  the  loss  of  the  28k 
and  30k  envelope  polypeptide  components  with  the  loss  of  the 
PA  and  HSF  activities  in  C-mode  cells.  The  present  study 
also  showed  that  the  2$k  and  30k  polypeptides  were  lost  in 
parallel  with  the  immunological  and  pathophysiological 
activities.  To  determine  the  precise  relationship  between 
the  bands  and  activities  and  to  determine  the  possible 
mechanism  of  modulation,  investigations  were  carried  out 
to  ascertain  whether  the  2$k  or  30k  polypeptides  were 
transiently  synthesized  in  C-mode  cells  during  modulation 
or  if  synthesis  of  the  polypeptides  was  switched  off 196 
immediately  upon  inoculation  of  X-mode  cells  into  C-medium. 
X-mode  cells  were  grown  in  X-  and  C-media  with  added 
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glutamate  and  the  incorporation  of  C  glutamate  into  the  28k 
and-30k  polypeptides  and  other  cell  components,  after  8h  growth, 
was  monitored.  B.  pertussis  prefers  glutamate  to  other  amino- 
acids  as  a  source  of  carbon  and  nitrogen  (Rowatt,  1957a). 
Thus  the  labelled  glutamate  in  the  medium  would  be  incorporated 
into  any  polypeptides  synthesized  in  the  new  growth  medium. 
When  cell  components  were  fractionated  by  SDS-PAGE,  the 
14C 
uptake  in  the  region  of  the  various  polypeptides  would  be  in 
proportion  to  the  amount  of  new  protein  synthesized.  If 
there  was  no  synthesis  of  a  particular  protein  in  the  new 
medium  then  there  would  be  no  detectable  labelled  glutamate  in 
that  particular  region  of  the  gel.  Although  the  results 
obtained  were  not  conclusive,  there  was  some  evidence  that 
polypeptide  components  with  molecular  weights  of  28k,  30k  and 
approximately  100k  were  not  synthesized  within  Sh  of  inoculation 
of,  X-mode  cells  into  C-medium.  Furthermore,  the  presence  of 
28k  and  30k  polypeptides  has  been  correlated  with  certain  of 
the  activities.  The  relationship  of  the  100k  polypeptide 
'bands,  however,  to  any  of  the  activities  is  not  known.  It  has 
been  reported  that  two  high  molecular  weight  (120k  and  90k) 
polypeptides  present  in  Phase  I  cell  envelopes  were  absent 
in  Phase  IV  cells  (Muse,  Findley,  Allen  and  Collier,  1978) 
but  no  indication  of  their  relationship  to  any  of  the 
activities  was  given.  However  recent  fractionation  studies 
(Sato,  1978)  have  shown  that  LPF  has  a  molecular  weight  of 
about  110k,  so  it  is  possible  that  the  100k  polypeptide  may 197 
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be  related  to  the  component  responsible  for  the  LPF  activity. 
In  the  uptake  experiment,  a  protein  component  of  the  X-mode 
L 
cells,  with  a  molecular  weight  of  approximately  25k  showed 
little  or  no  uptake  of  labelled  glutamate  after  8h  growth. 
However  it  is  possible  that  this  was  a  late  synthesized 
protein  since  it  is  known  that  different  envelope  proteins 
are  synthesized  at  different  stages  of  growth  (Schnaitman,  1974). 
Further  investigations  correlating  the  increase  in  viable 
cell  numbers  and  the  rate  of  loss  of  activities  in  C-mode 
cells  suggested  that  the  loss  of  activities  was  not  due  solely 
to  dilution  of  cell  components  amongst  the  progeny  cells. 
This  further  suggested  that  the  immunological  and  patho- 
physiological  factors  in  the  original  inoculum  were  presumably 
degraded  or  denatured  during  modulation.  One  interesting 
observation  in  this  project  was  that  some  of  the  activities 
were  not  completely  lost  during  one  subculture.  By  72h, 
after  inoculation  of  X-mode  cells  into  C-medium  and  when  the 
culture  had  reached  stationary  phase,  the  C-mode  cells  still 
had  about  2%  of  the  level  of  HSF  activity  present  in  the 
X-mode  cells.  It  would  be  necessary  to  carry  out  repeated 
subcultures  in  C-medium  to  see  if  activities  were  lost 
completely.  However,  it  is  also  possible  that  these 
residual  levels  of  activities  were  not  due  to  the  presence 
of  the  protein  components  designated  as  LPF  or  HSF  but  to  the 
endotoxin  content  of  the  C-mode  cells.  Endotoxin  has  been 
reported  to  have  some  HSF  activity  (Malkiel  and  Hargis,  1964; 
Kurokawa  and  Homma,  1975)  and  LPF  activity  (Kurokawa  et  al., 
1978). 198 
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Overall  results  in  the  present  study  showed  that  within 
10h.  of  inoculation  of  X-mode  cells  into  C-medium,  the  resulting 
cells  had  only  2%-20%  of  the  various  activities  present  in  their 
X-mode  counterparts  and  could  therefore  be  described  as  C-mode. 
The.  change  from  X-mode  to  this  C-mode  state  appeared  to  be  a 
rapid  process  requiring  only  1-2  cell  divisions.  Lacey  (1960) 
reported  that  the  transition  from  X-mode  to  C-mode  occurred 
between  21-36h  during  modulation  and  required  7-12  cell 
divisions.  There  could  be  several  possible  reasons  for  the 
discrepancy  in  the  number  of  cell  divisions  required  for 
6I_  modulation  in  these  studies.  Firstly,  different  criteria  were 
, usedýto  assess  the  mode  of  the  organism  in  the  two  studies. 
Lacey's  work  was  concerned  primarily  with  the  loss  of  virulence 
and  surface  agglutinogens.  In  the  present  study  the  various 
biological  activities  were  the  focus  of  investigation.  Secondly, 
different  strains  of  B.  pertussis  were  used.  Thirdly,  Lacey's 
work  was  done  with  solid  medium  whereas  the  present  study  was 
done  using  liquid  medium.  Some  reports  have  shown  that  the 
levels  of  different  activities  in  B.  pertussis  could  be 
influenced  greatly  by  the  growth  medium.  For  example,  Munoz 
(1971)  reported  that  cells  grown  on  solid  medium  had  more  HSF 
1  1, 
activity  than  cells  grown  in  liquid  medium.  Thus,  the  time  loss 
of  activities,  i.  e.  the  time  required  for  X-mode  cells  to 
modulate,  could  depend  on  the  type  of  medium  used  and  the  initial 
level  of  activites  present  in  the  cells. 
There  was  some  evidence  in  this  study  to  suggest  that 
during  modulation,  the  various  activities  were  lost  at  different 
rates.  The  PA  and  the  HA  activities  appeared  to  be  lost 199 
Jfaster  than  the  HSF  and  LPF  activities.  At  10h  during 
modulation,  the  best  estimated  potency  values  showed  that  the 
C-mode  cells  had  only  2%  of  the  mouse-protective  activity  and 
about  12%  of  the  HSF  activity  of  the  X-mode  cells.  This 
showed  a  six-fold  difference  in  the  levels  of  these  activities 
by  10h.  Results  from  individual  experiments  showed  a  similar 
pattern  of  a  faster  loss  of  the  mouse-protective  activity  than 
of  the  HSF  activity.  Wardlaw  et  al.,  (1976)  also  reported 
that  the  mouse-protective  activity  declined  more  sharply  during 
antigenic  modulation  than  does  the  HSF  activity.  Pusztai  and 
Joo  (1967)  also  noted  the  same  effect  with  three  B.  pertussis 
strains  grown  in  high  nicotinic-acid  medium.  However,  these 
workers  stated  that  the  changes  produced  by  high  nicotinic  acid 
were  not  quite  the  same  as  in  antigenic  modulation.  Dolby 
(196$),  produced  some  evidence  that  PA  and  HSF  do  not  necessarily 
occur  in  a  fixed  ratio  of  activities. 
Because  the  rate  of  growth  of  the  organism  was  slow,  samples 
were  not  taken  earlier  than  10h.  Furthermore,  because  of  the  low 
precision  of  the  intracerebral  mouse-protection  test,  it  might 
not  have  been  possible  to  detect  accurately  small  differences 
in  the  levels  of  protective  activity  within  the  first  few 
hours  of  modulation. 
y,  Similarly,  the  HSF  assay  method  used  in  this  study  was  based 
on,  the  rate  and  number  of  deaths  of  mice  as  an  estimation  of  the 
level  of  activity.  However,  a  very  recent  paper  (Ishida,  Iwasa, 
Asakawa  and  Kurokawa,  1978)  confirmed  that  this  HSF  assay  method 
was  too  insensitive  to  detect  relatively  low  HSF  content  with  any 
accuracy.  Instead  they  proposed  an  assay  method  which  was  based 2  00 
on  body  temperature  reduction  in  the  mouse  as  a  response. 
They  showed  that  the  body  temperature  of  mice  sensitized  with 
pertussis  vaccine  began  to  decrease  immediately  after  histamine 
challenge,  reaching  the  lowest  level  in  20-40  min,  and  then 
began  to  recover  slowly.  They  added  that  the  temperature  of 
the  mice  30  min  after  histamine  challenge  was  a  measure  of  the 
HSF  response  and  concluded  that  the  lowest  level  of  HSF  content 
detectable  by  the  temperature  measurement  was  20  to  30  times 
less  than  that  detectable  by  the  method  used  in  this  study. 
If  in  future  work  the  sensitivity  of  the  assay  methods 
used  were  improved,  the  time  sequence  of  loss  of  each  of  the 
activities  could  be  determined  more  precisely.  In  the  present 
work,  each  mouse-protection  test  in  which  four  samples  were 
assayed  involved  the  use  of  180  mice.  By  increasing  the  number 
of  mice  used  by  two-fold  or  three-fold,  more  precise  and 
reliable  results  might  be  obtained.  Also  the  use  of  the  HSF 
assay  method  based  on  mouse  body  temperature  reduction  could  help 
detect  small  changes  in  the  level  of  HSF  activity. 
Though  the  inability  to  detect  HA  activity  in  10h  C-mode 
samples  suggested  a  faster  rate  of  loss  than  the  HSF  activity, 
the  precision  and  sensitivity  of  the  assay  method  used  is 
questionable.  Though  Lacey  (1960)  was  unable  to  detect  any  HA 
activity  in  C-mode  cells  grown  on  solid  medium,  after  2h  of 
modulation,  it  might  be  possible  that  if  C-mode  cells  grown  in 
liquid  medium  were  assayed  earlier  than  10h  during  modulation, 
some  HA  activity  could  be  detected.  However,  some  workers,  like 
Keogh  and  North  (1948)  have  shown  that  the  PA  also  has  HA 
activity.  Also  Sato  (1978)  in  his  fractionation  studies 201 
obtained  a'fraction  which  possessed  high  HA  and  mouse- 
protective  activities.  The  faster  rate  of  loss  of  these 
two  activities  in  this  study  tend  to  agree  with  the  findings 
of  these  earlier  workers  and  thus  may  be  a  further  evidence 
for  the  relationship  between  the  PA  and  the  HA. 
The  most  recent  fractionation  studies  suggest  that  the 
HSF  and  the  LPF  are  the  same  component  of  the  cell  (Lehrer 
et  al.,  1974;  Morse  and  Morse,  1976).  In  this  study, 
10h  C-mode  cells  contained  only  20%  of  the  LPF  activity  but 
11%  of  the  HSF  activity.  Thus  a  two-fold  difference  in 
the  levels  of  the  activities  was  observed.  This  tends  to 
suggest  that  the  activities  were  lost  at  different  rates. 
However,  a  number  of  other  factors  like  HA  (Arai  and  Sato, 
1976)  and  endotoxin  (Ishida  et  al.,  1978)  have  been  reported 
to  induce  leukocytosis  in  mice.  Endotoxin  also  has  HS 
activity  as  already  stated.  Thus  because  different  cell 
components  may  exhibit  different  combinations  of  the  unusual 
pathophysiological  properties  of  B.  pertussis,  it  is  clearly 
very  difficult  to  draw  definite  conclusions  about  the  relationship 
of  the  various  components  by  monitoring  the  loss  of  the  activities. 
It  would  therefore  be  necessary  to  devise  a  way  to  assay  for  LPF 
and  HSF  activities  due  solely  to  the  protein  components 
known  as  LPF  and  HSF  respectively.  For  example,  the 
contribution  made  by  endotoxin  to  these  activities  could  be 
determined  by  finding  the  activity  of  boiled  vaccine  since  the 
HSF  and  LPF  but  not  endotoxin  would  be  destroyed.  These 
specific  assay  methods  are  necessary  to  determine  if  the  two- 
fold  difference  in  the  levels  of  HSF  and  LPF  activities  observed 
in  this  study  was  significant. 2  02 
Arai  and  Sato  (1976)  and  Irons  and  MacLennan  (1978) 
reported  the  presence  of  two  distinct  haemagglutinins,  LPF- 
HA  and  F-HA,  in  Phase  I  B.  pertussis.  Arai  and  Sato  (1976) 
stated  that  the  LPF-HA  had  very  low  haemagglutinating  activity 
and  high  leukocytosis-promoting  activity  while  the  F-HA,  which 
was  associated  with  the  fimbriae,  had  very  high  haemagglutinating 
activity  and  no  leukocytosis  promoting  activity.  Sato  (1978) 
showed  that  the  F-HA  also  had  protective  activity.  In  the 
present  study,  haemagglutinating  activity  was  undetectable  in 
C-mode  cultures  even  when  HSF  and  LPF  activities  could  still  be 
detected,  i.  e.  the  haemagglutinating  activity  of  the  component 
LPF-HA  was  undetected.  It  thus  appeared  that  the  low  haemagg- 
lutinating  activity  which  could  be  measured  in  X-mode  cells  was 
due  to  the  F=HA  component  which  may  be  identical  with  the  PA 
(Sato,  1978)  and  the  fimbriae  (Arai  and  Sato,  1976;  Morse  and 
Morse,  1976). 
There  was  also  some  evidence  in  this  study  to  suggest  that 
the  HLT  was  lost  at  a  slower  rate  than  the  HSF.  By  48h  during 
modulation,  C-mode  cells  had  22%  of  the  level  of  toxicity  and  2% 
of  the  HSF  activity  present  in  X-mode  cells.  Cells  harvested 
earlier  than  48h  were  not  assayed  for  their  levels  of  toxicity, 
It  is  possible  that  a  more  reliable  result  would  have  been 
obtained  by  following  the  time  course  of  the  HLT  loss  in  cells 
as  for  the  HSF.  Livey  et  ai.,  (1978)  showed  that  the  HLT 
activity  was  lost  at  a  slower  rate  than  the  HSF  activity.  In 
four  different  experiments,  after  65h  of  modulation,  C-mode  cells 
had  between  3.7%-9.3%  of  the  level  of  toxicity  and  between  0.4% 
and  1.9%  of  the  HSF  activity  present  in  X-mode  cells  of  the  same 
age.  In  the  present  study,  the  rate  of  loss  of  the  HLT  and  HSF 
in  C-mode  whole  cultures  did  not  differ  significantly. 2  03 
However,  the  distribution  of  toxicity  between  cells  and  culture 
supernatant  during  growth  was  not  established. 
During  the  early  stages  of  growth  in  X-medium  it  was 
observed,  in  this  study,  that  the  HSF,  LPF  and  HA  activities 
were  associated  with  the  cells  but  by  the  log  phase  of 
growth,  the  bulk  of  these  activities  were  contained  in  the 
culture  supernatant.  This  suggested  that  during  growth, 
these  components  were  synthesized  by  the  cells  and,  at  least 
a  proportion  of  these  components,  were  liberated  into  the 
culture  medium.  This  observation  was  in  accord  with  the 
reports  of  Munoz  (1971)  and  Sato  et  al.,  (1974)  who  stated 
that  in  they  youngercells  HSF  was  cell-associated  but  released 
into  the  supernatant  fluid  during  the  log  phase  of  growth. 
Fisher  (1950)  and  Masry  (1952)  also  showed  that  the  HA  was 
released  into  the  extracellular  medium  during  growth.  Similar 
results  for  LPF  were  reported  by  Morse  and  Bray  (1969)  and  Sato 
et  al.,  (1974)  who  showed  that  in  Phase  I  strains,  the  factor 
responsible  for  the  activity  was  associated  initially  with  the 
cells  but  the  bulk  of  it  was  released  subsequently  into  the 
culture  medium  as  growth  progressed. 
Despite  the  liberation  of  the  active  factors  into  the 
culture  supernatant,  it  was  observed  in  this  study  that  cells 
obtained  at  various  intervals  during  growth  in  X-medium  had 
maintained  a  constant  level  of  the  various  activities. 
In  the  course  of  investigations  into  the  distribution  of 
activities  between  cells  and  culture  supernatants,  some  evidence 
obtained  in  this  study  indicated  that  storage  by  freezing 
and  thawing  of  samples  prior  to  detoxification 204 
by  heating  had  some  effects  on  the  levels  of  the  various 
activities  present  in  the  samples.  When  cell  pellets, 
harvested  at  various  intervals  during  growth  from  a  fixed 
volume  of  culture  and  resuspended  in  saline  to  original  volume, 
were  treated  as  described  above,  the  levels  of  HSF  and  LPF 
activities  decreased  progressively  despite  a  steady  increase 
in  cell  number  during  growth.  However,  in  later  experiments 
where  all  suspensions  obtained  in  the  same  manner  as  above 
were  heated  immediately  after  harvest  and  preserved  by  the 
addition  of  thiomersal  instead  of  freezing,  it  was  found 
that  the  level  of  HSF  activity  in  the  cell  suspensions 
increased  in  parallel  with  cell  numbers.  Therefore  freezing 
and  thawing  prior  to  detoxification  of  samples  by  heating 
appeared  to  be  responsible  for  the  earlier  observation  in 
which  levels  of  activities  decreased  in  cell  suspensions 
despite  increase  in  cell  numbers.  It  may  be'that  freezing 
and  thawing  liberated  autolytic  enzymes  which  degraded  the 
envelope  components  before  they  in  turn  were  destroyed  by  the 
detoxification  process.  The  levels  of  these  enzymes  could 
have  increased  as  the  culture  aged  giving  a  greater 
reduction  of  activities  in  older  samples,  despite  the 
increase  in  cell  numbers. 
During  growth  of  X-mode  cells  in  X-medium,  it  was 
observed  in  this  investigation  that  the  levels  of  the  HSF, 
HLT  and  LPF  activities  in  whole  culture  samples  increased 
as  growth  progressed,  reached  a  peak  at  about  the  end  of 
log  phase  and  then  started  to  decline  during  the 
stationary  phase.  This  decline  in  the  levels  of  activities 2  05`? 
after  synthesis  had  ceased  might  have  been  due  to  the 
liberation  of  degradative  enzymes  or  to  an  increase  in  the 
pH  of  the  medium,  causing  denaturation.  Masry  (1952) 
showed  that  the  HA  titres  of  B.  pertussis  grown  in  liquid 
medium  increased  after  the  3rd  or  4th  day  until  a  maximum  was 
reached  on  the  8th  day.,  This..  was  then  followed  by  a  rapid 
decline  in  titre.  He  stated  that  the  decline  in  titres  was 
due  to.  the  medium  becoming  more  alkaline.  Sato  et  al., 
(1974)  reported  a  similar  decrease  in  HSF  and  LPF  activities 
in  Phase  I  strains  after  5  days  incubation  in  liquid  medium 
but  offered  no  explanation  for  this  decrease. 
On  correlation  of  the  levels  of  HSF  activity  of  X-mode 
cultures  with  increase  in  viable  cell  numbers  during  growth, 
it  was  observed  in  the  present  project  that  the  increase 
in  the  total  levels  of  activity  was  greater  than  could  be 
accounted  for  by  a  doubling  effect  resulting  from  an  increase 
in  viable  cell  numbers.  However,  Lane  (1968)  showed  that 
at  anytime  during  growth  of  B.  pertussis  in  liquid  medium, 
the  percentage  of  viable  cells  compared  to  the  total 
number  of  cells  in  the  culture  was  less  than  15%.  Thus 
in  this  study,  it  was  possible  that  the  dead  cells  in  the 
culture  presumably  still  had  some  HSF  activity.  Also, 
during  growth,  HSF  was  released  from  the  cells  into  the 
supernatant.  These  facts  would  explain  the  observed 
greater  increase  in  HSF  activity  compared  to  the  increase 
in  viable  cell  numbers. 2o6 
Because  of  the  toxic  side  effects  associated  with 
the  present  B.  pertussis  vaccines,  a  number  of  fractionation 
studies  have  been  carried  out  in  order  to  seperate  the 
component  of  the  cell  actually  responsible  for  protecting 
the  child  against  B.  pertussis  infection  from  that  causing 
toxicity.  In  recent  years  much  progress  has  been  made  in 
the  isolation  of  various  components,  like  HSF  (Lehrer 
et  al.,  1974)  LPF  (Morse  and  Morse,  1976)  and  HA  (Arai  and 
Sato,  1976).  However,  the  isolation  of  the  PA  still 
remains  elusive.  At  the  beginning  of  this  study,  it  was 
hoped  that  the  process  of  modulation  could  be  utilized  in 
the  seperation  of  these  components.  The  initial  speculation 
was  that  cells  with  high  levels  of  PA  and  low  levels  of  HSF, 
LPF  and  HLT  might  be  produced  by  this  process.  However, 
evidence  obtained  in  this  study  indicated  that  the  PA  activity 
was  lost  at  a  faster  rate  than  the  other  activities  during 
X  to  C  modulation.  The  difference  in  the  rate  of  loss  of 
the  various  activities  may  presumably  be  due  to  the  fact 
that  different  proteins  have  different  stabilities  and 
therefore  are  denatured  at  different  rates.  Unfortunately, 
the  PA  appeared  to  be  more  labile  than  the  HSF  and  other 
potentially  toxic  factors.  If  HSF  had  been  more  labile 
than  the  PA,  production  of  a  less  toxic  vaccine  would  have 
been  a  possibility.  How@  Ter  because  the  rates(,  of  loss  of  the 
various  activities  were---,  similar,  it  might  not  be  possible 
to  seperate  the  various  activities  by  modulation.  Thus  the 
present  investigation  revealed  that  the  approach  to  the 
production  of  a  safer  vaccine  by  utilizing  the  process  of 207 
X  to  C  modulation  might  not  be  feasible. 
However,  since  Lacey  (1960)  reported  that  the  C  to  x 
modulation  does  not  retrace  the  path  of  X  to  c  change,  it 
might  still  be  possible  to  explore  the  utilization  of  C  to 
X-modulation  for  the  production  of  cells  with  high  PA  activity 
and  less-toxic  activities.  In  this  work  only  a  superficial 
examination  of  C  to  X  modulation  was  made.  It  was  observed  that 
C-mode  cells  with  very  low  levels  of  HSF,  LPF  and  HLT  activities, 
when  grown  in  X-medium  for  48h,  regained  these  activities  almost 
to  the  levels  present  in  normal  X-mode  cells.  However,  no 
attempts  were  made  to  estimate  the  levels  of  the  various 
activities  at  different  intervals  during  this  reverse  process 
of  modulation  and  thus  there  was  no  indication  of  the  rate  of 
gain  of  these  activities.  A  more  detailed  study  of  C  to  X 
modulation  is  necessary  for  future  work  Asr  it  is  possible  that 
during  the  C  to  X  change,  the  PA  activity  might  be  regained  at 
a  faster  rate  than  the  other  activities.  If  this  should  be, 
then  the  utilization  of  the  reverse  process  of  modulation  for 
the  production  of  a  safer  vaccine  might  still  be  possible. 
A  number  of  other  factors  have  been  reported  to  induce 
modulation.  These  factors  include  growing  X-mode  B.  pertussis 
cells  at  low  temperature,  in  the  presence  of  certain  salts, 
fatty  acids,  tellurite  or  old  blood  (Lacey,  1960).  In  the 
present  study  only  the  effect  of  magnesium  sulphate  on  modu- 
lation  was  investigated.  Other  workers  (Holt  and  Spasojevic) 
1968;  Parton  and  Wardlaw,  1975;  Wardlaw  et  al.,  1976  and 
Livey  et  al.,  1978)  also  studied  the  effects  of  salts  on 208 
modulation.  Lacey  (1960)  also  looked  at  the  effect  of 
low  temperature  on  modulation.  He  found  that  B.  pertussis 
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cells  at  25  C  grew  in  the  C-mode  no  matter  what  salt  was 
included  in  the  medium  and  at  35°C  they  grew  like  the  wild 
type,  with  the  whole  population  modulating  according  to  the 
salt  content  of  the  medium.  He  gave  no  details  of  the 
pattern  of  changes  in  the  levels  of  the  various  activities 
during  modulation  induced  by  low  temperature  or  by  other 
factors.  It  would  be  of  interest  to  examine  if  the  same 
sequence  of  events  occurred  in  modulation  induced  by  other 
environmental  conditions  as  in  modulation  induced  by 
magnesium  sulphate.  It  is  possible  that  the  sequence 
of  changes  in  modulation  induced  by  different  factors  might 
vary. 
SECTION  3:  POSSIBLE  MECHANISM  OF 
MODULATION 
Although  the  sequence  of  changes  in  antigenic 
modulation  induced  by  the  different  environmental 
conditions  is  not  known,  Lacey  (1960)  emphasized  that  there 
was  no  evidence  to  show  that  any  of  these  factors  acted 
by  a  different  mechanism  or  gave  rise  to  different  types  of 
C-mode  cells.  Wardlaw  et  al..,  (1976)  showed  that  growth 
of  X-mode  cells  in  the  presence  of  high  nicotinic  acid, 
high  magnesium  sulphate,  sodium  sulphate  and  magnesium 
succinate  produced  C-mode  cells  as  shown  by  loss  of  HSF, 
PA  and  2$k  and  30k  polypeptides,  though  with  varying 
degrees  of  loss  of  activities.  The  fact  that  a  wide 209' 
variety  of  apparently  unrelated  factors  induced  modulation 
poses  the  question  :  Why  does  B.  pertussis  undergo  modulation  ? 
Although  this  question  has  not  been  investigated  experimentally, 
it  would  seem  likely  that  modulation  is  a  process  of  adaptation 
to  a  new  environment.  Modulation  appears  to  involve  the  switch- 
ing  off  of  the  synthesis  of  components  of  the  cell  which  are  not 
essential  under  all  conditions  of  growth.  These  components 
include  what  could  be  described  as  the  virulence  factors,  for 
example,  the  HSF,  HLT  and  LPF.  C-mode  cells  appeared  to  grow 
quite  normally  and  at  a  rate  comparable  with  that  of  X-mode  cells. 
Therefore,  the  C-mode  cells  are  not  apparently  handicapped  in  any 
way,  at  least  in  vitro.  Thus  modulation  could  be  a  process  of 
conserving  energy  under  certain  conditions.  Lacey  (1960) 
reported  that  C-mode  antibodies  have  been  found  in  several  adults 
with  persistent  cough  and  infection,  indicating  that  possibly 
modulation  does  occur  in  vivo.  It  is  difficult  to  see  how  loss 
of  the  ""virulence'  factors"  could  help  the  organism  in  vivo  but 
a  drastic  change  in  surface  antigens,  in  response  to  some  external 
stimulus,  might  help  the  organism  to  resist  host  defence  mechanisms 
This  stimulus  might  be  provided  if  the  organism  became  dislodged 
from  the  upper  respiratory  tract  and  transferred  to  another  site 
in  the  host.  The  different  environmental  conditions  could 
induce  modulation,  and  the  organism  would  conserve  resources  and 
resist  defence  mechanisms  until  it  could  regain  a  suitable  site 
in  the  host  or  in  a  different  host  and  then  revert  to  the 
original  virulent  form.  However,  at  present  the 210 
significance  of  modulation  in  the  life  cycle  of  B.  pertussis 
is  still  not  known. 
The  process  of  antigenic  modulation  is  not  unique  to 
B.  pertussis.  In  a  review  of  non-genetic  variation  of  surface 
antigens  of  micro-organisms,  Lacey  (1961)  reported  that 
changes  in  growth  conditions  resulted  in  changes  in 
structural  components  of  other  micro-organisms.  For 
example,  growth  at  26°C  led  to  lack  of  capsule  formation 
by  virulent  strains  of  Pasteurella  pestis;  also  growth  of 
Bacillus  subtilis  in  the  presence  of  manganese  increased 
the  levels  of  certain  envelope  polypeptidesof  the  organism. 
Some  other  bacteria  and  protozoa,  for  example,  Borrelia 
recurrentis,  Trypanosoma  rhodesiense  and  Trypanosoma  gambiense 
are  also  known  to  undergo  different  types  of  modulation  in 
-infected  hosts. 
Attempts  were  made  in  this  study  to  determine  the 
possible  mechanism  involved  in  modulation  of  B.  pertussis. 
Since  most  of  the  properties  lost  during  modulation  were 
associated  with  cell  envelope  proteins,  one  possibility 
was  that  pro-C-mode  conditions  favoured  higher  proteolytic 
activity  in  the  cells,  which  led  to  degradation  of  certain 
envelope  proteins  in  the  C-mode  cells.  However,  no 
significant  difference  in  the  proteolytic  activities  of 
the  X-  and  C-mode  cultures,  intact  cells  and  X-pressed  cells, 
was  found.  Thus  loss  of  activities  in  modulation  was  not 
apparently  as  a  result  of  enhanced  proteolytic  degradation 
of  cell  components. 211 
As  a  further  attempt  to  understand  the  mechanism  of 
modulation,  the  role  of  sodium  chloride  and  magnesium 
sulphate  in  modulation  were  examined.  Wardlaw  at  al., 
(1976)  investigated  the  effect  of  different  concentrations 
of  magnesium  sulphate  on  modulation  and  showed  that  the 
change  from  X-mode  to  C-mode  occurred  when  the  magnesium 
sulphate  concentration  in  the  medium  was  raised  from  4mM  to 
20mM.  They  showed  that  a  medium  containing  less  than  4mM 
of  magnesium  sulphate  was  pro-X-mode.  Aiphen  and  Lugtenberg 
(1971)  reported  the  influence  of  osmolarity  of  the  growth 
medium  on  the  outer  membrane  proteins  of  E.  cola.  They  stated 
that  the  addition  of  high  concentrations  of  NaCl,  KC1  or  sucrose 
to  the  growth  medium  caused  a  drastic  change  in  the  ratio  of 
two  outer  membrane  proteins  of  E.  coli  K12.  In  the  present 
study  the  replacement  of  sodium  chloride  in  the  medium  with 
magnesium  sulphate  would  decrease  th  osmolarity  of  the  medium. 
Thus  it  was  initially  thought  that  this  change  in  osmolarity 
might  be  causing  changes  in  the  outer  membrane  proteins  of 
B.  pertussis  cells  similar  to  those  reported  for  E.  coli. 
In  order  to  investigate  this  possibility,  X-mode 
cells  were  grown  in  medium  without  added  sodium  chloride 
or  magnesium  sulphate.  Cells  harvested  after  48h  showed 
between  a  two-fold  to  four-fold  decrease  (per  ou.  ml)  in  the 
level  of  HSF  activity  compared  to  the  level  of  activity  in 
normal  X-mode  cells.  The  growth  of  cells  in  C-medium 
resulted  in  a  ten-fold  decrease  in  the  level  of  HSF  activity 212 
compared  to  the  level  of  activity  in  X-mode  cells.  Thus 
though  an  increase  in  the  level  of  magnesium  sulphate  in 
the  medium  induced  modulation  it  does  appear  that  it  is  not 
only  the  magnesium  sulphate  that  has  a  role  in  the  modulation 
process  since  lack  of  sodium  chloride  in  the  medium  also 
resulted  in  a  decrease  in  HSF  activity.  Moreover,  the 
observed  changes  in  HSF  levels  cannot  be  explained  simply 
by  the  changes  in  osmolarity  in  the  different  media.  Lacey 
(1960)  reported  that  growth  medium  without  added  magnesium 
sulphate  or  sodium  chloride  was  slightly  pro-X-mode  but  that 
this  residual  pro-X-mode  property  of  the  medium  varied  with 
the  batch  of  blood  added  to  the  medium.  Thus  the  difference 
between  his  findings  and  the  observations  in  the  present 
study  may  be  due  to  differences  in  the  ionic  composition  of 
the  basal  media  used  in  these  studies. 
Recently,  Parton  and  Durham  (1978)  reported  the  loss  of 
adenylate  cyclase  activity  in  C-mode  cells.  Since  the  role 
of  cyclic  AMP  in  the  regulation  of  the  metabolism  of  other 
organisms  has  been  well  established  (Rickenberg,  1974), 
the  role  of  cyclic  AMP  as  a  possible  clue  to  the  underlying 
regulatory  mechanism  in  modulation  was  examined.  Results 
revealed  that  during  X  to  C  modulation,  the  original  cyclic 
AMP  content  of  the  culture  derived  from  the  inoculum  was  not 
detectable  after  10h.  However,  it  was  observed  that  during 
C  to  X  modulation  cyclic  AMP  and  the  pathophysiological 
activities  were  regained. 213.  ,  ý,.  ý 
Hewlett,  Underhill,  Vargo,  Wolff  and  Manclark  (1978) 
isolated  a  component  from  rabbit  blood  which  when  added  to 
the  growth  medium  increased  the  adenylate  cyclase  activity 
of  the  cells  by  several  folds.  This  activator  has  since 
been  found  in  other  mammalian  tissues  and  commercial  bovine 
liver  catalase  is  a  very  rich  source.  In  the  present  study, 
attempts  were  made  to  determine  the  relationship  between  the 
levels  of  cyclic  AMP  in  the  culture  and  the  levels  of 
activities  by  using  this  activator  to  enhance  cyclic  AMP 
levels  and  possibly  to  enhance  levels  of  the  activities. 
Even  in  the  presence  of  an  activator,  there  was  no  cyclic  AMP 
detected  in  C-mode  cultures.  Therefore  presumably  there 
was  not  even  unactivated  adenylate  cyclase  activity  in  the 
C-mode  state,  however,  it  is  also  possible  that  the  activator 
could  not  gain  entry  into  the  C-mode  cells.  The  presence  of 
catalase  enhanced  the  cyclic  AMP  levels  in  X-mode  cells  by 
about  two-fold.  With  B.  pertussis  strain  18334,  the  increase 
in  cyclic  AMP  due  to  catalase  was  not  accompanied,  by  increased 
HSF,  activity.  However,  with  strain  D30042I,  cells  grown  in 
X-medium  with  added  catalase  showed  a  corresponding  two-fold 
difference  in  the  level  of  HSF  activity  but  this  may  not  be 
significant. 
Different  concentrations  of  cyclic  AMP  may  be  required 
for  optimal  expression  of  different  operons  (Lis  and  Schleif, 
1973)  and  it  may  be  that  only  a  very  low  level  of  cyclic  AMP 
is  required  to  "switch  on"  the  synthesis  of  HSF.  Thus  if  the 
HSF  was  already  "switched  on"  in  the  X-mode  cells,  more  cyclic 
AMP  would  not  have  had  any  additional  effect  on  the  level  of 
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Furthermore,  the  effect  of  catalase  on  the  C  to  X  modulation 
was  investigated  to  see  if  synthesis  of  the  HSF,  LPF  and  HLT 
were  switched  on  faster  than  would  normally  be  observed. 
Cultures  grown  in  the  presence  of  catalase  had  increased 
levels  of  cyclic  AMP  after  8h  and  also  showed  a  three-fold 
increase  in  HSF  activity.  After  24h  the  cultures  grown  in 
the  presence  of  catalas'e  had  a  two-fold  increase  in  cyclic 
AMP  and  a  -corresponding  two-fold  increase  in  HSF  activity 
compared  to  control  cultures.  This  clearly  suggested  some 
relationship  between  the  presence  of  cyclic  AMP  and  the 
presence  of  the  HSF  activity.  It  also  gave  an  indication 
that  cyclic  AMP  might  have  some  role  in  the  control  mechanism 
of  modulation. 
Another  line  of  investigation  in  this  study  showed  that 
envelope  components,  which  had  been  correlated  with  the  PA 
and  HSF  activities  (Wardlaw  et  al.,  1976),  were  apparently 
not  synthesized  in  the  C-mode  cells.  Thus,  as  stated 
earlier,  it  appeared  that  the  process  of  modulation  involved 
the  switching  off  of  the  synthesis  of  some  non-essential 
components  of  the  organism  immediately  upon  transfer  of  X_ 
mode  cells  to  C-medium.  In  other  organisms  like  E.  cola, 
it  is  known  that  cyclic  AMP  plays  an  important  role  in  the 
regulation  of  certain  non-essential  function  in  the  organism. 
Cyclic  AMP  is  required  to  promote  transcription  of  certain 
inducible  enzymes,  for  example,  in  the  "glucose  effect"  where 
cyclic  AMP  represses  the  synthesis  of  ß-galactosidase  and 
other  catabolic  enzymes.  Also  E.  coli  mutants  lacking 
adenylate  cyclase  and  cyclic  AMP  have  been  shown  to  be 215 
unable  to  ferment  various  sugars,  to  have  abnormal  patterns 
of  membrane  fatty  acids  and  to  lack  flagella.  Thus  the 
construction  and  function  of  the  envelopes  of  these  mutants 
were  drastically  altered  (Dills  and  Dobrogos,  1977). 
B.  pertussis  does  not  utilize  carbohydrate  but  uses 
amino-acids  as  both  carbon  and  nitrogen  sources.  So,  cyclic 
AMP  in  B.  pertussis  is  presumably  doing  something  other 
than  controlling  the  synthesis  of  carbohydrate-degrading 
enzymes.  Since  cyclic  AMP  and  the  other  activities  are 
lost  in  the  C-mode  cells,  it  is  possible  that  in  the 
X-mode  cells  the  cyclic  AMP  may  be  involved  in  the  regulation 
of  the  genes  responsible  for  the  synthesis  of  the  cellular 
components  responsible  for  the  various  activities. 
One  of  the  main  aims  of  this  study  was  to  determine  if 
the  various  activities  were  lost  in  parallel  or  independently 
during  modulation.  If  found  to  beläst  in  parallel,  this 
would  have  supported  the  idea  that  all  the  activities  were 
different  manifestations  of  a  single  complex  macromolecule 
or  that  the  activities  were  distributed  amongst  different 
components  of  the  cell  but  that  their  expression  was  under 
a  common  control  mechanism.  On  the  other  hand,  if  the 
activities  were  found  to  have  been  lostindependently  then 
it  would  have  been  strong  evidence  that  different  components 
of  the  cell  were  responsible  for  the  different  activities. 
However,  it  has  become  apparent  that  this  initial  speculation 
was  too  simplistic.  T-_D  terminätion`-'of  the  relationship 
of  the  various  activities  was  more  complex  than  was  thought  at 
the  beginning  of  this  investigation.  For  example,  the  LPF ,,  IT" 
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and  HSF  activities  in  this  study  appeared  to  be  lost  at 
different  rates  despite  the  fact  that  a  single  protein 
component  of  the  cell  is  now  thought  to  have  both  activities. 
Such  observation  could  only  be  explained  by  the  fact  that 
other  components  of  the  cells,  with  some  activity  in  the 
tests  used,  were  not  lost  or  were  lost  at  different  rates. 
For  example,  there  may  be  some  synergistic  effect  whereby 
the  LPS  may  effect  a  leukocytosis  response  without  affecting 
the  HSF  activity.  Thus  results  obtained  from  this  study  alone 
may  not  be  sufficient  evidence  to  agree  or  disagree  with  the 
unitarian  hypothesis. 
However,  data  obtained  from  this  study  showed  that  the 
loss  of  the  different  activities  appeared  to  occur  at 
different  rates  during  modulation.  The  PA  and  the  HA 
activities  were±,  lostLat  a  faster  rate  than  the  'HSF  and  LPF 
activities  and  the  HLT  activity  was  lost  at  a  slower  rate 
than  the  HSF  activity.  From  the  known  properties  of 
adenylate  cyclase  (Hewlett  and  Wolff,  1976),  this  enzyme 
is  probably  quite  distinct  from  these  other  immunologically 
and  pathophysiologically  active  components  of  the  cell. 
Taking  into  account  these  observations  and  the  evidence 
from  recent  fractionation  studies  by  other  workers,  it 
could  be  speculated  that  at  least  four  seperate  cellular 
components  are  lost  during  modulation.  These  are  ; 
(_1)  the  PA/HA  complex,  (2)  the  HSF/LPF  complex  with  a 
variety  of  other  activities,  (3)  the  HLT  and  (4)  adenylate 
cyclase.  The  similar  pattern  of  loss  of  these 
activities  suggests  that  their  expression  may  depend 217 
on  a  common  control  mechanism.  It  may  be  that  cyclic  AMP 
regulates  the  expression  of  the  genes  which  are  responsible 
for  the  synthesis  of  the  cell  components  responsible  for 
the  various  activities  of  B.  pertussis.  Different 
concentrations  of  cyclic  AMP  may  be  required  for  switching 
on/off  of  the  different  genes,  therefore  when  the  production 
of  cyclic  AMP  in  the  cell  is  switched  off/on,  other  activities 
are  also  switched  off/on  at  slightly  different  times.  The 
exact  mechanism  involved  in  this  regulation  is  not  known  but 
it  could  be  speculated  as  follows  (Figure  35). 
In  the  X-mode,  there  is  an  unknown  environmental  factor 
which  stimulates  transcription  of  the  adenylate  cyclase 
gene.  Alternatively,  conditions  giving  C-mode  cells, 
actively  inhibit  transcription  of  the  gene.  In  the  presence 
of  adenylate  cyclase,  ATP  in  the  cell  is  converted  to  cyclic 
AMP  and  from  there  on,  the  cyclic  AMP  acts  in  a  way  very 
similar  to  that  in  E.  coli  as  described  by  Pastan  and 
Perlman  (1972).  Briefly,  the  cyclic  AMP  combines  with  a 
cyclic  AMP  receptor  protein  (CRP).  This  combination 
produces  an  allosteric  change  in  the  CRP.  The  cyclic 
AMP-CRP  complex  then  binds  to  the  DNA  at  the  promotor 
region  and  produces  a  change  in  the  DNA  so  that  RNA 
polymerase  can  bind  to  the  DNA.  The  RNA  polymerase  then 
initiates  the  transcription  of  the  virulence  genes, 
resulting  in  the  production  of  the  virulence  proteins 
notably  HA,  HSF,  LPF  and  HLT.  It  is  possible  that 
during  modulation,  some  factor  which  activates  the  adenylate 
cyclase  gene  is  either  absent  or  rendered  inactive  under 218 
Figure  35  Possible  role  of  cyclic  AMP 
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pro-C-mode  conditions.  Also  it  is  possible  that  this 
factor  is  an  inhibitor  which  inhibits  the  adenylate  cyclase 
gene  under  pro-C-mode  conditions.  The  factor  would  appear 
to  be  quite  distinct  from  the  activator  described  by 
Hewlett  et  al.,  (1978).  For  example,  adenylate  cyclase 
activity  can  be  switched  on  or  off  by  alteration  of  ionic 
composition  of  the  medium  although  it  is  possible  that  the 
Hewlett  activator  works  in  conjunction  with  other 
environmental  conditions.  Before  a  firm  conclusion  can  be 
made  concerning  theeroleaofngdenylate_cycläse'in  antigenic 
modulation,  it  will  be  necessary  to  see  if  all  conditions 
which  induce  antigenic  modulation  also  cause  loss  of 
adenylate  cyclase  activity.  It  is  of  interest  to  note  that 
high  nicotinic  acid  levels  which  give  a  C-mode-like  state 
also  cause  loss  of  adenylate  cyclase  activity.  (W.  McPheat, 
personal  communication). 
As  a  further  studybin  antigenic  modulation,  it  would  be 
. of  great  value  to  look  at  the  process  of  modulation  in  a 
continuous  culture  system.  In  a  batch  culture,  modulation 
apparently  ceases  when  growth  ceases  and  therefore  the 
process  may'not  be  complete  when  the  nutrients  run  out  and 
waste  products  of  metabolism  accumulate.  Furthermore,  the 
presence  of  large  numbers  of  dead  cells  and  the  accumulation 
of  the  various  activities  in  the  culture  supernatant  might 
be  complicating  the  actual  picture  of  modulation.  With 
continuous  culture,  a  number  of  variables  could  be  manipulated 
at  will.  These  include  growth  rate  of  the  culture,  the 
concentration  of  magnesium  sulphate  and  other  nutrients  in 220 
the  culture  and  the  cells  could  be  maintained  in  the 
exponential  growth  phase  for  days  or  even  weeks.  The 
continuous  culture  system  would  provide  a  continuous 
supply  of  cells  that  were  both  uniform  and  in  an  optimal 
physiological  state.  By  continual  sampling,  it  would  be 
possible,  under  this  system,  to  monitor  effectively  the 
time  taken  to  achieve  a  steady  state  i.  e.  true  X-mode 
or  true  C-mode,  or  stop  at  intermediate  stages  when  the  cells 
could  have  an  interesting  and  useful  range  of  properties. REFERENCES 221 
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Appendix  1 
Preparation  of  media 
1%  Casamino  acids  solution 
log  casamino  acids  (Difco  technical) 
0.  lg  MgC12.6H20 
0.016g  CaC12 
5g  NaCl 
Dissolve  in  1  litre  of  distilled  water.  Adjust  the 
pH  to  7.0  with  1N  NaOH. 
Bordet-Gengnu  plates 
Autoclave  for  15  min. 
200m1  Bordet-Gengou  agar  bane  (Gibco  Bio- 
Cult  Diagnostics,  Paisley,  Scotland)  melted 
and  cooled  at  450  C. 
2ml  glycerol  (autoclaved) 
40ml  fresh  citrated  horse  blood  (Gibco 
Europe,  Scotland)  warmed  to  37°C 
Add  glycerol  to  the  agar  and  add  the  blood  aseptically. 
Mix  gently  by  rolling  and  pour  into  90mm  diameter,  triple 
vent  plastic  plpeti'i  dishes.  Remove  surface  bubbles  by 
light  flaming.  These  plates  were  stored  in  the  refrigerator 
and  used  within  two  weeks  of  preparation. A2 
Appendix  1  (continued) 
Modified  Hornibrook  medium  (Parton  and  Wardlaw  1975). 
1.  Casamino  acids  (Difco  technical)  100g 
2.  Nicotinamide  (B.  D.  H.,  Poole, 
England)  0.1%  (w/v)  solution  lOmi 
3.  CaC12  (anhydrous)  0.02g 
4.  NaCl  50g 
5.  MgC12.6H20,1%  (w/v)  solution  25m1 
6.  KC1  2g 
7.  K2HPO4,10%  (w/v)  solution  25m1 
8.  Soluble  starch  (B.  D.  H.,  Poole, 
England)  log 
9.  distilled  water  800ml 
10.  glutathione  (Sigma  Chemicals, 
St.  Louis,  U.  S.  A.  )  0.1%  (w/v)  solution  lOml 
Prepare  solutions,  2,5  and  7  fresh  each  time  before  use. 
Dissolve  ingredients  1,3,4  and  6  in  800ml  distilled  water 
and  add  solutions  2,5  and  7.  Suspend  starch  in  25m1  distilled 
water.  Seperately  boil  up  175m1  of  distilled  water  and  add 
starch  suspension  to  it.  Mix  immediately  and  add  to  the  bulk 
medium.  Make  volume  up  to  1  litre  with  distilled  water. 
Bring  pH  to  7.0  with  approximately  0.458  of  Na2CO3.  Dispense 
in  100mi  amount  in  screw  cap  bottles  and  autoclave  at  121°C 
for  15  min.  Store  at  4°C.  This  is  a  10  times  concentrated 
medium. A3 
Appendix  1  (continued) 
When  required  for  use  dispense  the  100ml  concentrate 
into  900m1  of  distilled  water  in  2-litre  dimple  conical 
flasks.  Autoclave  at  121 
0C 
for  15  min.  Immediately 
before  use,  filter  sterilize  0.1%  (w/v)  solution  of 
glutathione  (Sigma  Chemical,  St.  Louis,  U.  S.  A.  )  and  add 
10ml  aseptically  to  each  dimple  flask.  This  is  Hornibrook 
X-medium.  Hornibrook  C-medium  is  prepared  by  replacing 
the  50g  NaCl  with  50g  MgSO4.7H20,  other  ingredients  being 
the-same. 
Stainer  and  Scholte  medium  (Stainer  and  Scholte,  1971). 
1.  L-glutamate  (monosodium  salt) 
(B.  D.  H.,  Poole,  England) 
2.  L-proline  (Sigma  Chemicals, 
St.  Louis,  U.  S.  A.  ) 
3,  NaCl 
4.  KH2P04 
5.  KC1 
6.  MgC12.6H20 
7.  CaCl2 
8.  Trio  (hydroxymethyl-methylamine) 
(Koch  Light  Laboratory,  Colnbrook, 
Bucks.,  England) 
9.  L-cyateine  (B.  D.  H.,  Poole, 
England) 
10.  Fe2S04.7H20 
10.72g 
0.249 
2.5g 
0.5g 
0.2g 
0.  lg 
0.02g 
6.075g 
o.  04g 
0.  Olg A4 
Appendix  1  (continued) 
11.  ascorbic  acid  (B.  D.  H.,  Poole, 
England)  0.02g 
12.  nicotinic  acid  (B.  D.  H.,  Poole, 
England)  0.0048 
13.  glutathione  (Sigma  Chemical, 
St.  Louis,  U.  S.  A.  )  O.  lg 
Dissolve  ingredients  1-8  in  800ml  distilled  water. 
Adjust  pH  to  7.6  with  2.5N  HC1.  Make  up  volume  to  990ml 
with  distilled  water.  Autoclave  at  15  p.  s.  i.  for  15  min. 
Immediately  before  use  dissolve  ingredients  9-13  in 
10mi  distilled  water,  filter  sterilize  with  millipore 
filter  of  0.45µ  pore  size  (Millipore  S.  A.  Molsheim,  France), 
and  add  aseptically  to  bulk  medium.  This  is  Stainer  and 
Scholte  X-medium.  Stainer  and  Scholte  C-medium  is 
prepared  by  replacing  the  2.5g  NaCl  with  5g  MgS04.711  20, 
other  ingredients  being  the  same. A5 
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Preparation  of  miscellaneous  reagents 
Reagents  for  the  Folin  test  for  protein  (Lowry 
modification  by  Herbert,  Phipps  and  Strange,  1971). 
Reagent  A. 
5%  (w/v)  Na2C03  in  distilled  water 
Reagent  B. 
1%  (w/v)  CuSO4.5H20  in  distilled  water 
2%  (w/v)  aqueous  solution  of  sodium 
potassium  tartrate. 
Mix  equal  volumes  of  the  above  two  solutions  and  allow 
the  precipitate  to  settle  before  using  the  supernatant. 
Reagent  C. 
To  50m1  of  reagent  A  add  2m1  of  reagent  B. 
Prepare  immediately  before  use  and  discard 
after  one  day. 
Reagent  D. 
Folin  and  Ciocalteu>>  phenol  reagent  (B.  D.  H., 
Poole,  England) 
Reagent  E. 
Protein  standard  -  1mg/ml  Bovine  serum 
albumin  (Sigma  Chemical  Co.,  St.  Louis,  U.  S.  A.  ). A6 
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Triton-toluene  scintillant 
1.  Triton  X-100  (Sigma  Chemical  Co., 
St.  Louis,  U.  S.  A.  )  1L 
2.  Toluene  (Koch  Light  Laboratories, 
Colnbrook,  Bucks.,  England)  2L 
3.  PPO(Intertechnique,  Uxbridge, 
Middlesex,  England)  8g 
4.  Dimethyl-Popop  (Intertechnique, 
Uxbridge,  Middlesex,  England)  200mg 
Mix  reagents  1  and  2.  Add  reagents  3  and  4  and 
allow  to  dissolve.  Leave  for  at  least  10h  in  the  dark 
before  use. 
0.1M  phosphate  buffer.  pH  7.0 
39m1  of  0.2M  NaH2PO4.2H20 
61m1  of  0.2M  Na2HPO4.  H20 
Mix  and  make  up  volume  to  200m1  with  distilled 
water. A7 
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Slab  and  tube-gel  electrophoresis. 
Stock  solutions 
1.  Acrylamide  solution 
acrylamide  (B.  D.  H.,  Poole,  England)  30g 
NN'-methylenebisacrylamide  (B.  D.  H., 
Poole,  England)  0.8g 
Add  distilled  water  to  100ml.  Filter  and  store  in 
brown  bottle  at  4°C. 
2.  Tris/HC1  buffer.  pH  8.8 
1M  Tris  (hydroxymethyl-methylamine)  50m1 
1N  HC1  8.1ml 
Add  distilled  water  to  100ml 
3.  Tris/HC1  buffer.  pH  6.8 
1M  Tris  (hydroxymethyl-methylamine)  50m1 
1N  HC1  45m1 
Add  distilled  water  to  100mi 
4.  Tris/glycine  buffer.  pH  8.3  (10x  concentrated) 
glycine  144.13g 
Tris  30.28g 
Add  distilled  water  to  1000ml A8 
Appendix  3  (continued) 
5.  Ammonium  persulphate 
0.8%  (w/v)  in  distilled  water 
Sodium  dodecyl  sulphate  (SDS) 
20%  (w/v)  in  distilled  water 
7.  Bromophenol  blue  (B.  D.  H.  Ltd.,  Poole, 
England). 
0.1%  (w/v)  in  distilled  water 
8.  Solubilizing  buffer 
Tris/HC1  (6.8)  2.  Oml 
SDS  3.2m1 
ß-mercaptoethanol  -ri  1.6m1 
glycerol  3.2ml 
Bromophenol  blue  0.32m1 
distilled  water  5.68ml 
Preparation  of  gel  plates 
The  gel  plates  are  prepared  with  glass  plates  (80mm  x  80mm), 
seperated  with  spacers  and  sealed  at  three  sides  with  adhesive 
tapes.  Seal  corners  by  dipping  in  molten  paraffin  wax. A9 
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Preparation  of  seperating  gel  solution 
acrylamide  solution  14.7m1 
Tris/HC1  (8.8)  15.  Oml 
20%  SDS  0.2m1 
N',  N',  N',  N'tetramethyl-ethylenediamine 
(TEMED)  l0µ1 
ammonium  persulphate 
distilled  water 
4.  Oml 
6.  lm1 
Mix  thoroughly  and  pipette  approximately  l4ml  into 
the  gel  plates  standing  vertically  in  a  rack.  Carefully 
overlay  with  5%  (v/v)  ethanol  without  disturbing  the  surface 
of  the  gel.  This  removes  the  meniscus  from  the  gel  and 
leaves  a  perfectly  flat  surface.  Allow  to  polymerise  and 
prepare  stacking  gel  solution. 
Preparation  of  stacking  gel  solution 
acrylamide  solution  1.7rnl 
Tris/HC1  (6.8)  1.25m1 
20%  SDS  0.05m1 
TEMED  2.5µl 
ammonium  persulphate  1.  Om1 
distilled  water  6.  Oml 
Mix  thoroughly  but  without-aöration.  Pour  off  overlay 
solution  from  seperating  gel.  Replace  the  plates  in  the 
rack  and  fill  to  within  3-4mm  of  the  top  with  stacking  gel 
solution.  Suspend  the  sample  ￿combs"  in  the  solution  and A10 
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fill  any  remaining  space  with  gel  solution.  Allow  to 
polymerise  then  remove  the  "combs',  carefully  under  running 
buffer  (Tris/glycine  buffer,  pH  8.  $,  diluted  1  in  10). 
Electrophoresis  conditions 
Dilute  the  Tris/glycine  stock  buffer  1  in  10  and  add 
SDS  to  give  a  final  concentration  of  0.1%  (w/v).  Fill  the 
lower  electrode  tank  with  approximately  2.5L  of  the  diluted 
buffer. 
Remove  the  tape  from  the  base  of  the  gel  plates  and 
insert  into  the  upper  electrode  tank  using  a  liberal  amount 
of  grease  around  the  gaskets  to  prevent  leakage.  Fill  the 
vessel  with  running  buffer  and  then  layer  25-5001  of  samples 
into  the  sample  wells. 
Connect  electrode  unit  to  power  supply  and  run  at  a 
constant  current  of  15mA/gel  for  approximately  21h.  When 
the  tracking  dye  reaches  the  end  of  the  gel,  switch  the 
power  off.  Carefully  remove  the  gels  from  the  plates  and 
immerse  in  fix-staining  solution  for  90  min.  Destain  by 
soaking  in  several  changes  of  destaining  solution. 
Fixing  and  staining  solution 
Coomassie  brilliant  blue  R250  1.25g 
50%  (v/v)  methanol  454m1 
glacial  acetic  acid  46m1 All 
Appendix  3  (continued) 
Destaining  solution 
methanol  50m1 
glacial  acetic  acid  75m1 
distilled  water  875m1 A12 
Appendix  4 
Statistical  Analysis 
Appendix  4a 
Comparison  of  LPF  responses  in 
male  and  female  Ham/ICR  mice 
Logl0  leukocyte  counts  in  individual  animals  after  injection 
with  B.  Pertussis  18334  heated  cell  suspensions. 
Sex  Dose  (ou.  ml) 
0.5  2.0  8.0 
4.3541  4.3180  4.7520 
4.2175  4.0890  4.3838 
Male  4.1523  4.3483  4.5185 
4.3674  4.3464  4.6821 
3.9764  4.1703  4.6553 
T=  21.0675(T  )  21.272(T  )  22.9615(T  ) 
$= 
£  2 
A 
4.2135 
B 
4.2544  C 
4.5923 
X  =88.8730  90.5554  105.5315 
S=  0.1612  0.1178  0.1425 
4.0253  4.0880  4.5944 
3.9794  4.2528  4.2945 
3.8172  4.0943  4.5038 
Female  4.1703  4.0985  4.5145 
4.1460  4.0492  4.5185 
T=  20.138  (TD)  20.583(TE)  22.4255(T  ) 
Xý  4.0276  4.1165 
F 
4.4851 
ýX  =81.1904  84.7551  100.6330 
S-  0.1428  0.0800  0.1131 
T=  sum  of  individual  leukocyte  counts 
X=  mean  leukocyte  count 
XX2  =  sum  of  the  square  of  individual  counts 
S=  standard  deviation A13 
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Interaction  table 
Sex  Dose  (ou.  ml)  Totals 
0.5 
Male  21.0675(TA) 
2.0  8.0 
21.272(TB)  22.9615(TC)  65.301(A+B+C) 
Female  20.138(TD)  20.583(TE)  22.4255(TF)  63.1465(D+E+F) 
Totals  41.2055(A+D)  41.855(B+E)  45.387(C+F) 
Analysis  of  variance 
Source  of 
variation 
Degrees  of  Corrected  variance  F- 
freedom  sum  of  or  ratio 
squares  mean  square 
Probability 
level 
2 
Total  -  CF  29  EX 
=  1.5784  1--  - 
Groups  5  ET2  -  CF 
5=1.1740  2-- 
Sex  1  (A+B+C)2+(D+E+F)2_CF  0.1509  8.93  <.  a% 
15 
=  0.1509  3 
Dose  2  (A+D)2+(B+E)2+(C+F)2 
-CF0.5057  29.923  1% 
10 
_  1.0114  4 
Interaction 
between  sex  22-3-40.0059  0.349  NS 
and  dose  0.0117  5 
Residual  24  1-2 
=  0.4044  6  0.0169  -- 
CF  =  Correction  factor  -  (LX)2/N  -  549.96 
N=  total  number  of  observations  =  30 A14 
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Tabulated  F-  value  for  degrees  of  freedom  (2,24) 
=  3.40  (P  =  0.05) 
=  5.61  (P  =  0.01) 
«  1%  =  there  is  a  highly  significant 
difference  (at  the  1%  probability 
level) 
NS  =  No  significant  difference 
(at  5%  probability  level). 
i A15 
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Comparison  of  the  effect  of  route 
of  inoculation  on  LPF  response 
Log  leukocyte  counts  in  individual  animals  after  injection 
with  B.  pertussis  1$334  heated  whole  culture 
Route  Dose  (ml) 
0  0.025 
4.2307  4.3178 
4.1298  4.2693 
Intravenous  3.9409  3.9911 
4.1298  4.2144 
4.0713  4.2197 
0.05  0.1 
4.2249  4.3717 
4.1899  4.5001 
4.2714  4.4974 
4.2300  4.3547 
4.3198  4.4974 
T  =20.5025  21.0122 
X=4.1005  4.2024 
LX2  =84.1150  88.3654 
s=0.1061  0.1254 
21.2360  22.2213 
4.2472  4.4443 
90.2035  98.7793 
0.0498  0.0742 
4.1330  4.1200  4.1101  4.2023 
4.0447  4.0287  4.0368  4.2235 
3.8509  3.9630  4.0786  4.0910 
Intraperitoneal  4.0563  4.1134  4.3072  4.2183 
4.0079  4.1756  4.2118  4.2022 
T  =20.0928  20.4007  20.7445  20.9364 
X  =  4.0186  4.0801  4.1489  4.1873 
£X2  =80.7876  83.2659  86.1149  87.6787 
S  0.1042  0.0839  0.1096  0.0548 
Student  t-test 
Calculated  mean  value  for  control  groups  =  4.06 
Calculated  standard  deviation  w  0.1100 
For  the  mean  (X)  of  a  test  group  to  differ  from 
control,  it  should  lie  outside  4.06  +  0.11  -  3.95  and  4.17 
X  values  were  inspected  for  each  group  and  scored  as 
S=  significantly  or  NS  =  not  significantly  different A16 
Appendix  4b  (continued) 
Route  Significance  of  differences  in 
X  values  of  test  groups  and  control 
at  doses  tested 
0.025(ml)  0.05(ml)  0.1(m].  ) 
Intravenous  SS 
Intraperitoneal  NS  NS  NS A17 
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Comparison  of  the  effect  of  strain  and 
age  of  mouse  on  LPF  response 
Log10  leukocyte  counts  in  individual  animals  after  injection 
with  B.  pertussis  18334  heated  cell  suspensions 
Strain  Age  of  mice 
5  week  old  8  week  old 
4.5634  4.7621 
4.8201  4.4986 
Ham/ICR  4.7250  4.6630 
4.8597  4.7899 
4,8260  4.6611 
T=  23.794(TA)  23.3345(Tß) 
X=  4.7588  4.6669 
ZX2  =  113.29  108.96 
S=  0.12  0.11 
4.72 
4.76 
NIH  4.66 
4.75 
4.87 
4.67 
4.58 
4.63 
4.77 
4.67 
T  =  23.76(TC)  23.32(TD) 
X  =  4.7520  4.6640 
LX2  =  112.93  108.78 
S  =  0.08  0.06 
Interaction  table 
Strain  Age  of  mice  Totals 
5  week  old  8  week  old 
Ham/ICR  23.794(TA)  23.3345(TB)  47.1285(A+B) 
NIH  23.76(TC)  23.32(TD)  47.08(C+D) 
Totals  47.554(A+C)  46.6545(B+D) Al 
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Analysis  of  variance 
Source  of 
variation 
Degrees 
freedom 
of  Corrected  sum  Variance 
of  squares  or 
mean  square 
F- 
ratio 
Probability 
level 
Total  19  XX2 
-  CF 
=  0.02  1 
Groups  LT2  -  CF 
5=0.0426 
2 
Strain  1  (A+B)2+(C+D)2_  CF  0  0  NS 
10 
=03 
Age  1  (A+C)2+(B+D)2 
-  CF  0.0425  4.336  NS  1 14 
10  jY 
=  0.0425  4 
Interaction 
between  1  2  -ý  3-4  0.0001  0.01  NS 
Age  and  Strain  =  0.0001  5 
Residual  16  1-2=0.1574  6  0.0098  -  - 
CF  =  correction  factor  =  (EX)2/N  =  443.76 
N  =  total  number  of  observations  =  20 
Tabulated  F-values  for  degrees  of  freedom  (1,19) 
_  4.38  (P  =  0.05) 
8.18  (P  =  0.01) 
NS  =  no  significant  difference  (at  5%  probability  level). Appendix  4d 
Statistical  distribution  of 
leukocyte  count 
Bartlett  test  for  homogeneity  of  variances  - 
arithmetic  leukocyte  count 
Number  of  groups  of  counts  =a=3 
Number  of  degrees  of  freedom  within  each 
group  =f=  19 
A19 
Calculate  C=1+ 
3a+l) 
_  (1  + 
3x3x19 
=  1.02339) 
Group  Standard 
deviation(S) 
variance 
(S2) 
Log10  of  variance 
(Log  S2 
10 
) 
1  14661  214944921  8.3323 
2  10093  101868649  8.0080 
3  5500  30250000  7.4807 
2 
ES  2=  347063570  £log10S2=  23.821  =A 
Log10 
IS  /a 
=  Log  347033570 
=  Log10  115687856.7 
10 
=  8.0633 
aLog10  182/a  =-3  x  8.0633  =  24.1899  =B 
Calculate  M/C  =  (B-A)  2.3026f/c 
=  24.1899  -  23.821  x  2.3026  x  19 
1.02339 
=  15.77 
Yt 
i} 
.4 
rý  P 
iý 
kt 
i' A20 
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Degrees  of  freedom  associated  with  M/C  =  (a-1) 
=  (3-1)  =2 
Tabulated  chi-square  values  at  2  degrees  of  freedom 
=  5.99  (P  =  0.05) 
9.21  (P  =  0.01) 
Calculated  M/C  value  of  15.77  is  greater  than  9.21, 
thus  at  1%  probability  level,  the  variances  between 
groups  are  highly  heterogeneous. 
Bartletts  test  for  homogeneity  of  variances  - 
Log}  leukocyte  counts 
Number  of  groups  of  counts  =a=3 
Number  of  degrees  of  freedom  with  inaelac,  hr-grPup 
=  If  =  19 
Calculate  C=1+ 
(a+l 
=  (1  + 
(3+1) 
=  1.02339) 
'2  ýP 
3x3x19 
,P  Ql 
Group  Standard  Variance  Log  of  variance 
deviation  (5)  (S2) 
10 
(log  52  10 
) 
1  0.114  0.012996  -1.8862 
2  0.14  0.0196  -1.7077 
3  0.135  0.018225  -1.7393 
i.  52=  0.050821  11og  S2=  -5.3333  =A  10  , A21 
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Log10  XS2/a  =  Log10 
0.050821 
=  Log10  0.01694 
=  -1.7711 
a  log10  IS2/a  =3x  -1.7711  =  -5.3132  =B 
Calculate  M/C  =  (B-A)  2.3026f/c 
_  (-5.3132  -  5.3333)  x  2.3026  x  19 
1.02339 
=  0.29 
Degrees  of  freedom  associated  with  M/C  =  (a-i) 
_  (3-1)  =2 
Tabulated  chi-square  values  at  2  degrees  of  freedom 
=  5.99  (P  =  0.05) 
9.21  (P  =  0.01) 
Calculated  M/C  value  of  0.29  is  less  than  5.99, 
thus  at  5%  probability  level,  the  variances  between 
groups  had  a  satisfactory  degree  of  homogeneity. 
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Appendix  4e 
Estimation  of  LPF  potency 
4-point  assay 
Tabulation  of  Log,  individual  counts  in  relation  to  dose 
X-mode  (10h  cell  suspension)  C-mode  (10h  cell  suspension) 
Low  dose  High  dose  Low  dose  High  dose 
4.4180  4.4378  4.2250  4.3666 
4.2090  4.4941  4.1299  4.2057 
4.4310  4.6305  4.1395  4.2891 
4.4437  4.5416  4.0248  4.2846 
4.2063  4.4378  3.9692  4.4041 
Results  of  analysis  of  variance 
Tabulated  F-  values  at  1,24  degrees  of  freedom 
_  4.26  (P  =  0.05) 
7.82  (P  =  0.01) 
Calculated  F-  values 
Source  of  Degrees  of  F-ratio  Probability 
variation  freedom  values 
Between 
preparations  1  26.3  <<  1% 
Slope  1  19.3  <<  1% 
Parallelism  1  0.28  NS(>  5%) 
Residual  12  -- 
Though  there  was  a  highly  significant  difference  between 
potency  of  preparations,  there  was  no  significant  difference 
in  parallelism.  Thus,  the  application  of  the  4-point  assay 
was  valid. A23 
Appendix  4f 
Estimation  of  LPF  potency 
6-point  assay 
Tabulation  of  individual  Logl0  leukocyte  count  in  relation  to 
dose 
X-mode  (l0h  cell  suspensions)  X-mode  (48h  cell  suspensions) 
Low  Medium  High  Low  Medium  High 
dose  dose  dose  dose  dose-'  dose 
4.2118  4.4919  4.5870  4.0618  4.2595  5.3495 
4.0080  4.2340  4.5084  3.9570  4.4310  4.5271 
4.0677  4.5124  4.8472  4.0693  4.3669  4.7361 
3.9742  4.2238  4.4630  4.0580  4.2940  4.7072 
3.9615  4.3810  4.6216  4.0909  4.5795  4.5546 
Results  of  analysis  of  variance 
Tabulated  F-values  at  1,2  degrees  of  freedom 
_  4.26  (P  =  0.05) 
7.82  (P  =  0.01) 
Calculated  F-values 
Source  of  F-ratio  Probability 
variation  values 
Between  preparations  0.0051  NS  (>  5%) 
Slope  94.9025  <<  1% 
Parallelism  0.0884  NS  (>  5%) 
Quadratics  1.5025  NS  (>  5%) 
Difference  in  0.1051  NS  (>  5%) 
quadratics A24 
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Appendix  4f  (continued) 
There  was  no  significant  difference  between  the 
potencies  and  parallelism  of  both  preparations  thus  the  use 
of  the  6-point  assay  was  valid. 
Tabulation  of  individual  Log,,  leukocyte  counts  in 
relation  to  dose 
X-mode  (10h  cell  suspensions)  C-mode  (10h  cell  suspensions) 
Low  Medium  High  Low  Medium  High 
dose  dose  dose  dose  dose  dose 
4.2118  4.4919  4.5870  3.9524  4.0447  3.9298 
4.0080  4.2340  4.5084  4.1911  4.1698  4.0195 
4.0677  4.5124  4.8472  4.0618  3.9132  4.0111 
3.9742  4.2238  4.4630  3.7683  3.9745  4.0813 
3.9615  4.3810  4.6216  4.1967  4.1871  3.9442 
Results  of  analysis  of  variance 
Tabulated  F-values  at  1,24  degrees  of  freedom 
=  4.26  (P  =  0.05) 
7.82  (P  =  0.01) 
Calculated  F-values 
Source  of 
variation 
F-ratio 
values 
Probability 
Between  preparations  42.6106  <<  1% 
Slope  20.3017  <<  1% 
Parallelism  26.4213  <<  1% 
Quadratics  0.7254  >  5%  (NS) 
Difference  in 
quadratics  0.0000  >  5%  (NS) 
ý' A25 
Appendix  4f  (continued) 
There  was  ahighly  significant  difference  between  the 
potencies  and  parallelism  of  the  two  preparations.  The 
application  of  the  6-point  assay  was  therefore  invalid. 71  A26 
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Appendix  4g' 
METHOD  FOR  COMBINING  THE  RESULTS  OF 
SEVERAL  INDEPENDENT  ASSAYS 
To  illustrate  the  procedure  used  to  combine  the  results 
of  two  or  more  HSF  or  MPT  assays  take  the  following  two  sets 
of  results.  The  blocked-in  figures  are  the  values  taken  for 
combining. 
RUN  1 
DOSE  LOG  DOSE  TESTED  RESPONDING 
STDl  1.000000  0.0  20  2. 
0.250DOO  -0.6021  20.  7. 
0.062500  -1.2041  19.  8. 
932A.  1.000000  0.0  19.  0.  4 
0.250000  -0.6021  20.  1.  1 
0.062500  -1.2041  20.  5. 
RE  L  POT  95  PC  LIMITS  ED50  SLOPE  LOG  R  WLOGR  OGED50  WLED5C 
STD1  0.07  -0.84  -1.185  2.7 
932A  6.338  1.761111.544  0.01  -1.55  0.802  1.2  -1.987  0.7 
RUN  2 
1 
DOSE  LOG  DOSE  TESTED  RESPONDING 
STD2  1.000000  0.0  19.  4. 
0.250000  -0.6021  20.  12. 
0.062500  -1.2041  20.  20. 
932D  1.000000  0.0  19.  1. 
0.250000  -0.6021  19.  6. 
0.062500  -1.2041  20.  13. 
REL  POT  95  PC  LIMITS  ED50  SLOPE  LOG  R  WLOGR  LOGED50  WLED5( 
STD2  0.41  -2.29  -0.390  22.8 
932D  3.349  1.761  7.218  0.12  -1.58  0.525  10.7  -0.915  21.41, 
:. A27 
Appendix  4g  (continued) 
Estimation  'of  R 
The  combined  estimate  of  Relative  Potency  (R)  is  given 
by  log  R  7-(Wlog  R  log  R) 
I  W1og  R 
_  (1 
.  2)  (0.802)  +  . 
(10.7)(0.525) 
1.2  +  10.7 
=  0.553 
:.  R=3.57 
Note  how  the  effect  of  the  much  higher  weight  of  Run  2  causes 
to  be  much  closer  to  the  R=3.35  of  Run  2  than  to  the 
R=6.34  of  Run  1. 
Estimation  of  95%  Confidence  Limits 
Note  that  the  computer  print  out  for  'tWLOGR'"  incorporates 
the  Student  term  't'. 
i.  e.  "WLOGR't  =  1/(ts)2 
Thus  there  is  no  t  factor  in  the  expression  for  the  limits 
because  it  is  already  present  in  the  weight. Appendix  4g  (continued) 
Limits  =  Antilog 
=  Antilog 
=  Antilog 
log  R+  1/  IW1ogR 
0.553  +  1/  1.2  +  10.7 
0.553  +  0.2904 
=  Antilog  0.262  and  0.843 
A28 
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Appendix  5 
Mouse  protection  test  'data 
Sample  Dose  per  mouse 
(ou.  ml) 
Number  of  survivors/number  challenged 
in  four  similar  experiments 
1  2  3  4 
X-mode  cells  2.5  9/10  -  -  - 
(10h)  0.5  9/9  8/10  8/10  7/10 
0.1  7/10  4/10  5/10  4/10 
0.02  -  3/10  3/10  3/10 
X-mode  cells  2.5  10/10 
(48h)  0.5  9/10  9/10  9/10  8/10 
0.1  8/10  6/10  6/10  5/10 
0.02  3/10  2/10  2/10 
C-mode  cells  12.5  8/10  6/10  7/10  6/10 
(10h)  2.5  5/10  3/10  3/10  3/10 
0.5  4/10  2/10  2/10  1/10 
C-mode  cells  25.0  6/10  5/7  6/8  5/10 
(48h)  5.0  3/10  4/10  4/10  3/10 
1.0  2/10  1/10  1/10  0/10 
Control 
Dilution  4 
ti  i  5 
105org/ml 
/  l  4 
2/10 
/10 
0/10 
1/10 
1/10 
2/1 
0/10 
2/10  on  lu  D  org  m  10  3  0 
Dilution  6  2000org/ml  5/10  3/10  5/10  4/10 
Dilution  7  400org/ml  7/10  7/10  7/10  7/10 
No.  of  LD50 
(Dilution  4)  0.03ml  50  110  50  70 
Viable  count 
per  ml 
(Dilution  4)  8.5x10  4.1xlO  3.2x10  3.5x109 
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Appendix  6 
Mouse  weight-gain  test  data 
Sample  Dose  (ou.  ml)  Weight  change  (in  grams)per  mouse 
Day  1  Day  2  Day  4  Day  7 
X-mode  cells  (10h)  10  -1.67  -0.88  +1.44  +2.68 
X-mode  cells  (24h)  10  -2.21  -1.04  +0.95  +2.39 
X-mode  cells  (48h)  10  -2.44  -1.31  +0.86  +2.88 
X-mode  cells  (72h)  10  -2.0  -1.15  +0.81  +3.82 
C-mode  cells  (10h)  10  -1.29  -0.13  +2.12  +3.56 
C-mode  cells  (24h)  10  -1.08  -0.28  +2.83  +5.91 
C-mode  cells  (48h)  10  -1.36  -0.11  +2.57  +6.56 
C-mode  cells  (72h)  10  -1.14  -0.28  +2.63  46.60 
Saline  -  +1.8  +2.4  +4.25  +8.65 
Uninoculated  -  +2.21  +3.7  +5.14  +9.07 
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Appendix  7 
Leukocyte  counts  obtained  during 
X-*C  and  C-ºX  modulation 
Sample  Mean  arithmetic  Log10  count  Mean  Log  count 
count  per  mouse  (+  Standard  deviation) 
36440  4.5616  4.5178 
x-ºX  27340  4.4368 
35140  4.5458  (+  0.06) 
33640  4.5268 
13655  4.1353  4.0712 
x-  00.  c  10255  4.0109 
12555  4.0988  (+0.0563) 
10955  4.0396 
10855  4.0356  3.9858 
C  -ºC 
10355  4.0152 
6218  3.7937  (_+  0.13) 
12555  4.0988 
24855  4.3954  4.3463 
C-*X  22955  4.3609 
16855  4.2267  (+  0.08) 
25255  4.4023 
7157  3.8547  3.6633 
Saline  4873  3.6878 
(Control)  3148  3.4980  (+  0.15) 
4097  3.6125 
i> 
ý 
k 